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ABSTRACT
As reuse of municipal water resource recovery facility (WRRF) effluent becomes vital to
augment diminishing fresh drinking water resources, concern exists that conventional barriers
may prove deficient and the upcycling of contaminants of emerging concern (CECs) could prove
harmful to human health and aquatic species if more effective and robust treatment barriers are
not in place.
There are no federal Safe Drinking Water Act (SDWA) regulations in place specifically
for direct potable reuse (DPR) of WRRF effluent. Out of necessity, some states are developing
their own DPR reuse regulations. Currently, reverse osmosis (RO) is the default full advanced
treatment (FAT) barrier for CEC control. However, the potential exists for tight thin-film
composite (TFC) nanofiltration (NF) membranes to provide acceptable CEC rejection efficacies
for less capital, operations and maintenance (O&M), energy, and waste generated.
Recognizing the inherent complexity of CEC rejection by membranes, this research
program was designed to elucidate the vital predictive variables influencing the rejection of 96
CECs found in municipal WRRF effluents. Each of the CECs was cataloged by their intended
use and quantitative structure activity relationship (QSAR) properties, and measured in
secondary effluent samples from WRRFs in Texas and Oklahoma. These secondary effluent
samples were then processed in bench-scale, stirred, dead-end pressure cells with water treatment
industry-specified TFC NF and RO membranes.
A multi-level, multi-variable model was developed to predict the probable rejection
coefficients of CECs with the studied NF membrane. The model was developed from variables
selected for their association with known membrane rejection mechanisms, CEC-specific QSAR
properties, and characteristics of the actual solute matrix. R statistics software version 3.1.3 was

utilized for property collinearity analysis, outlier analysis, and regression modeling. The Pearson
correlation method was utilized for selection of the most vital predictor variables for modeling.
The resulting Quantitative Molecular Properties Model (QMPM) predicted the NF rejection
CECs based on size, ionic charge, and hydrophobicity. Furthermore, the QMPM was verified
against a CEC rejection dataset published by an independent study for a similar commercially
available TFC NF membrane.

© 2016 by Steven Michael Jones
All Rights Reserved

ACKNOWLEDGEMENTS
First and foremost, I acknowledge my Lord and Savior, Jesus Christ, for allowing me the
aptitude and perseverance to complete this doctorate endeavor.
Thank you to my research partners and the many great folks at the City of Norman, City
of Garland, City of Lawton, GE Osmonics, and Eurofins Eaton Analytical. Much gratitude to
you for sharing my vision for this research. You were all a pleasure to work with.
Thanks to Dr. Kevin Hall, Dr. Ranil Wickramasinghe, Dr. Findlay Edwards, and Bob
Haslam for their guidance, patience, and commitment to see me through my program. Thank you
to Dr. David Sabatini for your confidence in me as a PhD candidate.
Many thanks to my partners and staff at Garver for their vision, support, and
encouragement throughout my doctoral program. This endeavor would not have been possible
without the extraordinary people at Garver. I am truly blessed to be a Garver Engineer.
Specifically, thanks to Dr. Michael Watts and Dr. Zaid Chowdhury for the manuscript peer
review. And, thanks to Diane Barton and Leona Shoemaker for your tireless editing and
formatting assistance.
Very special gratitude to my wife, Angela, and children, Mary Zada, Anna, and Zachary,
for their unconditional support and tolerance of me while I took the time necessary to complete
this task.

TABLE OF CONTENTS
CHAPTER 1 - INTRODUCTION .................................................................................................. 1
CHAPTER 2 - LITERATURE REVIEW ....................................................................................... 6
2.1

2.2

2.3

2.4

2.5

Potable Reuse ................................................................................................................ 6
2.1.1

Applications .................................................................................................... 6

2.1.2

Concern with DPR ........................................................................................ 10

CEC Occurrence ......................................................................................................... 11
2.2.1

Origin and Intended Use ............................................................................... 11

2.2.2

Occurrence in WRRF Effluents .................................................................... 13

Human Health Criterion .............................................................................................. 17
2.3.1

Epidemiology ................................................................................................ 17

2.3.2

Toxicology .................................................................................................... 17

2.3.3

Suggested CEC Criterion .............................................................................. 18

CEC Regulatory Framework for DPR ........................................................................ 19
2.4.1

Federal Framework ....................................................................................... 20

2.4.2

State Framework ........................................................................................... 22

2.4.3

CEC Regulatory Summary ............................................................................ 30

Best Available Technology for CEC Control ............................................................. 32
2.5.1

Regulatory BAT ............................................................................................ 32

2.5.2

Industry BAT................................................................................................. 32

2.5.3

Membrane Classification............................................................................... 33

2.6

NF Advantages over RO ............................................................................................. 37

2.7

Reported CEC Removal .............................................................................................. 39

2.8

2.9

2.7.1

Degradation and Sorption by WRRF ............................................................ 39

2.7.2

Rejection by NF and RO ............................................................................... 43

NF Membrane Rejection Theory ................................................................................ 49
2.8.1

Physiochemical Properties of CECs (QSAR) ............................................... 49

2.8.2

Rejection Mechanisms .................................................................................. 53

NF Membrane Rejection Modeling ............................................................................ 62

2.10 Needed Study .............................................................................................................. 69
CHAPTER 3 - METHODS........................................................................................................... 71
3.1

Overview ..................................................................................................................... 71

3.2

WRRF Descriptions .................................................................................................... 72

3.3

3.2.1

North Texas (NTX) WRRF ........................................................................... 72

3.2.2

Southwest Oklahoma (SOK) WRRF............................................................. 73

3.2.3

Central Oklahoma (COK) WRRF ................................................................. 74

3.2.4

WRRF Operational Data ............................................................................... 75

Sampling Program ...................................................................................................... 76
3.3.1

Sampling Schedule and Target Conditions ................................................... 76

3.3.2

WRRF Sampling Locations .......................................................................... 77

3.3.3
3.4

3.5

3.6

Sample Collection, Preservation, and Handling............................................ 80

Bench Scale Testing .................................................................................................... 82
3.4.1

Test Apparatus............................................................................................... 82

3.4.2

Membrane Properties .................................................................................... 85

3.4.3

Membrane Testing Protocol .......................................................................... 86

Analytics ..................................................................................................................... 88
3.5.1

Laboratory ..................................................................................................... 88

3.5.2

Analytical Methods and Equipment .............................................................. 88

3.5.3

Minimum Reportable Levels ......................................................................... 89

Data Analysis .............................................................................................................. 91

CHAPTER 4 - RESULTS AND MODELING............................................................................. 92
4.1

Overview ..................................................................................................................... 92

4.2

QSAR Properties Characterization ............................................................................. 93
4.2.1

Endocrine Disrupting Compounds ................................................................ 93

4.2.2

Pharmaceuticals ............................................................................................. 95

4.2.3

Stimulants ...................................................................................................... 99

4.2.4

Preservatives................................................................................................ 100

4.2.5

Artificial Sweeteners ................................................................................... 101

4.2.6

Pesticides ..................................................................................................... 101

4.2.7

Flame Retardants ......................................................................................... 102

4.3

4.4

4.5

Rejection Analysis .................................................................................................... 103
4.3.1

Observed Rejection ..................................................................................... 105

4.3.2

NF Rejection Coefficient Outliers............................................................... 113

Nanofiltration Rejection Model ................................................................................ 115
4.4.1

Pearson Correlation Analysis ...................................................................... 115

4.4.2

Model Predictor Variables .......................................................................... 119

4.4.3

NF Rejection Model .................................................................................... 125

4.4.4

Model Validation......................................................................................... 128

Model Verification .................................................................................................... 129

CHAPTER 5 - CONCLUSIONS AND FUTURE WORK ........................................................ 134
5.1

Rejection Conclusions .............................................................................................. 134

5.2

Modeling Conclusions .............................................................................................. 138

5.3

Future Work .............................................................................................................. 141

REFERENCES ........................................................................................................................... 144
APPENDIX A ............................................................................................................................. 158
APPENDIX B ............................................................................................................................. 163
APPENDIX C ............................................................................................................................. 190

LIST OF FIGURES
Figure 1-1: Big Spring, Texas, Direct Potable Reuse Facility (commissioned in 2013) .................3
Figure 2-1: Full-Scale Operating Direct Potable Reuse Treatment Trains ......................................9
Figure 2-2: Membrane Filtration Spectrum ...................................................................................34
Figure 3-1: NTX PFD ....................................................................................................................73
Figure 3-2: SOK PFD ....................................................................................................................74
Figure 3-3: COK PFD ....................................................................................................................75
Figure 3-4: NTX WRRF Site Aerial ..............................................................................................77
Figure 3-5: SOK WRRF Site Aerial ..............................................................................................78
Figure 3-6: COK WRRF Site Aerial ..............................................................................................79
Figure 3-7: Membrane Bench Test Apparatus – Schematic ..........................................................83
Figure 3-8: Membrane Bench Test Apparatus – As Tested ...........................................................84
Figure 4-1: Pearson Correlation Matrix for QSAR Properties of the Examined CECs...............117
Figure 4-2: MW versus Observed Rejection ...............................................................................119
Figure 4-3: Surface Charge Density versus Observed Rejection.................................................121
Figure 4-4: Frequency Distribution of NF Rejected Negative CECs ..........................................122
Figure 4-5: Frequency Distribution of NF Rejected Positive CECs ............................................123
Figure 4-6: NF Rejection as a Function of log (Kow/Kaw)............................................................124
Figure 4-7: Quantitative Molecular Properties Model .................................................................126
Figure 4-8: Distribution of Bin 4 CEC Rejection Coefficients ...................................................127
Figure 4-9: Observed (mean) Rejection for 10 Bin 4 CECs vs. Model Predicted .......................129

Figure 4-10: Observed Bin 4 CEC rejection (by NF) versus model-predicted CEC rejection for
Yangali-Quintanilla (2010) data set. Red dashed lines depict upper and lower 95% confidence
intervals on the regression line. ...................................................................................................131
Figure 5-1: NF Quantitative Molecular Properties Model (QMPM) ...........................................139
Figure 5-2: Bin Classification of Norman 96 ..............................................................................140

LIST OF TABLES
Table 2-1: CEC Intended Use Characterization.............................................................................12
Table 2-2: CEC Occurrence in Wastewater Effluent .....................................................................13
Table 2-3: Norman 96 Survey in WWRF Secondary Effluent ......................................................16
Table 2-4: NWRI Risk-Based Human Health Criterion ................................................................19
Table 2-5: CEC MCLs – NPDWR.................................................................................................21
Table 2-6: California CEC Monitoring List for DPR ....................................................................24
Table 2-7: Texas CEC List for DPR Systems ................................................................................27
Table 2-8: State Regulatory Summary for CEC Control ...............................................................31
Table 2-9: Membrane Classifications for Water Treatment ..........................................................35
Table 2-10: CEC Removal by WWRF Secondary Treatment .......................................................42
Table 2-11: Bench-Scale CEC Rejection by NF Membranes ........................................................44
Table 2-12: Pilot-Scale CEC Rejection by RO ..............................................................................45
Table 2-13: Full-Scale CEC Rejection by MF/RO Series Membranes .........................................46
Table 2-14: CEC Rejection Demonstration by NF and RO Membranes .......................................47
Table 2-15: Full-Scale CEC Rejection by RO Membranes ...........................................................48
Table 2-16: NF/RO Models for Predicting Solute Rejection.........................................................63
Table 3-1: Sample Shipping List ...................................................................................................82
Table 3-2: Test Apparatus Specifications ......................................................................................84
Table 3-3: Test Membrane Properties............................................................................................86
Table 3-4: Bench-Scale Batch Process Operating Sequence .........................................................87
Table 3-5: CEC Test Suite Analytical Mode and Minimum Reportable Level .............................90
Table 4-1: EDC QSAR Properties .................................................................................................95

Table 4-2a: Pharmaceuticals (neutral charge) QSAR Properties ...................................................97
Table 4-2b: Pharmaceuticals (positive charge) QSAR Properties .................................................98
Table 4-2c: Pharmaceuticals (negative charge) QSAR Properties ................................................99
Table 4-3: Stimulants QSAR Properties ......................................................................................100
Table 4-4: Preservatives QSAR Properties ..................................................................................100
Table 4-5: Artificial Sweeteners QSAR Properties .....................................................................101
Table 4-6: Pesticides QSAR Properties .......................................................................................102
Table 4-7: Flame Retardants QSAR Properties ...........................................................................103
Table 4-8: CEC Detections ..........................................................................................................104
Table 4-9: EDC Rejection ............................................................................................................106
Table 4-10a: Pharmaceuticals (neutral) Rejection .......................................................................107
Table 4-10b: Pharmaceuticals (positive) Rejection .....................................................................108
Table 4-10c: Pharmaceuticals (negative) Rejection ....................................................................109
Table 4-11: Stimulants Rejection.................................................................................................110
Table 4-12: Preservatives Rejection ............................................................................................111
Table 4-13: Artificial Sweeteners Rejection ................................................................................111
Table 4-14: Flame Retardants Rejection......................................................................................112
Table 4-15: Pesticides Rejection ..................................................................................................113
Table 4-16: Identified Outliers for Observed NF Rejection of CECs .........................................114
Table 4-17: QSAR Properties Tested for Predicting the Rejection of CECs by NF ...................116
Table 4-18: Summary Statistics for Bin 4 Equation ....................................................................128
Table 5-1: Human Health Criterion Factor of Safety with NF ....................................................135

LIST OF ABBREVIATIONS
ACS

American Chemical Society

ADEQ

Arizona Department of Environmental Quality

ADWR

Arizona Department of Water Resources

AFM

Atomic Force Microscopy

ANN

Artificial Neural Network

AOP

Advanced Oxidation Process

AS

Activated Sludge

AWT

Advanced Water Treatment

AWWA

American Water Works Association

ASR

Aquifer Storage and Recovery

BAT

Best Alternative Treatment

BNR

Biological Nutrient Removal

BOD

Biochemical Oxygen Demand

BOR

United States Bureau of Reclamation

CAS

Chemical Abstracts Service

CASN

Chemical Abstracts Service Number

cBOD

Carbonaceous Biochemical Oxygen Demand

CCL

Contaminate Candidate List

CDPH

California Department of Public Health

CEC

Contaminants of Emerging Concern

COK

Central Oklahoma

CWRCB

California Water Resources Control Board

DOS

Dissolved Organic Carbon

DPR

Direct Potable Reuse

DSP

Donan Steric Pore

EDC

Endocrine Disrupting Compound

EEA

Eurofins Eaton Analytical

EfOM

Effluent Organic Matter

EPA

United States Environmental Protection Agency

ESI

Electrospray Ionization

F:M

Food to Microorganism

FAT

Full Advanced Treatment

FDEP

Florida Department of Environmental Protection

FOS

Factor of Safety

GAC

Granulated Activated Carbon

GEPD

Georgia Environmental Protection Division

HB-I

Hydrophobic Ionic

HB-N

Hydrophobic Neutral

HL-I

Hydrophilic Ionic

HL-N

Hydrophilic Neutral

HP

High Pressure

IPR

Indirect Potable Reuse

ISE

Iterative Stepwise Elimination

Koa

Octanol-Air Partition Coefficient

Kow

Octanol-Water Partition Coefficient

LP

Low Pressure

LPRO

Low-Pressure Reverse Osmosis

LS-MS-MS

Liquid Chromatograph Separation and Series Mass Spectrometry

MAST

Membrane Applied Science and Technology

MCL

Maximum Contaminant Level

MCLG

Maximum Contaminant Level Goal

MDH

Minnesota Department of Health

MF

Microfiltration

MGD

Million Gallons per Day

MLSS

Mixed Liquor Suspended Solids

MOR

Monthly Operating Report

MOS

Membrane Operating System

MPCA

Minnesota Pollution Control Association

MRL

Minimum Reportable Level

MSA

Molecular Surface Area

MW

Molecular Weight

MWCO

Molecular Weight Cutoff

NCOD

National Contaminant Occurrence Database

NF

Nanofiltration

NMED

New Mexico Environmental Department

NOM

Natural Organic Matter

NPDES

National Primary Discharge Elimination System

NPDWR

National Primary Drinking Water Regulations

NSF

National Science Foundation

NTX

North Texas

NWRI

National Water Research Institute

O&M

Operations and Maintenance

ODEQ

Oklahoma Department of Environmental Quality

OPDES

Oklahoma Pollutant Discharge Elimination System

OWRB

Oklahoma Water Resources Board

PFD

Process Flow Diagram

PFA

Perfluorinated

pKa

Acid Dissociation Constant

PPCP

Pharmaceuticals and Personal Care Product

PSA

Polar Surface Area

PSO

Public Service Company of Oklahoma

PTFE

Polytetrafluoroetheylene

PWS

Public Water Supply

QMPM

Quantitative Molecular Properties Model

QSAR

Quantitative Structure Activity Relationship

R

Rejection

RO

Reverse Osmosis

RWC

Recycled Water Contribution

SASA

Solvent Accessible Surface Area

SE

Secondary Effluent

SIU

Significant Industrial Users

SK

Spiegler-Kedem

SOK

Southwest Oklahoma

SOP

Standard Operation Procedure

SRT

Solids Retention Time

Sw

Solubility

SDWA

Safe Drinking Water Act

SWS

Sensitive Water Supply

SWS-R

Sensitive Water Supply-Reuse

SIU

Significant Industrial Users

TCEP

Tris-2-chloroethyl Phosphate

TCEQ

Texas Commission on Environmental Quality

TDS

Total Dissolved Solids

TF

Trickling Filter

TFC

Thin-film Composite

TMP

Transmembrane Pressure

TOC

Total Organic Carbon

TPDES

Texas Pollutant Discharge Elimination System

TSCA

Toxic Substances Control Act

TSS

Total Suspended Solids

TWDB

Texas Water Development Board

UCMR

Unregulated Contaminant Monitoring Rule

UOSA

Upper Occoquan Service Authority

USGS

United States Geological Survey

UV

Ultra-Violet

VDEQ

Virginia Department of Environmental Quality

WEF

Water Environment Federation

WRA

WateReuse Association

WRRF

Water Resource Recovery Facility

WTP

Water Treatment Plant

α

Polarizability

ηg/L

Nanogram per Liter

µg/L

Microgram per Liter

CHAPTER 1 - INTRODUCTION
Record drought, shrinking water supply alternatives, and growing water demand from
population centers across the arid West and Coastal Southeast United States (US) have combined
to thrust municipal wastewater potable reuse to the forefront as a vital solution to augment public
water supplies (Tisdale 2015). Tisdale (2015) reported capital expenditures for potable reuse
infrastructure in the US will exceed $11 billion over the next decade. Augmentation of fresh
water supplies with reuse water is a significant component of recent state water plan updates for
California, Texas, and Oklahoma (CSWRCB 2014; TWDB 2015; ODEQ 2015).
Tchobanoglous et al. (2015) reported 30% of all wastewater collected in California could
be used for either direct potable reuse (DPR) or indirect potable reuse (IPR) projects by 2020.
The State of California recently updated its Department of Health Title 22 code with the
following statement:
DPR is defined as the planned introduction of reuse water either directly into a
public water system or into a raw water supply immediately upstream of a water
treatment plant (WTP). If DPR can be demonstrated to be safe and feasible, the
State Board’s goal of reusing 2 million ac-ft/yr (or 1.8 BGD) by 2025 will be
achieved. (CDPH 2011)
As reuse of municipal wastewater becomes vital to augment diminishing fresh drinking
water resources, the presence of contaminants of emerging concern (CECs) have become a major
concern (EPA 2014). CECs are water soluble contaminants suspected to exist in the water cycle
that can have an adverse effect on human health (EPA 2014). CECs in water resource recovery
facility (WRRF) effluent include pharmaceuticals and personal care products such as hormones,
antibiotics, stimulants, surfactants, preservatives, artificial sweeteners, and caffeine (Spellman
2014). Agricultural pesticide and herbicide CECs, designed to disrupt metabolic processes, have
also been found in WRRF effluents.
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With implementation of DPR, public water supply (PWS) managers and regulators are
faced with new water treatment challenges (NRC 2012). The public is concerned that
conventional barriers may prove deficient, and the upcycling of CECs could prove harmful to
human health if more effective and robust treatment barriers are not in place (ODEQ 2015).
WRRFs were not historically designed for the target removal of CECs (WEF 2012; Lemanik et
al. 2007). Although WRRF unit processes can contribute to removal of CECs, validating
effective removal has proven a challenge due to the extremely low concentrations (nanograms
per liter, ηg/L) and relatively high cost of analysis (Snyder et al. 2003). Degradation and sorption
in the bioreactors, precipitation through clarification, steric exclusion through tertiary filtration,
and disinfection/oxidation likely decrease the amount of CECs present, though there remains
considerable uncertainty regarding the recalcitrant trace residual in WRRF effluent (Watts et al.
2016; Snyder et al. 2005).
A new, robust multi-barrier treatment approach must be taken to successfully implement
DPR for augmentation of PWS (Tchobanoglous et al. 2015; McDonald et al. 2015; Gerrity et al.
2013a). Bench-scale studies indicate that RO and NF membrane-based process technologies
show potential as an effective barrier for rejection of CECs from lab-synthesized samples
(Bellona et al. 2004; Drewes et al. 2006; Kimura et al. 2003; Linden et al. 2012; Ngheim et al.
2004; Dang et al. 2015; Schafer et al. 2003; Snyder et al. 2004; Tchobanoglous et al. 2015;
Westerhoff et al. 2005; Yangali-Quintanilla et al. 2011; Yoon et al. 2007). However, more
industry-relevant study is needed to validate RO and NF rejection of recalcitrant CECs from
WRRF secondary effluents (Mohammad et al. 2015; Salveson et al. 2016; Watts et al. 2016).
IPR with environmental buffer has been practiced for decades in the US, Europe,
Australia, and Singapore. As of 2015, there were only three reported full-scale DPR PWS
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systems in operation (Tisdale 2015; Gerrity et al. 2013b). Since 1968, the Windhoek, Namibia,
DPR system has utilized a multi-barrier treatment approach that does not include RO membranes
(Rodriguez et al. 2009). In 2014, Wichita Falls, Texas, implemented a seasonal-use full-scale
DPR system that includes RO membranes for control of dissolved solutes (Jones and Sober
2014; Nix and Schreiber 2015). Commissioned in 2013, the Big Spring, Texas, DPR facility
provides up to 2.5 million gallons per day (MGD) of highly treated year-round reuse supply to
the WTP (Sloan 2013). A process flow diagram of this new DPR facility is presented in Figure
1-1. The DPR treatment process train includes WRRF tertiary treatment, microfiltration (MF)
membranes, reverse osmosis (RO) membranes, and an advanced oxidation process (AOP) prior
to blending with the conventional WTP raw surface water (SW) supply.

Figure 1-1: Big Spring, Texas, Direct Potable Reuse Facility (commissioned in 2013)

With the lack of experience for CEC control in PWS, the default approach to
implementing the best available technology (BAT) can be overly conservative and costly (ODEQ
3

2015). RO in the two existing US DPR treatment facilities has trended as the default BAT for
CEC control (Sloan 2013; Nix and Schreiber 2015). RO represents a major capital and
operations and maintenance (O&M) cost not typical of conventional water treatment
technologies (Watts et al. 2016; ODEQ 2015; Jones et al. 2014). Further, an RO system produces
a brine reject waste that can result in additional treatment and disposal challenges (Watts et al.
2016; ODEQ 2015; Jones et al. 2014; Wickramasinghe and Jones 2013). The default RO
approach to CEC control may be questioned if we consider commercially available thin film
composite (TFC) NF membranes (Watts et al. 2016; Jones and Sober 2014). Potentially, these
TFC NF membranes can provide similar CEC rejection efficacies as RO for less capital, O&M,
power, and waste generated (Watts et al. 2016; Jones and Sober 2014; Jones et al. 2014).
Currently, no federal or state regulations exist specifically for DPR (Tchobanoglous et al.
2015). Although the US Environmental Protection Agency (EPA) recently published the first
edition of “Guidelines for Water Reuse,” no federal Safe Drinking Water Act (SDWA)
regulations are in place for DPR drinking water systems (US EPA 2012). Out of necessity, some
states are developing their own DPR regulations (TWDB 2015; ODEQ 2015; CSWRCB 2014a).
State regulators and PWS managers have turned to water industry advisory boards and
committees to provide the knowledge and tools to identify the BAT and where to apply them in
the water use cycle (Tchobanoglous et al. 2015; TWDB 2015; ODEQ 2015; CSWRCB 2014a).
This research is needed to validate the NF and RO rejection of recalcitrant CECs
occurring in typical WRRF secondary effluents. Furthermore, a primary objective is to conceive
and develop a sound practical decision science tool (i.e., model), derived from the quantitative
structure-activity relationship (QSAR) properties of CECs and membrane rejection mechanisms,

4

for regulators and PWS managers to utilize when selecting the BAT to implement for DPR
applications.
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CHAPTER 2 - LITERATURE REVIEW
2.1

Potable Reuse
PWS in the US have historically originated from fresh (i.e., low dissolved solids)

groundwater and surface water, but population growth, arid climate, and extended drought are
stressing these supplies in some regions (Tchobanoglous et al. 2015). The US Southwest has
experienced spells of prolonged, severe drought throughout its history (Cayan et al. 2010).
Recent climate studies indicate significant risk for a 35-year or longer mega drought by 2100 in
this region (Cook et al. 2015).
New strategies are needed to help meet water demands and develop more sustainable
water supplies. One such strategy is planned potable reuse, in which treated municipal
wastewater is utilized to augment PWS (CSWRCB 2014; TWDB 2015; ODEQ 2015; McDonald
et al. 2015). At present, planned potable reuse in the US involves either IPR where treated
wastewater is introduced into an environmental buffer (e.g., groundwater aquifer, surface water
reservoir, lake, or river) before blended water is introduced into a PWS, or DPR where highly
treated wastewater is introduced without environmental buffer into a PWS (Tchobanoglous et al.
2015). In recent years, WRRF reuse in Texas (e.g., Big Spring and Wichita Falls) has expanded
from non-potable reuse and IPR to DPR applications (Sloan 2013; Nix and Schreiber 2015).
2.1.1

Applications
Planned IPR with an environmental buffer between wastewater reclamation and drinking

water treatment is not a new approach to PWS (McDonald et al. 2015). Planned full-scale IPR
has been implemented successfully in the US, Europe, Australia, and Singapore (Rodriguez et al.
2009). Rodriguez (2009) reported that in the US, California has the most planned IPR systems
with over 40 years of successful operation. Other US states with operating full-scale IPR systems
6

include Arizona, Colorado, Texas, Nevada, Florida, Virginia, and Georgia (Rodriguez et al.
2009; Gerrity et al. 2013b).
Several European countries, including Belgium, England, and Switzerland, utilize a
planned IPR approach to provide PWS (Rodriguez et al. 2009; Gerrity et al. 2013b; Ryan 2016).
Israel leads the world with reuse of more than 78 percent of its total municipal wastewater (i.e.,
287 of 366 MGD); however, to date, Israel’s reuse has been for non-potable applications as
required to meet agricultural and industrial water supply demands (Tirosh and Eting 2016). In
response to severe drought, Queensland, Australia, implemented three advanced treatment
systems (over 600 MGD in combined capacity) in 2008 with the intent to reclaim wastewater to
augment the public water supply portfolio. Due to public opposition, these systems have been
relegated to date for non-potable and emergency use IPR applications only (Rodriguez et al.
2009; Gerrity et al. 2013b; Ryan 2016). Since 2000, Singapore has successfully implemented
four operating full-scale IPR systems with a combined capacity of over 50 MGD (Rodriguez et
al. 2009; Gerrity et al. 2013b). As such, the planned IPR approach to potable reuse is widely
practiced in the US and internationally.
The DPR approach to potable reuse, where advanced barrier treatment technology is
utilized to replace the environmental buffer and shorten the reuse cycle time, is not widely
practiced. Although several systems are reported to be in planning or permitting, there are only
three full-scale (two year-round and one seasonal) DPR systems in operation world-wide for
public drinking water supply (Gerrity et al. 2013b; Tisdale 2015). In operation since 1968, with
several upgrades since original commissioning, Windhoek, Namibia (Africa), maintains a DPR
system that provides up to 35 percent of the total potable water supply portfolio (Gerrity et al.
2013b). The Windhoek treatment process train, as diagramed in Figure 2-1, includes multiple
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barriers designed for a variety of contaminants. Reverse osmosis membranes are not utilized
treatment barriers for the Windhoek DPR system.
The Big Spring, Texas, DPR system, commissioned in 2013, provides year-round reuse
supply of up to 2.5 MGD (Gerrity et al. 2013b; Sloan 2013). As shown in Figure 2-1, the Big
Spring DPR process train includes series membrane treatment with RO and an advanced
oxidation process (AOP) prior to conventional drinking water treatment. In response to severe
drought in 2014, Wichita Falls, Texas, commissioned a seasonal use full-scale DPR system with
up to 5 MGD capacity to augment the potable water supply (Jones and Sober 2014; Nix and
Schreiber 2015). Similar to Big Spring, the Wichita Falls treatment train, diagramed in Figure 21, also includes series membrane process units with RO barriers prior to conventional water
treatment. Another US DPR project is for the resort community of Cloudcroft, New Mexico.
Stalled in implementation and not yet in operation, the Cloudcroft treatment train with a planned
capacity of 100,000 gallons per day (gpd) is designed with RO membranes and AOP barriers
(Gerrity et al. 2013b; Edwards 2014; NMED 2014). RO membranes are trending as a barrier
treatment technology for US-based DPR systems.
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Windhoek, Namibia (Africa)

Big Spring, Texas

Wichita Falls, Texas

Figure 2-1: Full-Scale Operating Direct Potable Reuse Treatment Trains
Ref. Gerrity (2013b), Sloan (2013), Jones (2014), Nix (2015)
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2.1.2

Concern with DPR
To help offset the public “yuk” and “toilet-to-tap” factor associated with potable reuse of

municipal wastewater, the water industry has responded accordingly with recent action by the
Water Environment Federation (WEF). Founded in 1928, WEF is a leading organization of
engineers and water industry stakeholders in the field of municipal wastewater and water reuse
(WEF 2012). The term “water resource recovery facility” (WRRF), rather than “wastewater
treatment plant” (WWTP), was adopted by the WEF Board of Trustees in July 2012 (WEF
2012). “WEF changing WWTP to WRRF is the kind of thing we need to sustain ourselves. It
focuses on the concept of a renewable resource rather than waste. Words are powerful; they
motivate people,” said Julian Sandino, a vice president and water practice leader with the
international consulting firm CH2M Hill (WEF 2012).
While the focus of engineered treatment systems for potable reuse projects begins with
minimizing the risk associated with wastewater pathogens, non-regulated trace organic
contaminants, referred to as CECs, have become important considerations for treatment system
design (Dickenson and Drewes 2008; Gerrity et al. 2013a; EPA 2014; Tchobanoglous et al.
2015). CECs can be defined as unregulated chemical solutes potentially found in effluent
discharges and surface waters at trace levels, nanograms per liter (ηg/L), that may or may not
have an impact on human health (EPA 2015a; US BOR 2009). The majority of the well-studied
CECs have been classified as biodegradable to some degree (Rattier et al. 2014). Therefore, the
first critical treatment barrier for CEC mitigation is a biological wastewater treatment process.
Water quality monitoring from wastewater-receiving streams, however, indicates that a single
treatment barrier for CECs is not adequate to prevent downstream contamination (Gerrity et al.
2013b; Kolpin et al. 2002). As both public and regulatory concern grows over CECs in the water
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cycle, the use of advanced treatment barrier systems following biological treatment is
increasingly common at WRRFs to remove the recalcitrant CECs (Al-Rifai et al. 2011; Gomez et
al. 2012; Sloan 2013).
2.2

CEC Occurrence
To understand the occurrence of CECs in municipal wastewater, it is helpful to first

consider their origin and intended use.
2.2.1

Origin and Intended Use
There are approximately 13,500 chemical manufacturing facilities in the US owned by

more than 9,000 companies (Spellman 2014). Over 84,000 chemicals, as inventoried by the EPA
under the Toxic Substances Control Act (TSCA), are in use today with approximately 700 new
chemicals added each year (EPA 2014). Water-soluble organic chemicals, or CECs, enter the
water cycle through rainfall runoff or disposal to municipal wastewater collections systems
(Tchobanoglous et al. 2015). These CECs can be generally characterized by the following
intended use classifications (Anderson et al. 2010; CDPH 2011; NRC 2012; Luo et al. 2014;
MDH 2015):
1. Endocrine Disrupting Compounds (EDCs)
2. Pharmaceuticals
3. Stimulants
4. Preservatives
5. Artificial sweeteners
6. Pesticides
7. Flame retardants
Each of these CEC classifications is further characterized in Table 2-1.
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Table 2-1: CEC Intended Use Characterization
CEC

Classification

Sub-classification

CEC

Classification

Sub-classification

4-nonylphenol

EDC

Surfactant

Primidone

Pharmaceutical

Anti-seizure

4-tert-Octylphenol

EDC

Surfactant

Sulfachloropyridazine

Pharmaceutical

Antibiotic

Andorostenedione

EDC

Steroid hormone

Bisphenol-A (BPA)

EDC

Plasticizer

Sulfadiazine

Pharmaceutical

Antibiotic

Sulfadimethoxine

Pharmaceutical

Antibiotic

Estradiol

EDC

Estrogen hormone

Sulfamerazine

Pharmaceutical

Antibiotic

Estrone

EDC

Estrogen hormone

Sulfamethazine

Pharmaceutical

Antibiotic

Ethinyl Estradiol - 17α

EDC

Contraceptive

Sulfamethizole

Pharmaceutical

Antibiotic

Norethisterone

EDC

Steroid hormone

Sulfamethoxazole

Pharmaceutical

Antibiotic

Progesterone

EDC

Steroid hormone

Sulfathiazole

Pharmaceutical

Antibiotic

Testosterone

EDC

Male hormone

Theophylline

Pharmaceutical

Anti-asthmatic

Warfarin

Acetaminophen

Pharmaceutical

Analgesic

Albuterol

Pharmaceutical

Anti-asthmatic

Pharmaceutical

Cardio

1,7-Dimethylxanthine

Stimulant

Caffeine degradate

Amoxicillin

Pharmaceutical

Atenolol

Pharmaceutical

Antibiotic

Caffeine

Stimulant

-

Cardio

Cotinine

Stimulant

Nicotine degradate

Azithromycin

Pharmaceutical

Antibiotic

Theobromine

Stimulant

Caffeine degradate

Bendroflumethiazide

Pharmaceutical

Anti-hypertension

Bezafibrate

Pharmaceutical

Cardio

Butylparaben

Preservative

Anti-microbial

Ethylparaben

Preservative

Butalbital

Pharmaceutical

Analgesic

Antifungal

Isobutylparaben

Preservative

Antibacterial/fungal

Carbadox

Pharmaceutical

Antibiotic

Methylparaben

Preservative

Antibacterial/fungal

Carbamazepine

Pharmaceutical

Anti-seizure

Propylparaben

Preservative

Antibacterial/fungal

Carisoprodol

Pharmaceutical

Muscle relaxer

Triclosan

Preservatives

Antibacterial

Chloramphenicol

Pharmaceutical

Antibiotic

Trimethoprim

Preservatives

Antibacterial

Cimetidine

Pharmaceutical

Cardio

Acesulfame-K

Sweetener

Sugar substitute

Dehydronifedipine

Pharmaceutical

Cardio

Diazepam

Pharmaceutical

Anti-anxiety

Diclofenac

Pharmaceutical

Dilantin

Pharmaceutical

Erythromycin

Pharmaceutical

Flumeqine

Sucralose

Sweetener

Sugar substitute

2,4-D

Pesticide

Herbicide

Anti-inflammatory

Atrazine

Pesticide

Herbicide

Anti-seizure

Bromacil

Pesticide

Herbicide

Antibiotic

Chloridazon

Pesticide

Herbicide

Pharmaceutical

Antibiotic

Chlorotoluron

Pesticide

Herbicide

Fluoxetine

Pharmaceutical

Antidepressant

Clofibric Acid

Pesticide

Herbicide

Gemfibrozil

Pharmaceutical

Cardio

Cyanazine

Pesticide

Herbicide

Ibuprofen

Pharmaceutical

Analgesic

DACT

Pesticide

Atrazine degradate

Iohexal

Pharmaceutical

X-ray contrast

DEA

Pesticide

Atrazine degradate

Iopromide

Pharmaceutical

X-ray contrast

DEET

Pesticide

Mosquito repellant

Ketoprofen

Pharmaceutical

Anti-inflammatory

DIA

Pesticide

Atrazine degradate

Ketorolac

Pharmaceutical

Anti-inflammatory

Diuron

Pesticide

Herbicide

Lidocaine

Pharmaceutical

Analgesic

Isoproturon

Pesticide

Herbicide

Lincomycin

Pharmaceutical

Antibiotic

Linuron

Pesticide

Herbicide

Lopressor

Pharmaceutical

Cardio

Metazachlor

Pesticide

Herbicide

Meclofenamic Acid

Pharmaceutical

Anti-inflammatory

Propazine

Pesticide

Herbicide
Herbicide feedstock

Meprobamate

Pharmaceutical

Anti-anxiety

Quinoline

Pesticide

Naproxen

Pharmaceutical

Analgesic

Simazine

Pesticide

Herbicide

Nifedipine

Pharmaceutical

Cardio

TCEP

Flame Retardant

Fabric coating

Oxolinic acid

Pharmaceutical

Antibiotic

TCPP

Flame Retardant

Fabric coating

Pentoxifylline

Pharmaceutical

Blood thinner

TDCPP

Flame Retardant

Fabric coating

Phenazone
Pharmaceutical
Analgesic
Sources: Anderson et al. 2010; CDPH 2011; NRC 2012; Eaton et al. 2012; Luo et al. 2014; MDH 2015
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2.2.2

Occurrence in WRRF Effluents
Municipal WRRF primary and secondary effluents have been found to contain trace

levels of CECs (Purdom et al. 1994; Folmar et al. 1996; Harries et al. 1997; Rodgers-Gray et al.
2000; Drewes et al. 2006; Behera et al. 2011; Luo et al. 2014). Primary effluent (PE) indicates
water treated by physical processes (e.g., primary clarification) associated with WRRF primary
treatment, while SE indicates water treated by biological processes (e.g., activated sludge)
associated with WRRF secondary treatment (Tchobanoglous et al. 2014). Table 2-2 shows the
detectable concentrations of CECs and the variability in biodegradability observed between PE
and SE treated municipal wastewater effluents.
Table 2-2: CEC Occurrence in Wastewater Effluent
CEC

Range in Primary Effluents
(ηg/L)

17α-Ethynyl Estradiol
ND – 13
17β-Estradiol
ND – 150
4-t-Octylphenol
100 - 13,000
Bisphenol A
40 -100
Estriol
ND – 802
Estrone
7.3 -132
Nonylphenol
1,300 - 343,000
Testosterone
24 -180
Acetaminophen
3,540 – 10,234
Atenolol
5,113 – 11,239
Carbamazepine
43 – 127
Diclofenac
59 -243
Gemfibrozil
101 – 318
Ibuprofen
1,599 – 2,853
Ketoprofen
81 – 286
Lincomycin
3,095 – 19,401
Naproxen
1,360 – 5,033
Sulfamethazine
ND – 343
Sulfamethoxazole
79 – 216
Caffeine
1,608 – 3,217
Triclosan
247 – 785
Trimethoprim
101 – 277
Atrazine
20 – 28,000
Clofibric acid
ND – 65
DEET
2,560 – 3,190
Diuron
30 – 1,960
TCEP
60 – 500
TCPP
180 – 4,000
ND = Below analytical detection limit
Source: Drewes et al. 2006; Behera et al. 2011; Luo et al. 2014

Range in Secondary Effluents
(ηg/L)
ND - 7.5
ND - 43
ND - 1,300
ND - 17,300
ND - 18
ND - 108
ND - 9,100
ND
ND - 27
261 – 5,911
40 - 74
13 - 49
26-Sep
15 - 75
ND - 37
1,437 – 21,278
37 - 166
ND - 408
20 - 162
ND - 60
79 - 149
13 - 154
4 - 730
ND - 6
610 – 1,580
2 – 2,530
60 – 2,400
100 – 21,000
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Table 2-2 shows SE may contain recalcitrant (i.e., non-biodegraded fraction)
concentrations of natural and synthetic endocrine disruptors, pharmaceuticals, personal care
products, and pesticides in the nanogram per liter (ηg/L) range with some surfactant phenols,
pharmaceuticals, and flame retardants in the microgram per liter (µg/L) range (Drewes et al.
2006; Behera et al. 2011; Luo et al. 2014). Table 2-2 also reveals that the biological processes
associated with secondary treatment are effective for at least partial removal of most CECs.
The occurrence of CECs in municipal wastewater effluents is not new (Tchobanoglous et
al. 2015). It is reasonable to assume that as long as pharmaceuticals, personal care products, and
pesticides have been in use, these products and their metabolites have contributed to the effluent
trace contaminant load. However, our ability to analyze and detect trace amounts of these CECs
in water is new and evolving (Eaton and Haghani 2012; Vanderford et al. 2012; Tchobanoglous
et al. 2015).
The City of Norman, Oklahoma (Norman), in conjunction with Eurofins Eaton Analytical
of Monrovia, California, conducted an IPR Study to consider potential WTP impacts from the
augmentation of Lake Thunderbird surface water supply with SE from the Norman WRRF
(Crowley and Mattingly 2009). To prepare for the study, Norman conducted an analytical survey
for a study set of 96 (Norman 96) CECs in SE discharged from the WRRF.
The Norman 96 was selected based on review of occurrence data from gray literature
surveys conducted by WateReuse Association (WRA), National Water Research Institute
(NWRI), EPA, US Geological Survey (USGS), and the US Bureau of Reclamation (BOR). The
data reflected a compilation of CECs suspected to occur in WRRF effluents that could be
analyzed by an established standard method with acceptable precision and accuracy. The
“Framework for Direct Potable Reuse” released in 2015 by the WRA, NWRI, WEF, and
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American Water Works Association (AWWA), recommends 13 (see Appendix A) of the
Norman 96 CECs to be considered as control indicators when planning DPR projects
(Tchobanoglous et al. 2015). As such, the Norman 96 appears to be a relatively comprehensive
CEC study set.
Table 2-3 shows that CEC concentrations in the Norman WRRF SE range from nondetection to well above minimum reportable level (MRL). The higher concentration CECs
include pharmaceuticals for control of infection, blood pressure, cholesterol, pain, seizures, and
anxiety. Some of the estrogen-based hormones (e.g., estrone) were detected, but the testosteronebased hormones were non-detectable. Perhaps most revealing were the relatively high
concentrations of artificial sweeteners (e.g., acesulfame-K, sucralose). It is apparent such
compounds do not biodegrade (or biosorb) in the WRRF bioreactor. These data suggest artificial
sweeteners may be an ideal control indicator with which to monitor breakthrough integrity for
future membrane-based DPR treatment process trains. Unlike the artificial sweeteners, caffeine
is evidently biodegradable as concentrations were only slightly detectable. Also, pesticides were
found in the SE at recalcitrant trace residual (Crowley and Mattingly 2009).
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Table 2-3: Norman 96 Survey in WRRF Secondary Effluent
Compound

Effluent
(ηg/L)

MRL
(ηg/L)

Compound

Effluent
(ηg/L)

4-nonylphenol - semi quantitative
ND
100
Primidone
170
4-tert-Octylphenol
78
50
Sulfachloropyridazine
ND
Andorostenedione
ND
5
Sulfadiazine
ND
Bisphenol-A (BPA)
ND
10
Sulfadimethoxine
ND
Estradiol
ND
5
Sulfamerazine
ND
Estrone
130
5
Sulfamethazine
12
Ethinyl Estradiol - 17 alpha
ND
5
Sulfamethizole
ND
Norethisterone
ND
5
Sulfamethoxazole
1,300
Progesterone
ND
5
Sulfathiazole
33
Testosterone
ND
5
Theophylline
ND
Acetaminophen
ND
5
Warfarin
ND
Albuterol
ND
5
1,7-Dimethylxanthine
42
Amoxicillin (semi-quantitative)
4,600
20
Caffeine
60
Atenolol
300
5
Cotinine
42
Azithromycin
ND
20
Theobromine
ND
Bendroflumethiazide
ND
5
Butylparaben
ND
Bezafibrate
ND
5
Ethylparaben
ND
Butalbital
54
5
Isobutylparaben
ND
Carbadox
ND
5
Methylparaben
ND
Carbamazepine
400
5
Propylparaben
24
Carisoprodol
130
5
Triclosan
43
Chloramphenicol
ND
10
Trimethoprim
1,000
Cimetidine
ND
5
Acesulfame-K
4,100
Dehydronifedipine
82
5
Sucralose
49,000
Diazepam
ND
5
2,4-D
ND
Diclofenac
93
5
Atrazine
16
Dilantin
130
20
Bromacil
ND
Erythromycin
220
10
Chloridazon
ND
Flumeqine
ND
10
Chlorotoluron
ND
Fluoxetine
90
10
Clofibric Acid
ND
Gemfibrozil
550
5
Cyanazine
ND
Ibuprofen
ND
10
DACT
ND
Iohexal
ND
10
DEA
11
Iopromide
270
5
DEET
ND
Ketoprofen
150
5
DIA
100
Ketorolac
ND
5
Diuron
ND
Lidocaine
370
5
Isoproturon
ND
Lincomycin
15
10
Linuron
ND
Lopressor
1,200
20
Metazachlor
ND
Meclofenamic Acid
ND
5
Propazine
ND
Meprobamate
460
5
Quinoline
ND
Naproxen
ND
10
Simazine
220
Nifedipine
34
20
TCEP
830
Oxolinic acid
ND
10
TCPP
510
Pentoxifylline
ND
5
TDCPP
530
Phenazone
5.6
5
ηg/L = nanograms per liter.
ND = Non-detetectable. MRL = Minimum reportable level, EPA Method MS/MS/LS-ESI.
Source: Crowley and Mattingly 2009

MRL
(ηg/L)
5
5
5
5
5
5
5
5
5
20
5
10
5
10
10
5
20
5
20
5
10
5
20
100
5
5
5
5
5
5
5
5
5
10
5
5
100
5
5
5
5
5
10
100
100
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2.3

Human Health Criterion
CECs and their associated degradates represent a challenge for regulators to establish

human health based criterion due to the limited scientific knowledge regarding acute and chronic
health effects (Tchobanoglous 2015). There is limited public record of CEC human health effects
from ingestion of reuse water supply reported by epidemiology and toxicology studies.
2.3.1

Epidemiology
Epidemiological studies assess the measurable difference in disease incidence between

human populations exposed to a given set of conditions as compared to populations experiencing
less exposure (Tchobanoglous 2015). One limitation to epidemiology studies for establishing
human health criterion for the control of trace CECs in public water supply is the difficulty in
assessing or differentiating the incremental risks from background exposure to other
environmental sources such as food and pharmaceuticals that can be influenced by genetics and
socio-economics (Tchobanoglous 2015). An epidemiological study of the Windhoek DPR
system concluded that differences in diarrheal disease prevalence was associated with socioeconomic factors, not the source of water supply (Rodriguez et al. 2009). An epidemiological
study of the Montebello, California, IPR project concluded no evidence existed that the reuse
water had an adverse effect on liver cancer incidence, mortality, or infectious disease outcome
(Rodriguez et al. 2009). Another epidemiology study of the same California IPR project
concluded no significant association between reuse water and adverse birth outcomes, including
19 categories of birth defects, over a 10-year period (Rodriguez et al. 2009).
2.3.2

Toxicology
Animal or cellular toxicology dose-response testing is another approach to human health

risk assessments for I/DPR projects. A drawback to this approach is the dose levels tend to be
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orders of magnitude greater than human ingestion levels from drinking water. As such, the
observed dose-response relationship must be extrapolated to low dose potentially giving rise to
overly conservative public health criterion (Tchobanoglous 2015). Chronic toxicology testing
with rats and mice was conducted for DPR demonstration projects in Denver, Tampa, and
Singapore. All three animal toxicology studies concluded no adverse reproductive,
developmental, or carcinogenic outcomes from lifetime consumption of reuse water over two
generations (Lauer 1993; Rodriguez et al. 2009). Cellular mutagenic studies, utilizing the Ames
test with bacteria Salmonella typhimurium, were conducted for a variety of source waters in San
Diego, Tampa, Potomac, Orange County, and Montebello (Nellor et al. 1995). In general,
mutagenic activity was observed (in declining order) for wet weather surface water, dry weather
surface water, recycled water, and ground water. High false positive mutagenic activity was
reported for finished drinking waters due to disinfecting residuals (Nellor et al. 1995).
2.3.3

Suggested CEC Criterion
In recognition of the lack of human health based criterion related to reuse water supply,

the National Water Research Institute (NWRI) convened an independent advisory panel (IAP) to
develop a list of recommended CECs, based on collective knowledge, to be considered as
performance monitoring protocol for DPR systems (NWRI 2013). The IAP suggested risk-based
human health criterion for the control of 13 CECs in DPR applications is provided in Table 2-4.
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Table 2-4: NWRI Risk-Based Human Health Criterion
Criterion
(ηg/L)
MRL: 5
MRL: 5
320
1,000
10,000
2,000
200,000
4,000
10,000

CEC
Ethinyl estradiol
17-β-estradiol
Estrone
Cotinine
Primidone
Dilantin
Meprobamate
Atenolol
Carbamazepine
Sucralose

150,000,000

TCEP

5,000

DEET

200,000

Triclosan
Source: NWRI (2013)

2.4

50,000

Rationale
Should evaluate its presence in
source water
Surrogate for steroids
Surrogate for low MW ionic
CECs
Occurs frequently at ηg/L level
Unique structure
Surrogate for hydrophilic
neutral CECs
CEC of interest
Common CEC in highly treated
effluents
CEC of interest

CEC Regulatory Framework for DPR
Despite the rapidly increasing interest in potable reuse, no jurisdictions have established

CEC regulations for DPR projects (Tchobanoglous et al. 2015). The EPA has discussed the
status of potable reuse in its “2012 Guidelines for Water Reuse,” but has not prepared minimum
standards or other documents establishing a baseline for the design of DPR facilities and projects
(EPA 2012). In fact, EPA states in the 2012 Guidelines: “Water reclamation and reuse standards
in the US are the responsibility of state and local agencies – there are no federal regulations for
reuse.”
Unplanned reuse of treated wastewater effluent as a PWS is common practice in many of
the nation’s PWS systems, with some drinking WTPs using water with a large fraction
originating as wastewater effluent from upstream communities, especially under low-flow
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effluent dominated conditions (NRC 2012). The following sections summarize the potable reuse
regulatory status of the EPA and all US primacy states with active CEC control initiatives related
to potable reuse or prominent DPR projects.
2.4.1

Federal Framework
The US SDWA, as amended in 1996, requires EPA to publish a list every five years of

currently unregulated contaminants that may pose risks for drinking water (80 CFR 6076, EPA
2015b). EPA uses the Unregulated Contaminant Monitoring Rule (UCMR) program to collect
data for contaminants suspected to be present in PWS as required to generate a Contaminant
Candidate List (CCL). The 1996 SDWA Amendments provide the following for UCMR
database generation:
•

Monitoring by large systems and a representative sample of public water systems
serving less than or equal to 10,000 people

•

Storing analytical results in a National Contaminant Occurrence Database (NCOD)

The EPA CCL is a list of contaminants that are currently not subject to any proposed or
promulgated national primary drinking water regulations (NPDWR), but are known or
anticipated to occur in PWS and may require subsequent regulation under the EPA SDWA (EPA
2012). Since first announced in 1998, four CCLs have been published by the EPA in the Federal
Register. CCL1 listed 60 contaminants. No regulatory action was determined for nine and 51
were carried forward. CCL2 listed the 51 carried forward contaminants. No regulatory action
was determined for 11, two were promulgated, and 38 were carried forward (EPA 2015b). CCL3
listed 116 (104 chemicals and 12 microbial). A summary of the NCOD occurrence data for the
UCMR3 is provided in Appendix A (EPA 2015b). No regulatory action was determined for four,
two were promulgated, and 100 were carried forward from CCL3 (EPA 2015b,c).
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With publication of Draft CCL4 in 2015, the total list of carried forward and new
includes 100 chemical and 12 microbial contaminants (EPA 2015c). The CCL4 list of chemical
contaminants is provided in Appendix A (EPA 2015c). The SDWA identifies three criteria to
determine whether a CCL contaminant may require regulation:
1. The contaminant may have an adverse effect on human health.
2. The contaminant is known to occur or there is substantial likelihood that the contaminant
will occur in PWS with a frequency and at levels of public health concern.
3. In the sole judgement of the Administrator, regulation of such contaminant presents a
meaningful opportunity for health risk reduction for persons served by PWS.
If the EPA determines that these three statutory criteria are met and makes a final determination
to regulate a contaminant, the agency has 24 months to publish a proposed Maximum
Contaminant Level Goal (MCLG) and NPDWR (EPA 2012). Following comment period, the
agency has 18 months to publish and promulgate a final MCL and NPDWR.
Since the first CCL, the EPA has promulgated NPDWR MCLs for three herbicide CECs
as indicated in Table 2-5.
Table 2-5: CEC MCLs - NPDWRa
CEC

Intended Use

NPDWR MCL

Atrazine

herbicide

3,000 ηg/L

2, 4-Dichlorophenoxyacetic

herbicide

70,000 ηg/L

Simazine

herbicide

4,000 ηg/L

a

Adapted from EPA 2012, 2015b,c
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2.4.2

State Framework
Activity related to the control of CECs for I/DPR by the states has been on an as-needed

basis. The following discussion focuses on activity by the states known to be developing CECspecific regulatory control or that have DPR projects in implementation phase or operational.
2.4.2.1 California
Out of necessity, California has been a leader in the research and planning of IPR and
DPR options. The Orange County Water District and Los Angeles County Sanitation Districts
have led the effort for IPR over the last several decades to supplement groundwater supplies
(CSWRCB 2014a,b). This practice has been utilized for decades for saltwater intrusion barriers,
but is now being adapted for groundwater supply augmentation (Crook 2010). The City of San
Diego is nearing the end of a multi-year process to demonstrate the feasibility of IPR to augment
surface water supplies through a large-scale pilot treatment facility (CSWRCB 2014b). They
have also implemented a long-term, high-profile public education program to gain acceptance of
the proposed augmentation of surface water by IPR (CSWRCB 2014b). Due to the increase in
interest of reuse of municipal WRRF effluents, the State of California is developing regulations
to govern IPR and DPR systems and the control of CECs (CAEPA 2006; CDPH 2011).
2.4.2.1.1

Groundwater IPR

The California Department of Public Health (CDPH) published groundwater recharge
regulations under Title 22 in 2011 and has since updated these draft regulations several times,
most recently on May 30, 2014 (CDPH 2011, CSWRCB 2014a). On June 30, 2014 the
California legislature directed that these rules be adopted on an emergency basis. The regulations
represent a working understanding of requirements for the use of reuse water to recharge potable
groundwater supplies. These regulations also represent a starting point in the development of
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regulations for surface water augmentation IPR and likely development of DPR regulations. Key
provisions of the groundwater IPR regulations include:
1. Minimum retention times within the aquifer
2. Limits on reuse water contribution (RWC), with initial limit of 20% and
provisions for increasing contribution in step-wise fashion subject to maximum of
75% with continued successful operation
3. Reuse water must be treated with full advanced treatment (FAT), defined to
include RO (with 99% salt rejection) and an AOP process
4. Monitoring protocol for identified indicator CECs
5. Aquifer retention time shall not be less than 2 months prior to withdrawal
2.4.2.1.2

Surface Water IPR

The legislature has directed the CDPH and the California State Water Resources Control
Board (CSWRCB) to adopt regulations for surface water augmentation with IPR by December
31, 2016. No draft regulations are currently available, but an advisory group has been named,
and they in turn have made recommendations for selection of an expert panel to advise the
CDPH in developing criteria (CSWRCB 2014a).
2.4.2.1.3

Direct Potable Reuse

The legislature has also directed the CDPH and CSWRCB to investigate and report to on
the feasibility of developing regulatory criteria for DPR (CSWRCB 2014a). A public review
draft report is due September 1, 2016. The final DPR report is scheduled for December 31, 2016
(CSWRCB 2014a).
CDPH formed a CEC Expert Advisory Group in 2012 that is working with the CSWRCB
to develop a list of CECs for monitoring and bioassay testing. As reported at the May 2014
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CWRCB Meeting, 15 CECs as shown in Table 2-6 were adopted for monitoring of WRRF
effluents (CSWRCB 2014b).
Table 2-6: California CEC Monitoring List for DPR
Bisphenol-A
Bis (2-ethylhexyl) phthalate (BEHP)
Butylbenzyl phthalate (BBP)
Bifenthrin
Chlorpyrifos
Diclofenac
Estrone
Estradiol

17-beta estradiol
Galaxolide (HHCB)
Ibuprofen
PBDE -47 and -99
Permethrin
PFOS
p-Nonylphenol
Trisclosan

Source: CSWRCB 2014b

2.4.2.2 Texas
Texas has PWS systems practicing both IPR and DPR, but has no regulations specifically
designed for these projects (TWDB 2015). The Texas Commission on Environmental Quality
(TCEQ) and Texas Water Development Board (TWDB) have exercised control of IPR through
discharge permitting conditions and water rights provisions. These include groundwater injection
(El Paso), river transport and withdrawal followed by artificial wetland treatment (North Texas
Municipal Water District and Tarrant Regional Water District), and water accounting programs
within several reservoirs (Trinity River Authority) subject to significant effluent discharges.
According to the 2012 Texas State Water Plan, water reuse will provide approximately 1.53
million acre-feet per year of water supply statewide by the year 2060 and will meet
approximately 18% of the projected water needs. However, TWDB reports there is significantly
more potential for development of water reuse as a water management strategy than is currently
include in the state water plan. Much of this potential is likely to be realized as more reuse
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projects are implemented and progress is made in communicating the advantages, benefits and
safety of potable reuse to the public (TWDB 2015).
Three DPR projects (without environmental buffer) have been authorized, with at least
one additional project (El Paso) in development and review. One of these projects (Colorado
River Municipal Water District, in Big Spring) has been in operation since April 2013, while a
second (City of Wichita Falls) began production in early July of 2014. The third DPR project, in
Brownwood, has been authorized for construction (Sloan 2013; Jones and Sober 2014; Nix and
Schreiber 2015).
Over the course of reviewing and approving the three DPR projects, TCEQ has
developed some internal consensus-based standards it applies for such projects. The overarching
goal is to consistently and conservatively meet the requirements of the SWDA (McDonald et al.
2015). Key features required for DPR projects to date include:
1. Approximate “doubling” of SWTR pathogen inactivation is required: 8-log for
viruses (9-log if chloramine disinfection is utilized), 6-log for Giardia and 5.5-log for
Cryptosporidium using multiple barriers. This inactivation includes subsequent
surface water treatment if applicable, but does not recognize any credit from upstream
WRRF treatment processes. Higher requirements could be imposed if the source
water is at risk of elevated pathogen levels compared to sources tested for recent DPR
proposals.
2. Critical treatment processes require continuous online monitoring with provisions for
automatic shutdown if treatment goals for acute health protection are jeopardized. A
storage buffer could be required if satisfactory real-time monitoring cannot be
achieved.
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3. Continuous monitoring of flows and calculation of blend ratio is required to maintain
reuse water fraction within established limit for system.
4. Advanced pilot testing is required to demonstrate extended satisfactory performance.
5. Industrial pretreatment program is subject to review to identify potential public health
vulnerabilities.
Approved blending ratios have varied and no standard limit is established. It is
anticipated that up to 50% of blended finished water could be approved from a reuse water
source without special measures beyond those applied to other DPR projects (TWDB 2015).
Out of necessity, the TWDB recently took the lead to bring together several industry and
academic experts to form advisory committees, similar to California, and develop the “2015
Direct Potable Reuse Resource Document” to provide public water systems with information on
the practice, risks, benefits, and potential guidelines for potable reuse (McDonald et al. 2015).
The TWDB identified 51 CECs for monitoring where public water systems are planning DPR
augmentation with WRRF secondary or tertiary effluents. As provided in Table 2-7, this list of
51 was derived from the 90th percentile measured occurrence from the EPA NCOD for CCL3
(McDonald et al. 2015).
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Table 2-7: Texas CEC List for DPR Systems
CEC
17α-estradiol
17β-estradiol
4-Nonylphenol
4-Octylphenol
Bisphenol A
cis-Testosterone
Diethylstilbestrol
Estrone
Ethinyl Estradiol
Progesterone
Testosterone
Acetaminophen
Atenolol
Azithromycin
Carbamazepine
Ciprofloxacin
Diclofenac
Dilantin
Erythromycin
Flurosemide
Gemfibrozil
Ibuprofen
Iopromide
Ketoprofen
Lipitor
17α-estradiol

Usage
hormone
hormone
surfactant
surfactant
plasticizer
hormone
hormone
hormone
hormone
hormone
hormone
pain med
cardio med
antibiotic
anti-seizure
antibiotic
pain med
anti-seizure
antibiotic
diuretic
cardio med
pain med
radiology agent
pain med
cardio med
hormone

CEC
Meprobamate
Metoprolol
Naproxen
o-Hydroxy atorvastatin
Primidone
Propanolol
Prozac
Salicylic acid
Sulfamthoxazole
Warfarin
Zocor
Caffeine
Triclocarban
Triclosan
Trimethoprim
Sucralose
Clofibric acid
DEET
Methylisothio-cyanate
TCDPP
TCEP
TCPP
Musk ketone
NDMA
PFOA

Usage
tranquilizer
cardio med
pain med
cardio med
anti-seizure
cardio med
antidepressant
pain med
antibiotic
cardio med
cardio med
stimulant
preservative
preservative
preservative
sweetener
pesticide
pesticide
pesticide
flame retardant
flame retardant
flame retardant
fragrance
DBP
non-stick coating

Source: TWBD 2015

2.4.2.3 Oklahoma
According to a July 2015 report to the state legislature, the Oklahoma Department of
Environmental Quality (ODEQ) has commissioned a water quality standards and technology
work group comprised of a cross-section of industry stakeholders (ODEQ 2015). The work
group is charged with:
1. Providing information regarding historical and ongoing research related to potable
reuse
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2. Drafting regulations and guidelines for IPR and DPR
3. Identifying challenges and questions that need to be addressed related to
implementation of potable reuse in Oklahoma
4. Developing recommendations for a process and revised timeline for establishing
indirect and direct potable reuse regulations in Oklahoma
ODEQ identified “Category 1” with three sub-categories to address reuse involving
potable applications. Category specific recommendations from the July 2015 report for each
reuse category are described in the following paragraphs (ODEQ 2015).
2.4.2.3.1

Category 1a - DPR

If necessary, until specific DPR guidance is developed, DPR projects should be
considered on a case-by-case basis under the variance process, similar to what has been done in
other states (e.g., Texas). Initiation of guidelines development was deferred until 2016 to allow
the work group to take advantage of resources being utilized for IPR initiatives (ODEQ 2015).
2.4.2.3.2

Category 1b – IPR (Surface Water)

The stakeholder group defined surface water IPR as the use of reclaimed water for
potable purposes by intentionally discharging municipal wastewater to a surface water supply
source such as a lake or river. The mixed reuse and natural surface water then receives additional
treatment before entering the drinking water distribution system. Definition of what, if any,
additional water quality or treatment requirements are needed remains in progress. However, the
general approach that is currently being pursued includes the definition of a “default” best
alternative treatment (BAT) advanced treatment scheme that, if implemented, would receive
approval without the need for site specific modeling studies. The default BAT advanced
treatment scheme currently under consideration includes:
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1. Source control
2. Pretreatment for reverse osmosis
3. Reverse osmosis
4. Ultraviolet disinfection with advanced oxidation process (AOP)
Treatment schemes (e.g., NF) other than the default BAT scheme would require the
applicant to demonstrate (e.g., pilot treat) compliance with surface water quality standards and
requirements still to be determined (ODEQ 2015).
2.4.2.3.3

Category 1c – IPR (Groundwater)

Development of Category 1c reuse guidance documents are planned following the
development of guidance for Category 1a and Category 1b (ODEQ).
2.4.2.4 New Mexico
The New Mexico Environment Department (NMED) has approved construction of a
DPR project in Cloudcroft, a remote resort town in the southeastern part of the state, but does not
have published regulations for potable reuse (EPA 2012). The Cloudcroft project has been
subject to lengthy delays and is understood to not yet be operational (NMED 2014). NMED
governs non-potable uses with the “Guidance Document on Above Ground Use of Reclaimed
Domestic Wastewater” and indicates their highest classification, Class 1A, reuse wastewater may
be used for any purpose except direct consumption, food handling and processing, and spray
irrigation of food crops (NMED 2007). The document also specifies other uses of reuse
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wastewater not included will be evaluated on a case-by-case basis by NMED to determine the
appropriate water quality classification for the given use (NMED 2007).
2.4.2.5 Arizona
Arizona currently does not have regulations specific to IPR or DPR, but in 2013, they
established the Steering Committee on Arizona Potable Reuse (SCAPR 2013) with the following
goals to advance potable reuse in the state:
1. Identify impediments
2. Define a common terminology
3. Gather best practices, state of the industry information, and case studies
4. Track California and Texas efforts
5. Create Advisory Panels
6. Conduct a scoping process to provide recommendations to the Arizona Department of
Environmental Quality (ADEQ) and the Arizona Department of Water Resources
(ADWR)
7. Develop a road map to I/DPR in Arizona
2.4.3

CEC Regulatory Summary
The EPA provides potable reuse regulation directly for CEC control through the setting

of NPDWR standard. To date, MCLs have been established for only three pesticide CECs. EPA
provides potable reuse regulation indirectly for CEC control through the CCL program and
“2012 Guidelines for Water Reuse.” Table 2-8 summarizes the CEC control regulatory status for
the states reviewed with ongoing DPR activity.
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Table 2-8: State Regulatory Summary for CEC Control

State
California

Indirect Potable Reuse (IPR)
Groundwater
Surface Water
Augmentation
Augmentation
Regulated:
In development:
CEC monitoring
planned for 2016

Texas

Case-by-case:
1 system in
operation

No CEC control
other than
WRRF TPDES

Oklahoma

In development:
planned for 2017

In development:
planned for 2016

New Mexico

Case-by-case

Case-by-case

Arizona

Case-by-case:
1 system in
operation

In development

Direct Potable Reuse
(DPR)
In development:
planned for 2016
Case-by-case:
CEC monitoring
2 systems in operation;
1 system in
implementation
In development:
planned for 2016
Case-by-case:
1 system in
implementation
Under consideration

Sources: EPA, CDPH, CEPA, CSWRCB, TCEQ, TWDB, ODEQ, OWRB, NMED, ADEQ, SCAPR

Out of critical necessity to meet water demand, several cases are indicated in Table 2-8
where DPR systems are in operation or implementation prior to the establishment of regulations
for CEC control. For regulation to catch up with necessity, states are now under advisement from
stakeholder committees consisting of academia, engineers, industry consultants, and PWS
managers to provide the vital knowledge required for the control of CECs in I/DPR applications.
Direction is required for what CECs to monitor, what CEC treatment levels to achieve, and what
treatment technologies (i.e. BAT, FAT) are best suited for the control of CECs (SCAPR 2013;
NWRI 2013; CSWRCB 2014a,b; TWDB 2015; ODEQ 2015; Tchobanoglous et al. 2015;
McDonald et al. 2015).
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2.5

Best Available Technology for CEC Control
BAT is a term introduced by the EPA when the SWDA was passed in 1974 to assist PWS

managers with selecting and implementing the best water treatment process technology or
technologies to comply with the new act (EPA 2015a,c; Jones 1990). Although PWS managers
have since adopted a multi-barrier approach to meet the increasingly stringent water quality
criteria of the SDWA and subsequent amendments, they face new treatment challenges (e.g.,
CECs) with implementation of DPR programs (Tchobanoglous et al. 2015). BAT in addition to
conventional treatment barriers will be required to meet these new treatment challenges (TWDB
2015; ODEQ 2015).
2.5.1

Regulatory BAT
Although the federal government has opted thus far not to develop DPR regulations, the

EPA has identified membrane filtration as a BAT for I/DPR in the “Guidelines for Water Reuse”
(EPA 2012). RO is identified in this document as an effective treatment barrier for CEC control.
California, Washington, and Florida require RO membrane treatment for IPR systems
prior to direct injection of reclaimed water into an aquifer utilized for potable supply (CDPH
2011; WSL 2007; FDEP 2014). For PWS considering DPR, Texas has identified six multibarrier treatment schemes, five with membranes (TWDB 2015). In Oklahoma, RO membrane
treatment has been identified as BAT in the default advanced barrier approach for PWS
considering IPR (ODEQ 2015).
2.5.2

Industry BAT
Gerrity et al. (2013b) reported the findings of a world-wide survey of multi-barrier

process trains for the whole gamut of planned and unplanned potable reuse applications. Both
IPR and DPR application examples are cited. This survey identified only one international and
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two US-based DPR systems world-wide that are in operation (Gerrity et al. 2013). Integrated
membrane systems using MF followed by RO membranes are the adopted industry standard for
IPR applications via direct injection into an aquifer (Drewes et al. 2006; Asano et al. 2007; NRC
2012). In the absence of established DPR-specific regulations, both operational DPR PWS in
Texas (Big Spring and Wichita Falls) have adopted an advanced barrier approach including an
integrated membrane system with RO membranes followed by an advanced oxidation process
(AOP) in complement with conventional barriers (TWDB 2015). In the “Framework for Direct
Potable Reuse” recently published by AWWA, WEF, NWRI, and Water Reuse Research
Foundation, RO membranes and AOP are recommended final barriers in an integrated treatment
scheme to achieve advanced water treatment (AWT) for DPR application. In general, where RO
membranes are used, finished water is of higher quality than conventionally treated waters with
respect to total organic carbon (TOC), total dissolved solids (TDS), and trace CEC; however,
regulators, public health professionals, and practitioners have not reached consensus as to the
appropriate framework and governing BAT parameters for potable reuse (Tchobanoglous et al.
2015).
2.5.3

Membrane Classification
Membranes are man-made proprietary separation materials that provide a physical barrier

in which structural parameters such as pore size, molecular weight cutoff (MWCO), surface
charge (zeta potential), and hydrophobicity (contact angle) are designed for the rejection of target
constituents or contaminants such as CECs and their QSAR properties (Wickramasinghe and
Jones 2013; Abolmaali et al. 2015). Figure 2-2 illustrates the membrane filtration spectrum by
process separation classification, pore size, MW, and relative size of common materials.
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Figure 2-2: Membrane Filtration Spectrum

Membranes are classified according to their respective pore size, MWCO, and
transmembrane pressure (TMP). The pore size for a membrane quantifies the general size of
individual opening or void. MWCO is an approximate size of molecule that will be excluded
from passing through the membrane. TMP is the driving force required to force the solution
through the membrane. A general classification of membranes according to these parameters is
presented in Table 2-9 (Jonsson 1985; Bellona et al. 2004; Asano et al. 2007; Wickramasinghe
and Jones 2013; EPA 2014; Abolmaali et al. 2015).
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Table 2-9: Membrane Classifications for Water Treatment
Typical
TMP
Range
(psi)

MWCO
(Da)

Pore Size Range
(µm)

Microfiltration
(MF)

15 - 60

ND

0.1 - 1.0

Ultrafiltration
(UF)

30 - 100

≥ 103

0.01 - 0.1

virus

Nanofiltration
(NF)

50 - 150

≥ 200

ND

CEC: EDC,
pesticides,
PPCP

Reverse Osmosis
(RO)

100 – 1,000

< 200

ND

TDS, salts

Membrane
Classification

Typical
Target
Contaminants
TSS,
bacteria,
Giardia,
Crypto

Source: Jonsson 1985; Bellona 2004; Asano 2007; EPA 2014; Wickramasinghe 2013; Abolmaali 2015
ND = nondefinable

As shown in Table 2-9, membrane treatment processes are distinguished by the size of
contaminants removed. Microfiltration (MF) and ultrafiltration (UF) remove suspended solids
via steric exclusion based on the size of the membrane pores relative to the particulate matter.
NF and RO membranes, which do not have definable pores, remove dissolved solids (i.e. solutes)
and are thereby industry classified by MWCO (EPA 2014).
TMP can be energy intensive. The osmotic pressure alone for desalination of ocean
water, with 30,000 mg/L total dissolved solids (TDS), is over 300 psi. Osmotic pressure
combined with TMP, an RO desalination system pressure can approach 1,000 psi
(Wickramasinghe and Jones 2013; Abolmaali et.al 2015).
MWCO is a high pressure (e.g., NF and RO) membrane-specific parameter that is often
applied for selection of the appropriate membrane for solute separation. The industry accepted
practice for membrane MWCO identification is the minimum solute MW that is retained or
rejected by 90% or greater. Often, the MWCO for salt-rejecting membranes, such as NF, are
determined with freshly-prepared membrane coupons in idealized, pH buffered, salt solutions
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(typically CaCl2, NaCl, Na2SO4 and MgSO4) (Lin et al. 2007). A comparison of MWCO and
atomic force microscopy for assessing the mean pore diameter of membranes found excellent
agreement for low-MWCO membranes, like NF (Bowen and Doneva 2000). However, it has also
been shown that solvent-membrane interactions affect the MWCO determination for NF
membranes of equivalent pore size but varying membrane composition (Zwijnenberg et al.
2012). Therefore, while the manufacturer-supplied MWCO is useful in the initial screening of
membranes, a complete analysis of the system (i.e., solvent, solute for separation, membrane
properties) is necessary for optimized separation applications.
Membrane surface charge is quantified by zeta potential. Manufacturers design modern
TFC NF and RO membranes with a negative surface charge to resist fouling. Because many
CECs in reuse water are also charged, the negative membrane surface charge enhances the
rejection of ionic CECs. A membrane surface with a high affinity for water is called hydrophilic,
while those with a low affinity are called hydrophobic. The contact angle provides a measure of
hydrophobicity of a membrane surface. For hydrophobic membranes, the contact angle will have
a value greater than 90º, whereas the hydrophilic membranes will have a contact angle value less
than 90º (Yangali-Quintanilla et al. 2011; Wickramasinghe and Jones 2013; Abolmaali et al.
2015).
Membrane materials generally utilized for water treatment include cellulose acetates,
synthetic polymers (polyamides and polytetrafluoroethylene), and ceramics (Seader et al. 2011;
Abolmaali et al. 2015). Commercially available membranes in use today for DPR applications
are polymeric hollow-core fibers for low pressure removal of suspended solids and TFC for high
pressure rejection of dissolved solids (Drewes et al. 2001; Asano et al. 2007; Al-Rifari et al.
2011; EPA 2014; Jones and Sober 2014; McDonald et al. 2015; Abolmaali et al. 2015).
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Manufacturers of newer proprietary TFC membranes can add chemical functionality such as
sulfonic or carboxylic acid groups in order to improve target CEC rejection while allowing for
thinner membranes and a decrease in system pressure requirements (Bellona et al. 2004; Asano
et al. 2007).
Series membrane system configurations utilizing low-pressure (LP) membranes in series
with high-pressure (HP) membranes are the water industry standard for the treatment of reuse
source waters such as WRRF effluent, brackish water, and seawater (Drewes et al. 2001; Asano
2007; Wickramasinghe and Jones 2013; Sloan 2013; Nix and Schreiber 2015). LP membranes
serve as the best pretreatment to remove constituents attributable to HP fouling. The LP
membranes are typically designed in a submerged vacuum (described previously) or pressure
modular configuration, whereas operating pressures required for HP membranes dictate spiralwound pressure module configurations (Asano et al. 2007).
2.6

NF Advantages over RO
There has been abundant work to verify the best membrane separation system to achieve

the treatment objective for the least required energy and least waste generated (Bellona et al.
2008; Bellona et al. 2012; Jones and Kruger 2013; Jones et al. 2014; Abolmaali et al. 2015;
ODEQ 2015; Watts et al. 2016). RO represents a major capital and O&M expense not seen with
conventional PWS treatment technologies. For PWS source water applications of TDS < 2,000
mg/L, required TMP for RO is typically 100 psi or more than NF. This translates into more
energy requirements and higher pressure classifications for process pumps, pipes, and valves. An
RO system also produces a brine reject waste that can represent new treatment and disposal
challenges to a PWS.
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Previous side-by-side pilot testing of NF and RO membranes at a WRRF in California
(Bellona et al., 2008) observed nearly identical water recovery rates (>80%), TOC rejection rates
(>98%), ammonia rejection rates (>93%), and rejection of UV absorbing organics (>90%). Using
a DOW Filmtec NF-90 membrane filtration system, pilot performance indicated a significant
cost-savings (due to higher operating permeate fluxes) for full-scale water recycling with NF as
opposed to conventional RO membrane filtration. A critical economic comparison of the two
processes for full-scale potable reuse implementation estimated between $55,000 and $188,000
annual cost savings when operating NF membranes (instead of RO) at permeate fluxes between
17 and 25.5 LMH (Bellona et al. 2012).
Three commercially available NF and RO membranes by Dow Filmtec, Toray, and GE
Osmonics were pilot tested by Jones et al. (2014) in parallel for implementation of a new 4 MGD
series membrane WTP in Alabama. Both NF and RO were verified to meet treatment
performance objectives. Based on pilot testing results, it was determined total capital cost could
be reduced by $2.2 million and annual energy cost reduced by $55,000 with implementation of
NF rather than RO. An ancillary reject waste treatment process was required with the RO option.
The reject waste processing was not required with the NF option as reject was determined
acceptable for discharge to the WRRF (Jones et al. 2014).
An additional economic consideration for selection of ion-rejecting membrane is the cost
of concentrate treatment and disposal. Where RO rejects both mono- and multivalent ions, NF
rejects only the multivalent ions. An ongoing alternative water supply study for an Oklahoma
community estimated that RO concentrate disposal from a planned new DPR facility would
require $14 million for the construction of up to 2 MGD of RO reject conveyance and disposal
via deep-well injection (Watts et al. 2016). Due to the high initial capital costs of RO concentrate
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management, this project is currently evaluating NF as an alternative to RO that would produce a
less saline concentrate that could be safely discharged to the WRRF or a receiving stream (Watts
et al. 2016).
The default RO FAT approach to CEC control for DPR may be questioned if we consider
new commercially available tight (i.e., MWCO ≤ 200 Da) TFC NF membranes. Tight TFC NF
membranes may provide acceptable CEC rejection efficacies for less capital, O&M, power, and
waste generated (Bellona et al. 2008; Bellona et al. 2012; Jones and Kruger 2013; Jones et al.
2014; Abolmaali et al. 2015; ODEQ 2015; Watts et al. 2016).
2.7

Reported CEC Removal
The following section reviews previous literature on reported CEC removal by WRRF

biological and membrane treatment barriers.
2.7.1

Degradation and Sorption by WRRF
A conventional WRRF, required to meet National Primary Discharge Elimination System

(NPDES) secondary standards, is the first barrier treatment in a reuse system and typically
includes a liquid treatment process train consisting of physical, biological, and chemical units
(Tchobanoglous et al. 2014; Kolpin et al. 2002). Primary treatment typically includes screening,
grit removal, and primary clarification. Secondary treatment typically includes a biological
reactor and disinfection process. The biological process can range from a fixed-film reactor for
biochemical oxygen demand (BOD) removal to suspended-growth activated sludge for BOD
removal and ammonification to a biological nutrient removal (BNR) process that includes
anaerobic/anoxic/aerobic swing zones for BOD removal, ammonification, nitrification, denitrification, and phosphorus removal. In the event the NPDES permit requires disinfection,
chlorination/de-chlorination or ultra-violet (UV) oxidation is typically employed. Additional
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biodegradation (or digestion) can be provided in the solids treatment processing via either
aerobic or anaerobic digester units followed by dewatering, drying, and/or stabilization prior to
land application, landfill, or otherwise terminal application.
Previous work has been performed to provide a comprehensive description of the
behavior of CECs in WRRF processes (Luo et al. 2014; Rattier et al. 2014; Gerrity et al. 2013;
Dickenson and Drewes 2008; Drewes et al. 2006; Birkett and Lester 2003). Three main removal
pathways for CECs were identified:
1. Biodegradation and sorption to the mixed liquor suspended solids (MLSS)
2. Additional biodegradation through extended solids retention time (SRT) in
suspended-growth reactors and the solids destruction digesters
3. Oxidation in the disinfection process
CECs with relatively high (>2.0) octanol-water partitioning coefficients (Kow) may sorb
to MLSS before significant degradation occurs (Johnson and Sumpter 2001; Holbrook et al.
2002). As such, sorption to biosolids has been found to be a significant CEC removal
mechanism. Many studies have examined the removal of CECs by sorption to biosolids by
comparing influent, effluent, and solids concentrations of CECs. The highest concentration of
CECs were found in the biosolids at concentrations 1,000 times greater than that found in the
influent (Holbrook et al. 2002; Clara et al. 2004).
Biodegradation of CECs has also been demonstrated. Study of WRRFs has revealed
impressive CEC removal at SRT values greater than 10 days and food to microorganism (F:M)
ratios of 0.2 – 0.3 kg BOD5/kg TSS∙day. It was reported that the relatively low F:M ratio requires
the microorganisms to be more selective, thereby improving CEC removal performance (Lee et
al. 2003; Kreuzinger et al. 2004).
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Oxidation for removal of CECs by chlorination (30% to 82%) has been found more
effective than UV (<1 to 52%), thereby indicating disinfection processes not subject to
transmissivity may be more effective for CEC removal in secondary effluents and UV
disinfection more suitable for tertiary effluents (Luo et al. 2014). Table 2-10 shows that a
comprehensive evaluation of several secondary treatment WRRFs for the removal of CECs
revealed overall efficiencies ranging from 5% to 99% (Drewes et al. 2006; Behera et al. 2011;
Luo et al. 2014).
As shown previously in Table 2-2, and below in Table 2-10, others have reported varying
degrees of CEC biodegradability between WRRF primary and secondary treatment (Drewes et
al. 2006; Behera et al. 2011; Oppenheimer et al. 2011; Luo et al. 2014).
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Table 2-10: CEC Removal by WRRF Secondary Treatment
CEC
17α-Ethynyl Estradiol
17β-Estradiol
4-t-Octylphenol
Bisphenol A
Estriol
Estrone
Nonylphenol
Testosterone
Acetaminophen
Atenolol
Carbamazepine
Diclofenac
Gemfibrozil
Ibuprofen
Ketoprofen
Lincomycin
Naproxen
Sulfamethazine
Sulfamethoxazole
Caffeine
Triclosan
Trimethoprim
Sucralose
Atrazine
Clofibric acid
DEET
Diuron
TCEP
TCPP

Hydro
Classificationa
HB-N
HB-N
HB-N
HB-N
HB-N
HB-N
HB-N
HB-N
HL-N
HL-N
HB-N
HB-I
HB-N
HB-I
HB-N
HL-I
HB-N
HL-I
HL-I
HL-N
HB-I
HL-I
HL-N
HB-N
HB-N
HB-N
HB-N
HB-N
HB-N

Range in Primary
Effluents
(ng/L)
ND – 13
ND – 150
100 - 13,000
40 -100
ND – 802
7.3 -132
1,300 - 343,000
24 -180
3,540 – 10,234
5,113 – 11,239
43 – 127
59 -243
101 – 318
1,599 – 2,853
81 – 286
3,095 – 19,401
1,360 – 5,033
ND – 343
79 – 216
1,608 – 3,217
247 – 785
101 – 277
14,000 – 49,000
20 – 28,000
ND – 65
2,560 – 3,190
30 – 1,960
60 – 500
180 – 4,000

Range in Secondary
Effluents
(ng/L)
ND - 7.5
ND - 43
ND - 1,300
ND - 17,300
ND - 18
ND - 108
ND - 9,100
ND
ND - 27
261 – 5,911
40 - 74
13 - 49
9 - 26
15 - 75
ND - 37
1,437 – 21,278
37 - 166
ND - 408
20 - 162
ND - 60
79 - 149
13 - 154
15,000 – 43,000
4 - 730
ND - 6
610 – 1,580
2 – 2,530
60 – 2,400
100 – 21,000

Removal
Efficiencyb
(%)
100
100
48.4
81.1
100
87.1
60.4
100
99.9
64.5
< 10
81.4
92.3
98.2
94.2
< 10
95.7
13.1
51.9
99.2
79.6
69
< 10
12.5
93.6
61.9
48.5
< 10
< 10

ND = Below analytical detection limit
Sources: Drewes 2006; Behera 2011; Oppenheimer 2011; Luo 2014; ACS 2015, ChemAxon 2015; Yangali-Quintanilla 2010
a
Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charge
b
Calculated average values

In summary, reported data proves that WRRF secondary treatment is effective for
removal of some CECs. Best performance was seen with biological reactors optimized for 10day or greater SRT and lower than typical F:M ratios. For WRRF secondary treatment process
trains optimized for CEC removal, efficiencies greater than 50% should be anticipated for EDCs,
stimulants, and most pharmaceuticals. However, the literature indicates less than 50% removal
efficiencies can be expected from WRRF secondary treatment for preservatives, flame
retardants, pesticides, artificial sweeteners, and some pharmaceutical antibiotics.
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2.7.2

Rejection by NF and RO
The following section reviews previous literature on reported CEC rejection for bench,

pilot, and full-scale NF and RO membranes. In some cases results represent the total rejection
efficacy of an NF/RO membrane in series following an MF/UF membrane.
Appleman et al. (2013) reported the results of a bench-scale study comparing a loose NF
membrane (NF270) to three granular activated carbon (GAC) adsorption columns for the
removal of eight perfluorinated (PFA) compounds ranging in MW from 214 to 400 g/mole. The
testing used lab-synthesized PFA compounds in DI water as well as in a simulated ground water
matrix. Virgin membrane as well as membranes fouled with humic acids were employed. The
membrane experiments revealed that greater than 93% removal can be obtained for all of the
selected PFA compounds including the shortest chain compound. The data revealed that the
presence of natural organic matter (NOM) did not have a negative effect on the rejection of PFA
compounds (Appleman et al. 2013).
Yangali-Quintanilla (2010) conducted a bench-scale with two Dow Filmtec NF
membranes using synthetically contaminated water. The CEC rejection results and
corresponding hydrophobicity classification are provided in Table 2-11.
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Table 2-11: Bench-Scale CEC Rejection by NF Membranes
CEC

Classificationa

NF 90b
(%)

NF 200c
(%)

17β-estradiol

HB-N

92.7

80.6

Bisphenol-A

HB-N

91.5

50.4

Estrone

HB-N

93

92.2

Nonylphenol

HB-N

91.3

91.7

Acetaminophen

HL-N

75.2

68.5

Carbamazpine

HB-N

91.3

78.8

Ibuprofen

HB-I

96.2

77.3

Metronidazole

HL-N

83.5

53.7

Naproxen

HB-I

96.2

76.8

Phenacetin

HL-N

80

50.4

Phenazone

HL-N

85.9

60.4

Sulfamethoxazole

HL-I

94.5

61.6

Caffeine

HL-N

84.8

62.7

Atrazine

HB-N

95.7

88.6

Source: Yangali-Quintanilla 2010
a
Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic
b
NF90: MWCO = 200 Da; c NF200: MWCO = 300 Da

Drewes et al. (2006) studied the rejection of synthetic water spiked with CECs in a pilot
study using a single-stage Koch 2540 TFC-HR spiral wound element, an RO membrane with
full-scale installations in service for I/DPR. The pilot feed water was an effluent organic matter
matrix representing both a common makeup of secondary treated effluents (after MF) and a
consistent background quality throughout the test run. The synthetic matrix was prepared with
secondary effluent from a local WRRF in Colorado. The secondary effluent was microfiltered
and then concentrated to a 3:1 ratio using a Dow FilmTec XLE RO membrane. After a feed
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blank was taken for background control, the target CECs were spiked from the stock solution to
the feedwater in a SST drum and mixed overnight. During the pilot RO operation, the recovery
rate was established at 90.2%. To season the element, 20L of feedwater was passed through the
element and allowed to stabilize overnight. After 180L of additional feedwater was passed
through the membrane vessel, final samples were taken from the permeate and reject. Total
rejection was observed for the estrogen-based CECs. The phenol-based CECs were rejected at
99%. Table 2-12 shows that the rejection of CECs from the spiked water matrix during pilot
testing.
Table 2-12: Pilot-Scale CEC Rejection by RO

CEC
Nonylphenol
4-t-Octylphenol
Bisphenol A
17β-Estradiol
Estrone
17α-Ethinylestradiol

Spiked
EfOM
Feedwater
(ng/L)
6,958
812
80,720
21.9
43.2
25

Koch TFC-HR
Permeate
(ng/L)
86.1
11.1
689.4
ND
ND
ND

Reject
(ng/L)
8,814
1,053
115,042
28.9
57.5
42.5

Removal
(%)
98.8
98.6
99.1
100
100
100

Source: Drewes et al. 2006
ND = non-detectable

Snyder et al. (2004) evaluated the rejection of CECs for tertiary effluent in a full-scale
MF/RO integrated membrane operating system (MOS). Facility I, as it is known, is currently in
operation with a RO capacity of 12 MGD. The process train for Facility I consists of a typical
WRRF secondary effluent followed by MF/RO and includes grit removal, primary clarification,
activated sludge biological treatment through a sequence of anoxic and aerobic swing zones,
secondary clarification, tertiary dual-media filtration (anthracite/sand), chloramine disinfection,
and MF in series with RO. The MF/RO finished water is used for aquifer storage and recovery
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(ASR) via direct injection. Full-scale testing occurred over a 48-hr period using RO Train #4
with a process capacity of 1.0 MGD. The RO feedwater was nitrified/denitrified tertiary filtered
water that was pH adjusted to 6.3 using sulfuric acid, microfiltered (Siemens Memcor MF), and
dosed with an antiscalent (Hypersperse, GE Betz). The process train operated with an overall
recovery rate of 85%. The RO MOS design was a three-stage configuration of Koch TFC-H
Magnum spiral-wound elements (24-10-5) loaded with a specific flux of 0.07 gfd/psi (Snyder et
al. 2004).
Sampling of the full-scale RO MOS demonstrated rejection below the detection limit for
the suite of CECs tested. The tested CECs in these evaluations are all considered hydrophobic,
with low Kow values in the range of 3.13 to 5.28. Their molecular weights vary from 266-340 Da
and therefore represent a size well above the MWCO of the tested Koch RO membrane.
Therefore, hydrophobic/hydrophobic interactions between solutes and membrane as well as
steric exclusion were determined responsible for the high removal efficiencies observed for this
suite of CECs. Based on the CECs rejection results reported in Table 2-13, the research group
concluded RO is an effective barrier for CECs in reuse application (Snyder et al. 2004).
Table 2-13: Full-Scale CEC Rejection by MF/RO Series Membranes
Feedwater (MF Permeate)

RO Permeate

CEC
C1
(ng/L)

C2
(ng/L)

C3
(ng/L)

P1
(ng/L)

Nonylphenol

208

441

766

4-t-Octylphenol

13

14

61

Testosterone

4.6

3.8

Estrone

4.7

6.6

Removal
(%)

P2
(ng/L)

P3
(ng/L)

ND

33

ND

100

ND

ND

ND

100

4.7

ND

ND

ND

100

23.3

ND

ND

ND

100

Source: Snyder et al. 2004
ND = non-detectable
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The BOR and 14 Southern California PWS partners evaluated WRRF secondary effluent
for suitability for I/DPR application and conducted a demonstration study to verify membrane
technology as an effective barrier for CEC control (USBOR 2009; Snyder et al. 2007). Table 214 shows the rejection results of 36 CECs for the demonstrated NF and RO membranes.

Table 2-14: CEC Rejection Demonstration by NF and RO Membranes
CEC
Andorostenedione
Estradiol
Estriol
Estrone
Ethinyl Estradiol
Oxybenzone
Progesterone
Testosterone
Acetaminophen
Carbamazepine
Diazepam
(Valium)
Diclofenac
Dilantin
Erythromycin
Fluoxetine
(Prozac)
Gemfibrozil
Hydrocodone
Ibuprofen (Advil)

NF
(%)
50-80
50-80
50-80
50-80
50-80
>80
50-80
50-80
25-50
50-80

RO
(%)
>61
N/A
N/A
>95
N/A
>93
N/A
N/A
>90
>99

Iopromide
Lindane (a-BHC)
Meprobamate
Naproxen
Pentoxifylline
Sulfamethoxazole
Caffeine
Triclosan
Trimethoprim
Atrazine

50-80

N/A

DDT

50-80
50-80
>80

>97
>99
>98

DEET
Metazachlor
TCEP

>80

>96

Benzo(a)pyrene

50-80
50-80
50-80

>99
>98
>99

Fluorene
Galaxolide
Musk Ketone

CEC

NF
(%)
>80
50-80
50-80
20-50
50-80
50-80
50-80
>80
50-80
50-80

RO
(%)
>99
N/A
>99
>99
>96
>99
>99
>97
>99
N/A

>80

N/A

50-80
50-80
50-80

>95
N/A
>91

>80

>90

>80
50-80
>80

N/A
>98
N/A

Source: USBOR 2009; Snyder et al. 2007
N/A: Not Available

The EPA has released the results of an extensive literature review of published studies of
the effectiveness of various treatment technologies for CECs (EPA 2014). In response to
emerging concerns about the possible impacts of pharmaceuticals, hormones, detergents, and
other chemicals on human health and aquatic organisms, the EPA searched over 400 publications
that referenced treatment of CECs. About 100 of those sources contained treatment information
which was entered into the database. The EPA compiled and summarized the results reported by
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researchers in the last five years. The research occurred primarily in the US, Canada, and
Europe. Although the EPA database includes results from over 400 publications on the subject,
there were fewer than 10 operating RO membrane units, zero full-scale, and only 13 bench-scale
NF membrane units from which to report CEC rejection efficacies (EPA 2014). A query of the
database specific to full-scale membrane rejection yielded the data for 51 CECs as provided in
Table 2-15.

Table 2-15: Full-Scale CEC Rejection by RO Membranes
CEC

(% / #)

CEC

(% / #)

17α-estradiol
Andorostenedione
Bisphenol A
Diethylstilbestrol
Equilin
Estradiol
Estrone
Ethinyl Estradiol
Oxybenzone
Testosterone
Acetaminophen
Carbadox
Carbamazepine
Cephalexin
Ciprofloxacin
Diazepam (Valium)
Diclofenac
Dilantin
Enfroflaxacin
Erythromycin
Fluoxetine (Prozac)
Gemfibrozil
Hydrocodone
Ibuprofen (Advil)
Iopromide
Lincomycin

23 / 1
81 / 1
33 / 2
65 / 1
31 / 1
65 / 2
77 / 4
19 / 1
75 / 7
75 / 2
64 / 4
35 / 1
84 / 6
85 / 1
98 / 1
58 / 1
97 / 4
99 / 5
83 / 1
99 / 4
90 / 4
84 / 5
98 / 4
91 / 4
87 / 6
80 / 1

Meprobamate
Monensin
Nalidixic acid
Naproxen
Norfloxacin
Pentoxifylline
Primidone
Roxithromycin
Sulfachloropyridazine
Sulfamethazine
Sulfamethizole
Sulfamethoxazole
Sulphasalazine
Caffeine
Triclosan
Trimethoprim
Atraton
DEET
Metolachlor
TCPP
TDCPP
Tri(chloroethyl) phosphate
Alachlor
Galaxolide
Musk Ketone

99 / 5
90 / 1
25 / 1
73 / 5
90 / 1
98 / 2
98 / 1
88 / 1
12 / 1
19 / 1
17 / 1
81 / 5
89 / 1
66 / 5
95 / 4
95 / 5
5/1
93 / 6
14 / 1
98 / 1
89 / 1
97 / 6
6/1
99 / 3
85 / 3

Source: EPA 2014. http://water.epa.gov/scitech/swguidance/ppcp/results.cfm. Reported rejection rates are reported Average
Rejection % / # units.
No NF membrane units reporting
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2.8

NF Membrane Rejection Theory
This section reviews previous work relative to membrane rejection theory for the control

of CECs in I/DPR applications. Specifically, an understanding of relative CEC QSAR properties
and membrane rejection mechanisms is necessary for modeling purposes.
2.8.1

Physiochemical Properties of CECs (QSAR)
The American Chemical Society (ACS) maintains and catalogues an authoritative

collection of disclosed chemical substance information in a registry by Chemical Abstracts
Service Number, or CASN (ACS 2015; ChemAxon 2015). The CAS Registry is maintained by
the ACS CAS Division. Currently, the CAS Registry identifies more than 81 million organic and
inorganic substances, with physiochemical and/or structural characterization information about
each substance. The registry is updated with approximately 15,000 additional new substances
annually (ACS 2015). A tool for the molecular characterization of CECs, the CAS Registry
maintains QSAR properties such as molecular weight, size, ionic charge, ionizing and
partitioning coefficients, polarity, and solubility.
2.8.1.1 Molecular Weight
Molecular weight (MW) of a compound is the sum of the mass of each constituent atom.
Atomic weight of a substance is the average atomic mass for an element. Atomic weights of the
atoms are available from the periodic table and can be summed to obtain molecular weight. MW
of a substance is measured in the unit grams/mole (g/mole).
2.8.1.2 Molecular Surface Area
Molecular and polar surface area are usually expressed in units of square angstroms (Å2).
Molecular surface area (MSA) can be defined as the surface area of a molecule that is accessible
to a solvent (ChemAxon 2015). MSA was first described by Lee and Richards (1971) and is

49

sometimes called the Lee-Richards surface area. However, MSA is typically calculated using the
“rolling ball” algorithm developed by Shrake and Rupley (1973).
2.8.1.3 Net Electrical Charge
The electrical charge of a CEC is generated when the compound of ions, atoms, or
molecules includes a total number of electrons that is not equal to the total number of protons,
giving the compound a net positive (+) or negative (-) electrical charge (ACS 2015). When the
number of electrons and protons are in equilibrium, the compound has no charge and is referred
to as neutral (0). Since all ions are charged, they are attracted to opposite electric charges and
repelled by like charges. In chemical terms, if a neutral atom loses one or more electrons, it has a
net positive charge. If an atom gains electrons, it has a net negative charge. The net charge of an
ionizable atom is zero, or neutral, at a certain pH. This pH is referred to the isoelectric point
(ChemAxon 2015).
2.8.1.4 Acid Dissociation Constant (pKa)
The Acid Dissociation Constant (pKa) value of a CEC is a quantitative measurement of a
chemical compound’s acidity in solution (Schwarzenbach et al. 2003; Benjamin and Lawler
2013). The pKa is derived from the equilibrium constant for the acid’s dissociation reaction, Ka.
pKa = -log10 Ka = pH + log10 (conjugate acid/conjugate base)

Eq. (2.1)

An organic conjugate acid is a species formed by the reception of a proton (e.g.,
hydrogen ion); conversely, an organic conjugate base is a species formed by the removal of a
hydrogen ion from an acid. The lower the pKa value, the stronger the acid. The higher the pKa,
the weaker the acid. Very strong acids have pKa values less than zero, while weak acids
generally have pKa values between 0 and 9 (Schwarzenbach et al. 2003; Benjamin and Lawler
2013).
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2.8.1.5 Octanol-Water Partition Coefficient
The octanol-water partition coefficient (Kow) can been utilized to quantify the
hydrophobicity of a CEC (Yangali-Quintanilla et al. 2011). Organic compound Kow values are
defined as the ratio of the compound’s concentration in a known volume of n-octanol to its
concentration in a known volume of water after the octanol and water have reached equilibrium
(EPA 2015a). Expressed another way, Kow is a dimensionless concentration ratio whose
magnitude expresses the distribution of a compound between n-octanol (a non-polar solvent) and
water (a polar solvent). The higher the Kow, the more non-polar the compound. And, the lower
the Kow, the more polar the compound. Log Kow values are generally inversely related to CEC
solubility and directly proportional to MW (Schwarzenbach et al. 2003; Benjamin and Lawler
2013).
A high log Kow is a relative indicator of the CEC tendency to come out of aqueous
solution and adsorb to a solid medium such as a filter medium or membrane. Generally, CECs
with log Kow values less than 2.0 are considered hydrophilic (HL), or having a relatively high
affinity for water, whereas CECs with log Kow values greater than or equal to 2.0 are considered
hydrophobic (HB), or having a relatively low affinity for water (Schwarzenbach et al. 2003;
Yangali-Quintanilla et al. 2011; Benjamin and Lawler 2013).
2.8.1.6 Octanol-Air Partition Coefficient
The octanol–air partition coefficient, Koa, is defined as the ratio of solute concentration in
air versus octanol solvent when the octanol–air system is at equilibrium (Li et al. 2006). Koa has
been used extensively for describing the partitioning of organic compounds between air and
solute organic phase. Koa has a strong temperature dependence, which can be described by
Log Koa = A + (ΔHoa)/(2.303RT)

Eq. (2.2)

51

where A is the intercept; ΔHoa is the enthalpy change involved in octanol-to-air transfer of a
chemical, R is the ideal gas constant, and T is absolute temperature (Schwarzenbach et al. 2003).
This temperature dependence is important for assessing the potential long-range transport of
CECs. As such, Koa has been shown to be a key QSAR property pertinent to the long-term Great
Lakes contamination potential of CECs, where relatively soluble CECs are subject to transport in
colder climates (Wren 1991; Mac et al. 1993).
Koa can also be expressed as a function of the Kow and air-water partition constant (Kaw),
known as Henry’s law constant (Schwarzenbach et al. 2003).
Koa = Kow / Kaw

Eq. (2.3)

Henry’s law is one of the ideal gas laws formulated by the British chemist William Henry
in 1803 and can be expressed for dilute solutions as a function of the solubility of a gas in a
liquid and the partial pressure of the gas subjected to the liquid (Schwarzenbach et al. 2003;
Benjamin and Lawler 2013). Various forms of Henry’s law exist. For assessing the equilibrium
distribution of a given CEC in an air-water system, the dimensionless form below will be
assumed for standard atmospheric pressure and a given temperature.
Kaw = Ca/Cw = KH/RT

Eq. (2.4)

where Ca is the equilibrium concentration in the air phase and Cw is the equilibrium
concentration in the water phase. Similar to Kow, as discussed previously, the value of Kaw for a
given CEC has been observed to generally decrease with increased water solubility (YangaliQuintanilla et al. 2011).
2.8.1.7 Polarizability (α)
An induced dipole is generated by partial charges of a CEC molecule that has a tendency
to alter the external electric field (Miller and Savchik 1979). This phenomenon is referred to as
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polarizability, α. An empirical equation for the calculation of the average molecular
polarizability, α, was developed by Miller and Savchik (1979):
α = (4/N) [ƩAґA]2 (Å3)

Eq. (2.5)

where ґA represents the sum of atomic hybrid components of α, N is the total number of electrons
in the molecule, and A represents all atoms (A = 1, 2, 3…), and is expressed as cubed angstroms,
Å3. The ACS maintains polarizability values for each recorded chemical compound as a QSAR
molecular property within the CAS Registry database (ACS 2015).
2.8.1.8 Water Solubility
The solubility of a CEC in water may be defined as the maximum amount, or
concentration, of the compound that will dissolve in pure water at a specified temperature (EPA
2015a). Above this concentration, the water is considered a super-saturated aqueous solution.
Generally speaking, water solubility is the extent to which a CEC will dissolve in water. Log
water solubility (Sw) is typically inversely related to MW. Aqueous concentrations are usually
stated in terms of mass per volume or weight ratios (e.g., mg/L, µg/L, or ηg/L).
2.8.2

Rejection Mechanisms
Bellona et al. (2004) conducted a comprehensive literature review of previous work to

identify the rejection mechanisms and factors affecting rejection of organic solutes (i.e., CECs)
by NF/RO membranes. The authors reported the following key CEC physical-chemical
properties affect rejection:
1. Molecular weight (MW) and size (length and width)
2. Ionic charge (neutral, +, or -), as a function of the acid disassociation constant (pKa)
3. Hydrophobicity (HB or HL), as a function of the octanol-water coefficient (log Kow)
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Bellona also reported the following key membrane mechanisms affect rejection:
1. Steric exclusion (as a function of MWCO)
2. Electrostatic surface charge exclusion or adsorption (as a function of zeta potential)
3. Hydrophobic/hydrophilic adsorption, as a function of contact angle
The authors also concluded that tight NF membranes (with MWCO ≤ 200 Da) exhibit
similar membrane rejection properties as RO and are preferred over open NF membranes (with
MWCO >200 to 400 Da) for CEC control. Furthermore, the membrane skin for most TFC
membranes is designed by the manufacturer to carry a negative charge to minimize fouling
attributable to the adsorption of negatively charged solutes present in feed waters as it relates to
the electrostatic charge rejection mechanism. This negative charge (i.e., zeta potential) for most
membranes has been observed to become increasingly more negative as feed water pH is
increased. Based on this phenomenon, the authors concluded that increased pH in the solute feed
water led to increased rejection rate of ionic charged CECs with modern TFC membranes
(Bellona et al. 2004).
Another study of CEC rejection phenomena by Linden et al. (2012) reported the key
solute parameters that determine how effectively a membrane will reject a given CEC are its
molecular weight, its dissociation constant (pKa), its hydrophobicity (expressed as partitioning
constant log Kow), and its ionic charge (+, -, or neutral). Additional study determined the key
rejection mechanisms of the membrane include the MWCO, pore size, surface charge (zeta
potential), roughness, and hydrophobicity (Bellona et al. 2004).
Sanches et al. (2013) found that size exclusion (MWCO) and membrane surface charge
(zeta potential) are the most relevant rejection mechanisms of select TFC NF membranes that
impact CEC rejection efficiency with only minor contributions from hydrophobic interactions.
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The CEC properties of MW, charge, and polarizability correlated best with the observed
rejection. The research group observed the rejection of eight model CECs, including hormones
and pesticides, in synthetic water with a bench-scale cross-flow test apparatus and commercially
available GE Osmonics DK Series NF membranes with a MWCO range of 150-300 Da.
Kimura et al. (2003) reported negatively charged CECs are effectively rejected by NF
and RO membranes because of electrostatic repulsion by the negatively charged membranes,
whereas neutral CECs are removed based on the molecular size of the CEC and the MWCO of
the membrane. This finding was based on the observed rejection potential of an NF membrane
(zeta potential = -11mV: MWCO = 200 Da) and an RO membrane (zeta potential = -10mV;
MWCO = 100 Da) for selected CECs. The cross-flow bench test apparatus included two
commercially available membranes (NF: Hydranautics ESNA; RO: Dow Film-Tec XLE). Both
membranes showed a >90% rejection for negatively charged CECs, whereas the RO membrane
outperformed the NF membrane for neutral CECs, removing 99% of BPA. These experiments
were conducted with three target CECs spiked in synthetic model waters in the absence of DOC
from WRRF secondary effluent. When the authors lowered their model CEC concentrations in
the laboratory prepared sample matrix to simulate the concentrations typically occurring in a
WRRF secondary effluent matrix, the performance of both membranes declined but could not be
explained by the molecular weights of the analytes. The authors further reported this work
supports the need not only for membrane performance studies to be run at environmentally
relevant levels of target CECs but also for further investigation into the combined effects of
molecular size and membrane affinity (Kimura et al. 2003).
Ngheim et al. (2002) conducted research using a bench-scale experimental rejection
program, apparatus, and membranes identical to Schafer et al. (2003). This study reported on the
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variable effects of differing water matrices. In addition to matrix solutions of MilliQ DI water
and carbonate buffer, matrix solutions were also supplemented separately with 10 mg/L doses of
NOM, fulvic acid, and SE. The authors reported that the adsorption rejection mechanism was
only slightly reduced due to the presence of competing organics in the matrix; however, the
overall rejection remained high (80-100%) for estrone, thereby suggesting steric exclusion was
the major rejection mechanism (Ngheim et al. 2002).
Yoon et al. (2006) utilized a bench-scale stainless steel dead-end stirred-cell filtration
apparatus (SEPA ST, Osmonics) to study the NF rejection of 52 EDC and PPCP compounds in
four lab spiked samples, one with DI matrix and three with source (not WRRF secondary
effluent) water matrix. The three source water samples were pre-filtered to remove any
particulate matter prior to spiking with the select CECs. The commercially available
Hydraunatics ESNA NF membrane tested was reported with a MWCO of 600 Da and zeta
potential of -10.6 mV. The 52 CECs were characterized for their QSAR properties of size,
hydrophobicity, and polarity. Experiments were performed at environmentally relevant spiked
CEC concentrations ranging typically from 2 to <250 ng/L. Results showed that the NF
membrane rejection mechanisms were steric/size exclusion, hydrophobic adsorption, and
electrostatic repulsion. The authors reported a general separation trend was observed due to
hydrophobic adsorption as a function of octanol-water partition coefficient (log Kow) between the
hydrophobic CECs and hydrophobic membrane. Among the CECs observed with <100%
rejection, the hydrophobic neutral CECs with log Kow >2.8 generally exhibited <50% rejection,
while hydrophobic neutral CECs with log Kow <2.8 showed rejection of >75%. The authors also
reported that NF rejection performance was observed to be better in the synthetic DI matrix than
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the three source water matrix samples. This led to the author’s hypothesis that the synthetic water
had the least competition among CECs for membrane adsorption sites.
In follow-up to their 2006 study, Yoon et al. (2007) conducted additional research with
the same SEPA dead-end bench-scale apparatus and Hydranautics NF membrane. The objective
of this study was to further investigate the CEC-to-membrane hydrophobic relationship for 27
select CECs with a range of octanol-water partition coefficients (log Kow) from -2.1 to 4.77. This
study confirmed the hydrophobic adsorption relationship observed from the previous study in
that CEC rejection by NF membranes generally increases with CEC log Kow (or degree of
hydrophobicity).
Dang et al. (2015) conducted follow-up research utilizing the bench-scale cross-flow
experimental conditions identical to the previous paper (Dang et al. 2014). This study
investigated the rejection of two biodegradable phytoestrogens: geneistein and formononetin.
These lab-synthesized compounds were found to strongly adsorb initially to the membranes, but
at steady-state conditions, the rejections reduced to less than 50% for the loose NF270
membrane. The authors reported that size exclusion, adsorption, and convection are key rejection
mechanisms, while electrostatic repulsion was reported as the most significant rejection
mechanism (Dang et al. 2015).
Schafer et al. (2003) researched rejection of the highly biodegradable natural hormone,
estrone, by eight different NF and RO membranes from Koch and Trisep. Experiments were
carried out in bench-scale batch mode with lab-synthesized samples of MilliQ DI and carbonate
matrix with a target ethanol concentration of 100 ηg/L. Rejection by these membranes ranged
from 80% for the XN-40 to 100% for all remaining membranes. The authors concluded that size
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exclusion and adsorption are the major rejection mechanisms for both membrane types (Schafer
et al. 2003).
Wintgens et al. (2002) studied 11 different bench-scale commercially available NF
membranes for the rejection of bisphenol-A (BPA) and nonylphenol (NP) from a landfill
leachate matrix following pretreatment by a membrane bioreactor (MBR). Observed rejection
rates of the two CECs ranged from 70% to 100% for the 11 NF membranes. The authors
confirmed membrane contact angle was an indicator for the hydrophobicity of a membrane,
whose influence on NP rejection was evident. As reported, a membrane with low contact angle
(<50º) is considered hydrophilic, while a membrane with a high contact angle (>50º) is
considered hydrophobic. As observed for the study data set, rejection was greater with the
hydrophilic membranes than with the hydrophobic membranes. (Wintgens et al. 2002).
To elucidate key factors governing the rejection of trace organic contaminants, the
research team of Dang et al. (2014) reported the results of a bench-scale study on the removal of
16 hydrophilic and hydrophobic solutes, consisting of EDCs and PPCPs, by a MWCO = 300 NF
membrane (Dow-Filmtec NF270) and LPRO (Hydranautics ESPA2) membrane using a SST
cross-flow apparatus. Synthesized samples of the solutes at a target concentration of 25 µg/L
were lab prepared with a matrix of methanol and DI water. Experiments were conducted at pH
values of 4.7, 7, and 11. All tested pH values were above the isoelectric point of the membranes,
which ranged from 3.5 to 4, indicating the membranes were negatively charged at all test
conditions. The authors utilized the QSAR property Log D to correlate solute hydrophobicity
rather than Log Kow. A solute with a Log D value of 3 or higher was determined hydrophobic. In
general, the rejection of charged compounds was better than neutral compounds at all tested pH
conditions. However, 4-tert-butylphenol, bisphenol A, 4-tert-octylphenol, and triclosan were
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rejected at less than 50% rejection which was attributed to adsorption and subsequent diffusion
through the membrane. The cross-flow apparatus allowed mass balance calculation to estimate
adsorption levels of the solutes. Adsorption levels of the hydrophobic solutes ranged 14% to
94% for the NF270 and 79% to 94% for ESPA2, whereas the hydrophilic solutes ranged 0 to
32% and 0 to 12%, respectively. A good correlation was observed between rejection and MW for
hydrophilic neutral and charged species (Dang et al. 2014).
Several studies have reported a correlation between the rejection of hydrophobic CECs
and their affinity for the membrane, expressed as log Kow (Agenson et al. 2002; Agenson et al.
2003; Van der Bruggen et al. 2002). The authors reported that rejection of hydrophobic CECs by
NF membranes increased linearly with increasing log Kow values, indicating that hydrophobic
interactions between the CEC and membrane were the dominant rejection mechanism for CECs
with MW close to or less than the MWCO.
The phenomenon of low-molecular-weight solute rejection by porous and semi-porous
membranes is well documented (Fane et al. 1983; Xu and Lebrun 1999). Dissolved organic
matter has been experimentally shown to be a significant driver of MF and UF membrane
fouling (Howe and Clark 2002). A well-known example of this phenomenon is the fouling of
sterilization membranes in the pharmaceutical industry by product proteins that are smaller than
the nominal membrane pore size. Adding hydrophilic coatings to MF membranes surfaces has
been demonstrated to reduce the rate of protein fouling (Loh et al. 2009). For UF of organic
protein solutions, investigations have concluded that by manipulating the electrostatic
interactions between the low-MW organic solute and the charged membrane with solution pH,
the membrane flux rate and subsequent protein rejection can be tuned (Musale and Kulkarni
1997). This tuning effect with variable solution pH can be amplified by membrane surface
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doping. Acrylic acid nanobrushes grafted to NF membranes have been shown to improve the
rejection of soluble sugars at pH greater than 7 (Himstedt et al. 2011). Recent testing with
charged UF membranes indicated that rejection of reactive dye tracers is greatest with the most
negatively-charged dye molecules (Chen et al. 2015). Thus, electrostatic interactions between
charged solutes and membranes, as well as solution pH, can play a significant role in membrane
fouling and solute rejection performance.
Feed water matrix composition can have a significant effect upon CEC rejection with NF
and RO membranes (Schafer et al. 2001; Nghiem et al. 2002; Majewska-Nowak et al. 2002).
Schafer and Ngheim reported that estrone samples prepared with a WRRF SE matrix showed
poorer rejection rates from eight NF/RO membranes than the same estrone concentration
samples prepared with synthetic matrix. The main driving mechanism for the removal estrone,
which has a high log Kow of 3.13, was determined hydrophobic sorption by the NF membrane.
The authors concluded that the competition for adsorption sites by other CECs in the SE matrix
resulted in the poorer rejection rates. Conversely, Majewska-Nowak et al. (2002) found that
pesticides such as atrazine could adsorb to the organic matter in a WRRF secondary effluent
matrix, thereby increasing the rejection rate of the NF as a result of increased size and
electrostatic interaction.
Boussu et al. (2007) conducted a bench-scale cross-flow study of the rejection of 13
spiked CECs in synthetic matrix with three commercially available membranes manufactured by
GE Osmonics and Nitto-Denko. The membranes were reported to have MWCOs of 200, 260,
and 310 Da; with contact angles of 47, 44, and 70º; and with zeta potentials of -13, -17, and -15
mV, respectively. Two of the NF membranes were characterized as hydrophilic, while the other
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NF membrane was characterized as hydrophobic. Based on the results, Boussu concluded the
following:
1. CEC rejection was inversely related to MWCO.
2. Ionic charged CECs were best rejected by the membrane with the highest zeta
potential.
3. Neutral charged CECs were best rejected by the hydrophilic membranes.
Yangali-Quintanilla (2010) studied the rejection of 17 model CECs with two Dow FilmTec TFC NF membranes (NF-90: MWCO = 200 Da, contact angle = 58º, zeta = -48 mV; NF200: MWCO = 300 Da, contact angle = 37.5º, zeta = -10.8 mV). Synthetic matrix test samples
were spiked with stock solutions of CECs. To simulate environmentally relevant CEC
concentrations reported in actual reuse water, the CEC concentration of the prepared feed water
ranged from 6.5 to 65 µg/L. Rejection test runs were performed with two SEPA CF II (GE
Osmonics) bench-scale stainless steel dead-end cells operated in parallel. Based on rejection
results and correlation/modeling of the physical-chemical interactions between solute and
membrane, the author concluded that the CEC rejection mechanisms of NF membranes are
MWCO, surface charge, and hydrophobicity.
Sanches et al. (2013) reported that the use of synthetic waters is a suitable strategy to
“unravel” the individual correlation of specific physical-chemical properties and membrane
rejection mechanisms. However, this approach is not accurate enough to model the removal of
CECs in actual natural matrices and recommended future study with actual reuse water.
In summary, research shows the predominant NF and RO mechanisms for rejection of
CECs are steric exclusion, electrostatic interaction, and hydrophobicity.
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2.9

NF Membrane Rejection Modeling
With an understanding of NF rejection theory gained from the previous section, this

section shifts focus to the review of previous rejection modeling efforts. Emanating from this
work, three different approaches are seen for the modeling of solute rejection by NF and RO
membranes.
Plakas and Karabelas (2012) conducted a review of the removal of pesticides by NF and
RO membrane processes starting from the early history to recent work on modeling the removal.
The authors summarized the types of published models for solute rejection, including SpieglerKedem-based irreversible thermodynamic models, mass transport hydrodynamic Fick’s-based
models, and regression-based QSAR models along with their advantages and disadvantages in a
simple tabular form, as provided below in Table 2-16. The authors concluded that all three
considered modeling approaches could be utilized for the rejection of pesticides since membrane
rejection is mostly attributable to size exclusion. However, the authors stated for predicting
rejection of solutes smaller than membrane MWCO, the QSAR-based approach would be most
suitable for modeling rejection mechanisms other than size exclusion. The authors cited other
such rejection mechanisms included electrostatic interactions and hydrophobicity (Plakas and
Karabelas 2012).
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Table 2-16: NF/RO Models for Predicting Solute Rejection
Models

Advantages

1.
Irreversible film theory
thermodynamics
(Spiegler-Kadem)

2.

No rejection mechanism or
solute molecular structure input
(membrane treated as a “black
box”).
Ideal for RO desalination
application.

Disadvantages

1.

2.
3.

1.
2.

1.
Mass transport
hydrodynamic
(Fick’s Law)

2.

Simple models provide
estimates for technically
demanding separations.
Linearization facilitates rapid
calculations.

3.
4.

1.
2.

QSAR-based regression

3.

4.

Easy to use.
No application of physical laws
or transport phenomena, thus
overcoming complexity.
Accurate statistics estimates
based on mechanisms and solute
properties.
Valid models regardless of
rejection performance of
membranes tested.

1.

2.

Highly dependent on driving
forces (pressure and
concentration gradient), which
restricts practical application.
Unrealistic assumptions must be
made.
System must be in equilibrium to
be applicable.

Valid only for high rejection
membranes.
Variation of the solute mass
transfer coefficients with
different water qualities and
operating conditions and intrinsic
membrane properties constrains
model portability to other
systems.
Mainly applicable to singlesolute compounds.
Solute mass transfer coefficients
depend on the test unit scale,
limiting the model accuracy in
membrane scale-up.

Specific; applicable in the range
of experimental conditions
employed for development.
Changes in membrane properties
as a result of fouling, or swelling,
influence model accuracy.

Source: Plakas and Karabelas 2012
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Bellona et al. (2004) reported that many attempts have been made with little success to
model the process performance of membrane separations in order to optimize membrane
applications. To predict inorganic constituent (e.g. salts) mass transfer through high pressure
membranes, the authors report modeling attempts have included irreversible thermodynamics,
fate and transport, linear homogeneous solution-diffusion, film theory, and statistical-mechanical
theory. One successful organic solute retention model, developed by Williams et al. (1999),
utilized a modified solute-diffusion adsorption equation to describe the sorption and partitioning
of chlorinated phenols in RO and NF membranes. The solution-diffusion equation, however, is
not as applicable to newer generation TFC RO and NF membranes since the contribution of
solute/membrane interaction is not considered nor is steric exclusion a primary rejection
mechanism. Bellona (2004) reported that although past modeling theory has shown promise in
describing the separation of components during specialized membrane processes, the need for a
truly predictive rejection model based on membrane and solute properties is urgent. With their
review of such properties, the authors created a rejection diagram to predict degrees of high
pressure membrane rejection as high, moderate, or poor.
Ngheim et al. (2004) studied the rejection of estradiol, estrone, progesterone, and
testosterone spiked at 100 ηg/L in a synthetic matrix. Two negatively charged TFC NF
membranes (Dow/Filmtec NF270 and NF90) were utilized with the cross-flow bench-scale
apparatus. They also developed mechanistic hydrodynamic (i.e. Fick’s Law) models for
predicting solute rejection. The authors acknowledged that the thermodynamic (i.e. SK)
approach is more appropriate for modeling RO performance, but the hydrodynamic approach is
better suited for modeling NF performance. Radiolabeled hormone samples were prepared in DI
water from purchased stock solutions in ethanol and were measured using a scintillation counter
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with a detection limit of 0.5 ηg/L. The pore radius of NF90 was determined to be 0.34 nm while
the pore radius of NF270 was determined to be 0.42 nm. Based on the MW of the hormones
tested (270 to 315 g/mol) the authors estimated a Stokes radius of 0.5 nm. The experimental
results suggest (performed at pH 6) the steady state removal was as low as 90%, although
initially the removal was 100%. The authors hypothesized that a combination of adsorption and
steric exclusion caused the initial removal. However, with time, the adsorption mechanism was
exhausted (much like carbon adsorption), leaving only steric exclusion. They also hypothesized
that these hormones pass through the membranes by a diffusion mechanism via a sequence of
“make and break” bonding (Ngheim et al. 2004).
Ahmad et al. (2009) presented results of experimental work and modeling performed to
study rejection of atrazine and dimethoate by Dow/Filmtec NF90 polyamide nanofiltration
membranes. The contaminant solutions were synthesized in the laboratory at mg/L level to
simulate chemical spill conditions. No solvent matrix data were presented for the solutions. It is
not clearly stated, but it seems a single solution was prepared that contained both pesticides. The
membrane rejection tests were performed using a 300 mL stirred cell from Sterlitech SST benchscale membrane coupon test apparatus. The experiments were performed in dead-end batch
mode. The experimental data were used to derive fitting parameters for the SK thermodynamics
model. For the SK model, the authors assumed that the retention of a solute through the
membrane is a function of three parameters: specific hydraulic permeability (solvent flux), local
solute permeability (solute flux), and reflection coefficient (a measure of portion of the
membrane through which solute cannot be transferred). Rejection versus flux and rejection
versus pressure data were presented in the paper along with prediction by SK model. Observed
permeate flux versus pressure did not match the predicted values from SK model. There was
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agreement between the model predictions and observed data; however, the model generated data
was utilized to estimate the fitting parameters (Ahmad et al. 2009).
QSAR molecular properties based regression models are based on the assumption that
similar molecules behave similarly (Silva et al. 2013). Li and Colosi (2012) proposed that a
QSAR model could be used to predict the rejection of as-yet uncharacterized emerging
contaminants of regulatory interest. Another study used a QSAR model to rank CECs found in
environmental waters, including their parent compounds, metabolites, and transformation
products, to select the most relevant compounds to be considered as monitoring indicators in
drinking water treatment systems (Delgado et al. 2012).
Sanches et al. (2013) developed statistical, multivariate, regression-based models to
describe the rejection of CECs by a commercially available TFC NF membrane. A group of 37
rejection values, generated from eight CEC profiles analyzed over five runs with three
discounted anomalies, were utilized to develop the models. The models were developed to
correlate rejection attained during NF membrane experiments with specific QSAR molecular
property descriptors of the target CECs. Statistical regression analysis was applied to model
rejection through best-fit linear correlations of the multiple input parameters. Specific input
parameters considered were QSAR properties of the CECs: MW, log of the distribution
coefficient at pH 7.4 (log D), dipole moment, pKa, water solubility, molar volume, and
polarizability. Additional CEC size parameters considered were molecular length, molecular
width, and molecular depth as generated by 3-D visualization software for chemical structures
(www.jmol.org). Iterative stepwise elimination (Boggia et al. 1997) and the Martens uncertainty
test (Forina et al. 2004) were used to select the best-fit QSAR properties to model. The authors
concluded that the developed models have good descriptive capability and contributed to an
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overall comprehension of rejection of the CECs studied. Size exclusion and electrostatic
interactions with minor contribution from hydrophobic interaction were the three modeled
mechanisms. Since the models were calibrated with only eight CECs in synthetic matrix
samples, the authors acknowledged that more comprehensive modeling with additional CECs in
reuse matrix waters is necessary to extend this research (Sanches et al. 2013).
Yangali-Quintanilla (2010) utilized QSAR analysis to quantify compound rejection by a
NF membrane in terms of CEC physical-chemical properties and membrane rejection
mechanisms. The QSAR model was constructed using the internal experimental data described
previously for synthetic waters. The model was internally validated using measures of goodness
of fit and prediction, and subsequently was validated with external data. The QSAR model
verified that steric exclusion and log Kow are the most important variables that influence
rejection. Using QSAR to describe CEC rejection was later improved and extended with the use
of non-linear artificial neural network (ANN) models. Use of ANN models based on QSAR
equations was an important tool to predict rejection of neutral CECs by NF and RO membranes
with standard errors of estimation close to 5% and regression coefficients, R2, of 0.97. The
ANN-QSAR models demonstrated that rejection of neutral CECs by NF and RO membranes is
controlled more by size exclusion and less by hydrophobic interaction.
Fujioka et al. (2014a,b) developed and validated a mathematical model based on
irreversible thermodynamic principles (SK) for predicting removal of N-nitrosamines by spiralwound RO membrane. The modeling approach included subdividing the membrane surface into
layers and determining rejection behavior for each section similar to a finite element approach.
Pilot testing was conducted using a three-stage membrane pilot using ESPA2-4040 elements
from Hydranautics. The pilot was operated in a loop where the concentrate stream and the
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permeate streams were returned to the feed tank. The feed solution was made using DI matrix
spiked with stock solutions of nitrosamines, NaCl, CaCl2, and HCO3 were added to simulate
treated wastewater conditions. Three different fluxes were tested (10, 20, and 30 l/m2h). The
rejection of higher molecular weight nitrosamines were 90% or higher at all fluxes. The rejection
of the lower molecular weight nitrosamines varied with flux and ranged from 31% to 54%. A
strong correlation was observed between boron removal and NDMA removal thereby suggesting
boron could be a potential surrogate indicator for nitrosamines. Elevated temperature was
reported to lower the removal of NDMA. However, pH was not found to have a strong effect on
removal of NDMA. The authors reported model predicted rejections correlated well with
observed rejection results (Fujioka et al. 2014a,b).
Shamansouri and Bellona (2013) conducted research to develop and validate a model for
predicting rejection of a study set of 67 nonionic (i.e., neutral charged) CECs by Dow/Filmtec
NF270 NF membranes. Predictive models explored for best fit with the observed rejection data
were an SK irreversible thermodynamic transport model and a hybrid QSAR-based regression
model with fitting parameters for flux and CEC diffusion. The test apparatus utilized for the
experimental work was a bench-scale cross-flow configuration. Test conditions included
constant temperature (18 C), pH (6.3), and steady-state influent flow rate. Solute sample matrix
was synthesized with DI water. Pressure was varied between 10 and 200 psi to produce 5
incremental flux conditions ranging from 10-120 l/m2h. Sixteen of the 67 compounds tested
showed significant deterioration of rejection performance between the 2 hour and 24 hour run
times, indicating adsorption saturation. These 16 compounds were scrubbed from the data set for
model development. Eighty percent of the remaining results were used to develop the model
while the other 20% (11 CECs) were used for internal model validation. The SK model could not
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be validated to produce acceptable predictive results. The SK approach was determined to not
correlate well (R2 < 0.8) with CECs rejected by mechanisms other than steric exclusion. The
hybrid QSAR model proved to correlate well (R2 > 0.9) between predicted and observed
rejection of the validation set of 11 CECs (Shamansouri and Bellona 2013).
Mohammad et al. (2015) conducted a comprehensive review on recent advancements in
NF membranes that characterized the latest commercially available models from GE Osmonics,
Dow-Filmtec, Koch, Nitto-Denko, TriSep, Synder, and Toray. The authors provided discussion
on predictive modeling, fabrication, applications, operations, fouling, and future prospects for
NF membranes. The research team stated that
the overwhelming majority of NF predictive rejection models to date are
inadequate because they have been developed with idealized solutions typically
containing only 2, 3, or sometimes 4 solutes. If accurate modeling of concentrated
multi-solute solutions realistic of industrial processing is to become commonplace
then more effort needs to be placed into modeling systems of real industrial
relevance (Mohammad et al. 2015).
2.10

Needed Study
There are three primary areas of needed study:
1. Determine the recalcitrant CECs in typical WRRF SE.
2. Determine NF and RO rejection efficacies for the recalcitrant CECs in SE matrix.
3. Develop a practical predictive modeling tool to assist regulators, engineers and
PWS managers with CEC control for I/DPR applications.
Whether planned or unplanned, IPR is in practice world-wide. DPR systems are currently

operating in Africa and Texas. Many state water plans have identified billions of dollars in
capital infrastructure for the implementation of I/DPR systems over the next decade. As PWS
portfolios take on more reuse water, conventional treatment barriers may prove deficient and the
upcycling of CECs could be harmful to human health if more effective and robust treatment
69

barriers are not in place. PWS managers are looking for guidance from regulators and industry.
For now, EPA has opted to leave it to the states for that guidance. State regulators are looking to
industry advisory committees to provide the knowledge and tools to identify what CECs to
monitor and what barrier treatment technologies to implement for CEC control. This need is
critical and immediate.
With the lack of knowledge, the default approach can be an overly-conservative and costprohibitive design. RO is trending in planned and recently implemented DPR systems as the
default FAT barrier for CEC control. NF has many advantages over RO including lower system
pressure, less energy consumed, and less waste generated. An extensive literature review
performed by EPA in 2014 of over 400 publications on control of CECs found zero full-scale
and only 13 bench-scale NF studies from which to gather knowledge. Review of the 13 and
subsequent studies revealed the NF rejection study of spiked CECs in lab-synthesized matrix
solutions. Although this approach may provide a fundamental understanding of rejection theory,
it is not representative of I/DPR conditions for NF rejection of recalcitrant CECs occurring in
WRRF effluent matrices.
To achieve the study objectives of this research, PE and SE samples will be collected
from WRRFs in Texas and Oklahoma. SE samples will be processed by bench-scale
commercially available TFC NF and RO membranes in parallel. All samples will be analyzed by
a CCL EPA-certified lab for the Norman 96 set of CECs. The Norman 96 CECs will be
characterized by intended use and physiochemical properties. Results will be analyzed to verify
rejection performance and develop a practical QSAR-based predictive modeling tool.
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CHAPTER 3 - METHODS
3.1

Overview
Research was conducted to develop a practical modeling tool for regulators and PWS

managers to predict the rejection of recalcitrant CECs from typical municipal WWRF secondary
effluents for I/DPR applications by commercially available NF.
To determine membrane rejection for the recalcitrant CEC trace residual following
secondary treatment, actual SE was collected from three full-scale operating WRRFs. The
collected SE samples were processed through bench-scale dead-end TFC NF and RO
membranes, and analyzed by a certified laboratory to ascertain actual occurring CECs in the
WRRF effluent and their respective rejection coefficients across the membranes. Prior to and
concurrent with processing the collected SE through the membranes, the CEC concentrations
were determined for the SE of each of the three WRRF biological treatment systems. The
membranes evaluated under this research represent tertiary, or advanced, treatment unit
processes that could potentially be implemented downstream of a secondary activated sludge
biological process for reuse application.
Ultimately, the reduction (e.g., rejection coefficient) of recalcitrant CECs that can be
effectively removed from actual SE by TFC NF membrane processes with a MWCO of 200 and
negative surface charge was determined. The observed NF rejection coefficients were then
correlated with researched molecular properties of the CECs and membrane removal
mechanisms to develop a QMPM to predict organic solute rejection from secondary effluents
with similar TFC NF membranes for planned I/DPR applications.
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3.2

WRRF Descriptions
Actual municipal WRRF secondary effluent was collected from the following three

facilities downstream of the respective biological process but upstream of any disinfection or
tertiary treatment.
3.2.1

North Texas (NTX) WRRF
The City of Garland, Texas, owns and operates two tertiary WRRFs (Rowlett Creek and

Duck Creek) to treat flows from their Dallas/Fort Worth suburb population of 235,000 residents
(Sober 2016). Secondary effluent for this research was collected from the Rowlett Creek WRRF,
a fixed-film trickling filter and suspended-growth activated sludge (TF/AS) facility, permitted to
treat 24 MGD. The TCEQ administers a Texas Pollutant Discharge Elimination System
(TPDES) permit which dictates the monthly average effluent limits from Rowlett Creek to a
carbonaceous biochemical oxygen demand (cBOD) of 10 mg/L, total suspended solids (TSS) of
15 mg/L, and seasonal ammonia nitrogen limits of 5 mg/L (December through March) and 2
mg/L (April through November). Effluent is discharged to the East Fork of the Trinity River and
ultimately to the Trinity River. There is no reuse practice at this time for the NTX facility.
However, during dry summer months and periods of drought, the river flow consists primarily of
WRRF effluent. As such, the performance of the Rowlett Creek WRRF is critical to the Trinity's
health and usefulness as a drinking water source for those downstream.
Figure 3-1 illustrates the NTX process flow diagram (PFD) of the Rowlett Creek facility,
which consists of influent screening, grit removal, primary clarification, trickling filters,
intermediate clarification, activated sludge, final clarification, tertiary traveling bridge sand
filters, chlorine disinfection, and effluent pumping.
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Figure 3-1: NTX PFD
3.2.2

Southwest Oklahoma (SOK) WRRF
The City of Lawton, Oklahoma, owns and operates a tertiary TF/AS plant to treat flows

from their southwest Oklahoma population of 85,872 residents (Graves et al. 2015). The Lawton
WRRF currently treats an average daily flow of 10 MGD with average daily effluent water
quality of 3 mg/L cBOD, 9 mg/L TSS, and 0.2 mg/L ammonia nitrogen. Effluent is discharged to
Nine Mile Creek in the Red River watershed; however, up to 5 MGD is dedicated for reuse by
the Public Service Company of Oklahoma (PSO) for their industrial cooling towers.
Figure 3-2 illustrates the PFD of the Lawton facility, which consists of influent screening,
grit removal, primary clarification, trickling filters, intermediate clarification, activated sludge,
final clarification, UV disinfection, and tertiary anthracite filtration.
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Figure 3-2: SOK PFD
3.2.3

Central Oklahoma (COK) WRRF
The City of Norman, Oklahoma, owns and operates a WRRF to treat flows from their

Oklahoma City suburb and major University population of over 100,000 residents (Kruger et al.
2013). The Norman WRRF is a conventional suspended-growth activated sludge (AS) facility,
permitted to treat 12 MGD. The ODEQ administers an Oklahoma Pollutant Discharge
Elimination System (OPDES) permit which dictates the monthly average effluent limits from the
WRRF to a cBOD of 13 mg/L, TSS of 30 mg/L, and ammonia nitrogen limits of 4.1 mg/L.
Effluent is discharged to the Canadian River in the Arkansas River watershed. The Norman
WRRF provides seasonal reuse to the University of Oklahoma for irrigation of the Jimmie
Austin Golf Course.
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Figure 3-3 illustrates the PFD of the Norman facility, which consists of influent
screening, grit removal, primary clarification, conventional activated sludge, final clarification,
UV disinfection, and post aeration.

Figure 3-3: COK PFD
3.2.4

WRRF Operational Data
Where available, monthly operating reports (MORs) were collected during the sampling

interval. Notably, MOR data collected at the WRRFs such as cBOD, TSS, ammonia nitrogen,
and total phosphorus were typically measured on a 24-hour composite sample and reported
weekly. CEC research samples were taken on the same day as the MOR composite samples if the
WRRF staff did not measure it daily. Typical MOR data included DO, pH, cBOD/COD,
TSS/VSS, and ammonia nitrogen. Also, where available, additional standard operating procedure
(SOP) data relative to the WRRF secondary process was collected during the sample period such
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as solids retention time (SRT) and mixed liquor suspended solids (MLSS). Collected WRRF
operational data is provided in Appendix B.
3.3

Sampling Program
During 18 sampling events in the summer months, 108 samples were collected from the

three WRRFs. Sampling program tasks involved collecting, preserving, packaging, and shipping
samples for analysis. Primary objectives of the sampling program included:
•

Collecting representative I/DPR source water samples from full-scale WRRFs

•

Collecting multiple samples over time during base-flow dry-weather conditions when
CEC concentrations are generally greatest

•

Collecting samples to assess actual recalcitrant CEC remaining in the SE following
full-scale WRRF biological degradation

•

Collecting SE samples for bench-scale NF and RO membrane rejection analysis of
the recalcitrant CECs

3.3.1

Sampling Schedule and Target Conditions
To capture base-flow, dry-weather conditions, the sampling period occurred during the

summer of 2014 over six weeks from July through August. Samples were collected weekly if
target conditions were acceptable for sample collection. If target conditions were not ideal,
sampling was deferred to the following week. The target conditions for sampling were as
follows:
•

Plant flow of no more than average day

•

No storm event within seven days

•

Not during a daily diurnal peak

•

Sample on or near the day that samples were taken for regulatory reporting
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3.3.2

WRRF Sampling Locations
Sampling locations for each WRRF represented the combined effluent from all operating

liquid process trains downstream of the biological process. The SE samples were collected from
combined final clarifier effluents, but prior to any tertiary treatment or disinfection. Sampling
locations were illustrated previously in the WRRF PFDs (Figures 3-1, 3-2, and 3-3) and are also
shown on the plant site aerials in Figures 3-4, 3-5, and 3-6.

Figure 3-4: NTX WRRF Site Aerial (Google Maps)
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Figure 3-5: SOK WRRF Site Aerial (Google Maps)
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Figure 3-6: COK WRRF Site Aerial (Google Maps)
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3.3.3

Sample Collection, Preservation, and Handling
As defined in this section, sample collection, preservation, and handling protocol was

followed in accordance with guidelines provided by the following references: Snyder et al. 2003;
ASTM 2006; Rice and Bridgewater 2012; Vanderford et al. 2012. Grab samples were collected
in amber glass bottles with preservatives, chilled to target temperature below 6°C but above
freezing, and analyzed within 30 days of sampling.
3.3.3.1 Collection Protocol
Grab sampling was the site collection method utilized for this research. Sampling
equipment included a 950 ml wide-mouth amber glass packer attached to an 8-24 ft. telescoping
fiberglass swing pole. Collection equipment was cleaned thoroughly before use with nonantibacterial detergents and rinsed well with lab-provided Type 1 (ASTM D1193) laboratory
reagent grade DI water after detergent wash. No wetted collection equipment was made of
Tygon, polyethylene, or other such plastics. Notably, detergents and plastics can be a source of
interference in the analysis of CECs. The final rinse of collection samplers was with a methanol
rinse. The collection bottle was submerged into the SE collection boxes to mid-depth and filled
completely. Care was taken that the mouth of the bottle did not come into contact with anything
other than the sample water. Collected SE in the glass packer was transferred to the lab-provided
amber glass bottles. Using indelible ink, all samples were clearly marked with appropriate
identifying information as provided in Appendix B.
3.3.3.2 Preservation Protocol
As samples were transferred to the amber glass bottles provided by the laboratory,
sodium omadine and ascorbic acid were utilized to inhibit CEC biodegradation and oxidation
between sampling and analysis. The samples were refrigerated until ready for shipping overnight
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to the membrane bench-test facility or to the laboratory for CEC analysis. Ice or gel packs were
utilized to target a temperature below 6°C during shipping. Sample collection data forms, kit
order forms, and chain-of-custody forms were prepared for shipping, placed in sealed bag, and
placed in the shipping cooler on top of the packing material as identified in Appendix B.
Samples were shipped via FedEx next day service. Samples were promptly removed from the
coolers and refrigerated below 6°C, but above freezing, until analysis. All lab analyses were
performed within 30 days of sampling.
3.3.3.3 Handling Protocol
Analytes being measured at ηg/L (i.e., parts per trillion) levels are prone to contamination
(or interference) from handling. Nitrile gloves were worn at all times when handling samples.
Gloves were changed between each sample location. Care was taken not to touch or breathe
directly into samples or equipment. On the day of sampling, contact with pharmaceuticals,
pesticides, or personal care products that may contaminate samples was avoided. A field control
blank sample of DI water was collected, shipped, and analyzed. Potential sample interference
from mishandling could occur from any one or more of the following common utilized
substances:
1. Soaps and detergents, including antibacterial cleansers
2. DEET (insect repellent)
3. Weed killers
4. Fragrances (perfume, cologne, after shave, etc.)
5. Caffeine and sweeteners
6. Prescription and over-the counter medications
7. Tobacco
8. Sunscreen
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Table 3-1 identifies the 108 samples that were collected and shipped to the destinations as
identified in Appendix B for testing and analysis.

Table 3-1: Sample Shipping List

No. of
Sampling
Events

40 ml SE
samples to
Laboratory
(EEA)

SOK

6

12

12

12

COK

6

12

12

12

NTX

6

12

12

12

TOTAL

18

36

36

36

WRRF

3.4

40 ml
NF/RO
permeate
samples
to
Laboratory
(EEA)

1 liter
samples to
NF/RO
Testing
(GE
Osmonics

Bench Scale Testing
SE samples collected from the three study WRRFs were dead-end bench-tested with NF

and RO membranes at GE Osmonics’ purpose-built test laboratory facility in Minnetonka,
Minnesota. SE and NF/RO permeate samples were analyzed for CEC content by Eurofins Eaton
Analytical (EEA) of Monrovia, California.
3.4.1

Test Apparatus
Figure 3-7 illustrates that the bench-scale testing apparatus consisted of flat-sheet

membrane coupons secured in stirred dead-end permeation cells. Figure 3-8 depicts three SEPA
ST (Sterlitech Corp., Kent, Wash.) model HP4750, 316 stainless steel, high-pressure stirred cells
that operated in parallel for each permeate process run. Regulated high-pressure high-purity
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nitrogen (>99.9%) gas was utilized for driving head. Table 3-2 shows the apparatus
specifications.

Source: Sterlitech Corp, WA

Figure 3-7: Membrane Bench Test Apparatus – Schematic
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Figure 3-8: Membrane Bench Test Apparatus – As Tested
Table 3-2: Test Apparatus Specifications
Parameter
Membrane Coupon Diametera
Active Membrane Areaa
Batch Process Volumea
Constant TMP (Pressure Head)a
Specific Flux Rangea
Sample Temperaturea
Sample pHa
Pressure Inlet
Permeate Outlet
Wetted Materials of Construction:
Cell Body
O-Rings and Gaskets
Stir Bar
Cell Dimensions:
Body Diameter
Top Width (w/ clamp)
Bottom Width (w/ clamp)
Height
a

Specification
49 mm (1.93 in)
14.6 cm2 (2.26 in2)
300 mL
DK: 65 psi; AG: 145 psi
10 -12 GFD
20ºC ± 0.5
7.0 – 7.5 (no sample adjustment)
1/4 inch FNPT
1/8 inch 316SST tubing
316 SST
Buna-N
PTFE-coated magnet

5.1 cm (2.0 in)
10.2 cm (4.0 in)
13.3 cm (5.25 in)
22.1 cm (9.5 in)

Sources: GE Osmonics; Sterlitech
As tested & verified

84

3.4.2

Membrane Properties
Two commercially available polyamide TFC membranes (GE Osmonics) were selected

for this research: DK Series (manufactured in California) and AG Series (manufactured in
Minnesota). The TFC laminate for both membranes includes a polyester backing, a polysulfone
UF layer, a proprietary layer to adjust Zeta potential, and an engineered steric exclusion
polyamide NF or RO layer (Abolmaali et al. 2015). For this research, flat sheet coupons were cut
from this TFC laminate and utilized in the bench-scale testing, whereas for full-scale application
modules, this TFC laminate is spiral wound with a feed spacer mesh and impermeable envelope.
The selection of the test membranes was based on: (1) a qualitative steric rejection
assessment of CECs with a MW of more than 150 g/mol by membranes with a MWCO between
100 and 200 Daltons, and (2) their established performance in full-scale applications. Appendix
B provides manufacturer data sheets for both commercially available full-scale membrane
modules. In addition to membrane data provided by the manufacturer, membrane physical
property testing was performed by the National Science Foundation (NSF) Membrane Applied
Science and Technology (MAST) Research Center at the University of Arkansas (Fayetteville)
Cato Springs Laboratory (Wickramasinghe R. 2015). Appendix B provides MAST lab results.
Table 3-3 provides the relevant test membrane properties as required for QSAR analyses and the
rejection modeling of the recalcitrant CEC residual that was performed subsequently in Chapter
4. Both test membranes were found to have contact angles less than 90º and are thereby
considered hydrophilic (Yangali-Quintanilla 2010).
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Table 3-3: Test Membrane Properties
MWCO
(Da)

Zeta Potentiala
(mV)

AG Series RO

100

-20

23

DK Series NF

200

-12

20

Test Membrane

Contact Angle
(degrees)

Sources: GE Osmonics, NSF MAST Research Center at University of Arkansas
a
Zeta Potential at neutral pH

3.4.3

Membrane Testing Protocol
Permeate runs were processed in parallel for all three WRRF SE sample events with the

select DK (RO) membrane coupons. Subsequently, permeate runs were processed in parallel for
all three WRRF SE sample events with the select AG (NF) membrane coupons. This process
operating sequence was repeated for all sample events. Each permeate run was eight hours in
duration. A total of 18 membrane permeate runs were processed. Table 3-4 details the batch
process operating sequence for each permeate run.
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Table 3-4: Bench-Scale Batch Process Operating Sequence
Process Sequence

Procedure

Rinse and load

Rinse SEPA cells with DI water and load fresh membrane coupons.

Conditioning

Load 300 ml of standard salt solution (2,000 mg/L NaCl for AG and 2,000 mg/L
MgSO4 for DK) and process 100 ml of permeate to waste (225 psi for AG and 110
psi for DK).

Pre-compaction

Rinse SEPA cells with DI, load 300 ml of DI and process 100 ml permeate to waste
(225 psi for AG and 110 psi for DK).

Ripening

Load 300 ml of SE sample and process 150 ml permeate to waste at standard
operating conditions: constant-rate TMP (145 psi for AG and 65 psi for DK);
declining-rate flux (12-10 GFD).

Verification

Verify membrane operation over batch ripening run is within specification. Record
volume or weight collected every 10 g/10 ml to verify flux is within specification.
Collect 5-10 ml of permeate in graduated cylinders and record run time to determine
flux.

Rinse

Rinse SEPA cells with DI, load 300 ml DI, and process 20 ml permeate to waste.

Permeate Run

Load 300 ml of SE sample and process to 100 ml permeate at standard operating
conditions for TMP (145 or 65 psi) and flux (12-10 GFD):
1.

Waste first 20 ml permeate (verify flux is within specification as defined
above),

2.

Collect next 40 ml permeate sample for CEC analysis (verify flux is within
specification as defined above),

3.

Collect last 40 ml permeate sample for CEC analysis (verify flux is within
specification as defined above).

Breakdown/Clean

Remove membrane coupons and rinse cells with methanol and DI.

Package and Ship

Prepare samples, label, package, complete manifests, and ship for CEC analysis by
EEA as detailed previously.

Sources: Abolmaali et al. 2015
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3.5

Analytics
Collected WRRF SE samples, as well as the NF and RO permeate test samples, were

analyzed for CEC content at EEA of Monrovia, California.
3.5.1

Laboratory
As shown in Appendix B, EEA is certified by EPA and 46 states as an accredited lab for

Test Methods 539 and 1964 (US EPA 2010; US EPA 2007). Furthermore, EEA recently served
as a co-principal investigator on a Water Research Foundation project that evaluated over 20
analytical methods for CEC analysis in water (Vanderford et al. 2012). That research validated
US EPA Methods 539 and 1964 as the best overall methods for precision and accuracy of CEC
analysis. Subsequently, the EPA requires these validated methods for analysis and reporting of
CECs as required by the UCMR3 program.
3.5.2

Analytical Methods and Equipment
Methods 539 and 1964 provided quantitative data on the suite of 96 CECs being

investigated for this research. These methods involved online pre-concentration followed by
liquid chromatograph separation and series mass spectrometry (LS-MS-MS) with electrospray
ionization (ESI) in positive and negative modes. Instrumentation included an atmospheric
pressure ionization API 5000 LC-MS-MS in connection with a Dionex Ultimate 3000 HPLC
system.
For the utilized methods, Eaton and Haghani report:
Appropriate mass transitions for each CEC analyte were determined by direct
infusion of each analyte. Multiple mass transitions were used for each analyte to
ensure unequivocal compound identification. A sample was injected into the
HPLC through a ten port switching valve. Analytes were concentrated onto an
Oasis HLB solid phase extraction column and the matrix diverted to waste. The
valve position was then changed and the target analytes were refocused on an
analytical column and then separated and eluted into the mass spectrometer, using
an acidic eluent for positive mode and basic eluent for negative mode to gain
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sensitivity on the mass spectrometry. Measurements of mass intensity were then
determined using ESI in positive and negative mode, depending on whether the
CEC has an affinity to protonate or de-protonate in high voltage creating an
ionized adduct specie with negative or positive charge to be guided by electrical
gradient through the MS filter quads. In general, a CEC containing nitrogen (N)
will trend toward ESI positive, whereas a CEC with a carboxylic group (COOH)
will trend toward ESI negative. All standards, test samples, and quality control
(QC) samples were processed in the same manner. (Eaton and Haghani 2012)
3.5.3

Minimum Reportable Levels
Minimum reportable levels (MRLs) represent the lowest calibration point for the test

method, typically limited by the instrumentation. The utilized test methods MRL for the subject
96 CECs ranged from 5 to 100 ηg/L. The test suite of 96 CECs with corresponding analytical
LC-MS-MS ESI mode and MRL is provided in Table 3-5.
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Table 3-5: CEC Test Suite Analytical Mode
and Minimum Reportable Level
CEC

Analytical
Mode

1,7-Dimethylxanthine
ESI +
2,4-D
ESI 4-nonylphenol
ESI 4-tert-Octylphenol
ESI Acesulfame-K
ESI Acetaminophen
ESI +
Albuterol
ESI +
Amoxicillin
ESI +
Andorostenedione
ESI +
Atenolol
ESI +
Atrazine
ESI +
Azithromycin
ESI +
Bendroflumethiazide
ESI Bezafibrate
ESI +
Bisphenol-A (BPA)
ESI Bromacil
ESI +
Butalbital
ESI Butylparaben
ESI Caffeine
ESI Carbadox
ESI +
Carbamazepine
ESI +
Carisoprodol
ESI +
Chloramphenicol
ESI Chloridazon
ESI +
Chlorotoluron
ESI +
Cimetidine
ESI +
Clofibric Acid
ESI Cotinine
ESI +
Cyanazine
ESI +
DACT
ESI DEA
ESI +
DEET
ESI +
Dehydronifedipine
ESI +
DIA
ESI +
Diazepam
ESI +
Diclofenac
ESI Dilantin
ESI +
Diuron
ESI +
Erythromycin
ESI +
Estradiol
ESI Estrone
ESI Ethinyl Estradiol - 17 alpha
ESI Ethylparaben
ESI Flumeqine
ESI +
Fluoxetine
ESI +
Gemfibrozil
ESI MRL = Minimum reportable level
EPA Analytical Method: MS/MS/LS-ESI (+ or -)
Source: Eurofins Eaton Analytical, Inc.

MRL
(ηg/L)
10
5
100
50
20
5
5
20
5
5
5
20
5
5
10
5
5
5
5
5
5
5
10
5
5
5
5
10
5
5
5
10
5
5
5
5
20
5
10
5
5
5
20
10
10
5

CEC
Ibuprofen
Iohexal
Iopromide
Isobutylparaben
Isoproturon
Ketoprofen
Ketorolac
Lidocaine
Lincomycin
Linuron
Lopressor
Meclofenamic Acid
Meprobamate
Metazachlor
Methylparaben
Naproxen
Nifedipine
Norethisterone
Oxolinic acid
Pentoxifylline
Phenazone
Primidone
Progesterone
Propazine
Propylparaben
Quinoline
Simazine
Sucralose
Sulfachloropyridazine
Sulfadiazine
Sulfadimethoxine
Sulfamerazine
Sulfamethazine
Sulfamethizole
Sulfamethoxazole
Sulfathiazole
TCEP
TCPP
TDCPP
Testosterone
Theobromine
Theophylline
Triclosan
Trimethoprim
Warfarin

Analytical
Mode

MRL
(ηg/L)

ESI ESI ESI ESI ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI ESI ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI ESI +
ESI +
ESI ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI +
ESI ESI +
ESI -

10
10
5
5
100
5
5
5
10
5
20
5
5
5
20
10
20
5
10
5
5
5
5
5
5
5
5
100
5
5
5
5
5
5
5
5
10
100
100
5
10
20
10
5
5
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3.6

Data Analysis
Each of the selected CECs was classified by use and cataloged by their quantitative

chemical properties, cited from literature and scientific databases as identified in Chapter 4.
Rejection coefficients (R = 1 – C/C0) were also determined for each of the 940 discrete generated
data events (CECs measured).
With the end-goal to develop a novel, but practical, CEC rejection model for the studied
commercially available NF membrane, this research program was designed to elucidate the vital
predictive variables influencing the rejection of CECs in municipal reclaimed secondary effluent
samples. As such, a multi-level, multi-variable model was developed to predict the probable
rejection coefficient (R) of each CEC with the studied NF membrane. The model was developed
from predictor variables selected for their association with known membrane removal
mechanisms for organic solutes (size-exclusion, electro-static interactions, hydrophobicity, etc.),
CEC-specific chemical properties based on QSAR, and wastewater quality characteristics of the
actual SE matrix. R statistics software version 3.1.3 was utilized for property collinearity
analysis, outlier analysis, and regression modeling. The Pearson correlation method was utilized
to select the most vital predictor variables for modeling. The resulting QMPM, as presented in
Chapter 4, was then successfully developed to predict the NF rejection of more than 90 CECs.
Furthermore, the QMPM was verified against a CEC rejection dataset published by an
independent study for a similar commercially available NF membrane (Yangali-Quintanilla
2010).
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CHAPTER 4 - RESULTS AND MODELING
4.1

Overview
The rejection of CECs by NF or RO membranes is a developing reuse treatment

application to remove trace anthropogenic, recalcitrant organic contaminants from WRRF
secondary effluents. As described previously in Chapter 2, many laboratory studies to date have
identified rejection mechanisms for CECs across RO membranes that can be classified by either
steric exclusion or surface interactions. A 2007 laboratory-scale, stirred-membrane-cell study
identified hydrophobic adsorption and size exclusion as the predominant mechanisms for NF
membrane rejection of 27 different CECs (Yoon et al. 2007). However, multiple studies have
found solution matrix pH, and consequently electrostatic attraction/repulsion, are the most
important predictors for CEC rejection by NF and RO membranes (Lin and Lee 2014; YangaliQuitanilla 2010; Ozaki et al. 2008).
Recognizing the inherent complexity of CEC membrane rejection models, this research
program was designed to elucidate the vital predictive variables influencing the rejection of more
than 90 CECs in municipal reclaimed secondary effluent samples. Each of the selected CECs
was cataloged by their intended use and QSAR properties (cited from literature and scientific
databases) and measured in treated effluent samples (taken over multiple weeks) from three
WRRFs in Texas and Oklahoma. These effluent samples were then filtered in bench-scale,
stirred, dead-end membrane test cells with commercially available water treatment industry
specified NF (DK) and RO (AG) membranes as provided by GE Osmonics (Minnetonka,
Minnesota). As detailed in Chapter 3, the manufacturer-specified MWCO for the NF and RO test
membranes were 200 and 100 Daltons, respectively. Both membranes were also analyzed by
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atomic force microscopy (AFM) and determined to be hydrophilic with negative zeta potential
surface charges of -12 and -20 mV, respectively (Wickramasinghe 2015).
A multi-level, multi-variable model was developed to predict the probable rejection
coefficient (Rp = 1 – C/C0) of a CEC in reclaimed secondary effluent with the studied industryspecified commercially available thin-film composite NF (MWCO 200) membrane. The model
was developed from predictor variables selected for their association with known membrane
removal mechanisms for dissolved organic solutes (size-exclusion, electro-static interactions,
hydrophobicity, etc.), CEC-specific chemical properties based on QSAR properties, and matrix
characteristics of the treated samples. The developed QMPM was then successfully applied to an
independent database to verify the modeled mechanisms governing the rejection (by NF) of the
selected CECs.
4.2

QSAR Properties Characterization
The study set of 96 CECs was classified in Chapter 2 by the seven intended use

classifications of EDCs, pharmaceuticals, stimulants, preservatives, artificial sweeteners,
pesticides, and flame retardants. Within each intended use classification, each of the 96 CECs is
characterized as follows by the physical-chemical QSAR properties: MW, PSA, ionic charge at
neutral pH, partitioning constants (e.g., pKa, Kow, Koa), polarizability (α), and solubility (Sw).
Based on these QSAR properties, each of the 96 CECs was further classified as hydrophobicneutral (HB-N), hydrophobic-ionic (HB-I), hydrophilic-neutral (HL-N), or hydrophilic-ionic
(HL-I).
4.2.1

Endocrine Disrupting Compounds
EDCs can be defined as both natural and synthetic exogenous estrogens, anti-androgens,

and agents that interfere with the production, release, transport, metabolism, action or otherwise
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elimination of natural hormones in the body responsible for the maintenance of homeostasis and
the regulation of developmental processes (Spellman 2014). Disrupting the endocrine system can
occur in various ways. Some chemicals can mimic a natural hormone, “fooling” the body into
over-responding to the stimulus (e.g., a growth hormone that results in increased muscle mass) or
responding at inappropriate times (e.g., producing insulin when it is not needed). Other EDCs
can block the effects of a hormone from certain receptors. Still others can directly stimulate or
inhibit the endocrine system, causing overproduction or underproduction of hormones.
Significant published literature has suggested that wildlife species have suffered adverse
health effects after exposure to EDCs in the aquatic environment. Examples include reproductive
problems in wood ducks from Bayou Meto, Arkansas (White and Hoffman 1995); embryonic
deformities in Great Lakes fish-eating birds (i.e., gulls, terns, and cormorants) (Peakall and Fox
1987); feminization and embryonic mortality in lake trout and salmonids in the Great Lakes
(Mac and Edsall 1991; Mac et al. 1993; Leatherland 1993); developmental effects in Great Lakes
snapping turtles (Bishop et al. 1991); abnormalities of sexual development in Lake Apopka
alligators (Guilette et al. 1995); reproductive failure in mink and otter from the Great Lakes area
(Wren 1991); and reproductive impairment in the Florida Panther (Facemire et al. 1995). In each
of these cited cases, detectable concentrations of EDCs were reported in the animals or in their
environment.
Characterization of the CEC study set reveals 10 CECs that can be classified as EDCs.
Table 4-1 provides a review of the CAS Registry for the subject EDCs identified the QSAR
properties.

94

Table 4-1: EDC QSAR Properties
CEC

CASN

Androstenedione
(C19H26O2)
Norethisterone
(C20H26O2)
Progesterone
(C21H30O2)
Testosterone
(C19H28O2)
4-Nonylphenol
(C15H23KO)
4-tert-Octylphenol
(C14H22O)
Bisphenol-A
(C15H16O2)
Estradiol
(C18H24O2)
Estrone
(C18H22O2)

MW
(g/mol)

PSA
(Å2)

Charge
pH 7.0
(mV)

pKa

log
Kow

log
Koa

α
(Å3)

Sw
(mg/L)

Hydro
Classa

63-05-8

286.4

34.14

0

2.75

8.57

32.71

65.97

HB-N

68-22-4

298.4

37.30

0

3.22

10.6

34

7.04

HB-N

57-83-0

314.5

34.14

0

4.15

9.45

36.4

8.81

HB-N

58-22-0

288.4

37.30

0

3.37

10.16

33.26

23.4

HB-N

25154-52-3

220.5

23.06

0

10.3

5.74

8.62

27.21

7

HB-N

140-66-9

206.3

20.23

0

10.2

4.69

9.02

25.63

31.63

HB-N

80-05-7

228.3

40.46

0

9.78

4.04

12.75

26.59

120

HB-N

50-28-2

272.4

40.46

0

10.3

3.75

12.84

31.31

3.9

HB-N

53-16-7

270.4

37.30

0

10.3

4.31

10.94

30.76

30

HB-N

57-63-6
296.4
40.46
0
10.3
3.9
13.16
17α-Ethinyl
Estradiol
(C20H24O2)
Compiled from: ACS 2015, ChemAxon 2015
a
Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charged

33.9

11.3

HB-N

Table 4-1 QSAR properties show that all studied EDCs have a MW greater than 200
g/mol, MSA greater than 400 Å2, a neutral charge, α ranging from 26 to 36 Å3, and tend to be
basic in nature with high pKa values greater than 9. In addition, the studied EDCs appear to have
a relatively low affinity for water with a high (> 2.0) partitioning constant (log Kow) and low
water solubility. As such, the ten analyzed EDCs can be classified as HB-N.
4.2.2

Pharmaceuticals
Characterization of the CEC study set reveals 49 of the 96 are classified as

pharmaceuticals, representing the largest use classification. Abundant study over the last 10
years shows the bioaccumulation and toxicity of fisheries in WRRF effluent-dominated Texas
streams with pharmaceutical exposure at or below 1 µg/L, a common trigger for environmental
assessments (Brooks 2014; Brooks et al. 2005).
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Review of the CAS Registry reveals the QSAR properties characterization for the 49
pharmaceuticals as provided in Table 4-2. The analyzed pharmaceutical CECs were found to be
both neutral and ionic charged (positive and negative). The 20 neutral charged pharmaceutical
CECs, shown in Table 4-2a, consist of a wide range of medicinal applications: pain relief, antiseizure, muscle relaxers, anxiety suppressors, antidepressants, cardiovascular, radiocontrast
tracers, and anti-inflammatory. The neutral charged pharmaceutical CECs also possess high
variability in size, solubility, polarity, and hydrophobicity.
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Table 4-2a: Pharmaceuticals (neutral charge) QSAR Properties
CEC

Acetaminophen
(C8H9NO2)
Butalbital
(C11H16N2O3)
Carbamazepine
(C15H12N2O)
Carisoprodol
(C12H24N2O4)
Dehydronifedipine
(C17H16N2O6)
Diazepam
(C16H13ClN2O)
Dilantin
(C15H12N2O2)
Fluoxetine
(C17H18F3NO)
Gemfibrozil
(C15H22O3)
Iohexal
(C19H26I3N3O9)
Iopromide
(C18H24I3N3O8)
Ketoprofen
(C16H14O3)
Ketorolac
(C15H13NO3)
Meprobamate
(C9H18N2O4)
Naproxen
(C14H14O3)
Nifedipine
(C17H18N2O6)
Pentoxifylline
(C13H18N4O3)
Phenazone
(C11H12N2O)
Primidone
(C12H14N2O2)
Warfarin
(C19H16O4)

Charge
pH 7.0
(mV)

MW
(g/mol)

PSA
(Å2)

log
Koa

α
(Å3)

Sw
(mg/L)

Hydro
Classa

103-90-2

151.2

49.33

0

9.46

0.27

11.04

15.82

30,400

HL-N

77-26-9

224.3

75.27

0

8.48

1.59

12.46

22.56

1,700

HL-N

298-46-4

236.3

46.33

0

15.96

2.45

10.81

26.95

17.66

HB-N

78-44-4

260.3

90.65

0

15.06

2.36

9.90

26.69

201

HB-N

67035-22-7

344.3

108.63

0

3.47

3.15

14.51

34.67

5.56

HB-N

439-14-5

284.7

32.67

0

2.92

2.82

9.65

30.32

50

HB-N

57-41-0

252.3

58.20

0

9.47

2.47

11.85

27.12

178.6

HB-N

54910-89-3

309.3

21.26

0

3.93

9.26

30.44

60.28

HB-N

25812-30-0

250.3

46.53

0

4.42

4.39

11.08

27.93

4.96

HB-N

66108-95-0

821.1

199.89

0

11.73

-1.95

23.91

57.82

106.5

HL-N

73334-07-3

791.1

168.66

0

11.1

-0.44

24.34

55.37

23.75

HL-N

22071-15-4

254.3

54.37

0

3.88

3.61

12.18

28.01

51

HB-N

74103-06-3

255.3

59.30

0

3.84

2.28

13.18

26.84

572.3

HB-N

57-53-4

218.3

104.64

0

0.93

8.82

21.22

4,700

HL-N

22204-53-1

230.3

46.53

0

2.99

11.04

26.39

15.9

HB-N

21829-25-4

346.3

107.77

0

1.82

13.73

33.98

357.5

HL-N

6493-05-6

278.3

75.51

0

0.23

11.93

27.12

7,700

HL-N

60-80-0

188.2

23.55

0

0.37

1.22

7.95

20.89

10,000

HL-N

125-33-7

218.3

58.20

0

11.5

1.12

9.01

23.07

500

HL-N

81-81-2

308.3

63.60

0

5.63

3.52

9.65

33.26

17

HB-N

CASN

pKa

4.19

log
Kow

Compiled from: ACS 2015, ChemAxon 2015
a
Hydrophobicity class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charge

The 11 positive charged pharmaceutical CECs, shown in Table 4-2b, consist of a
narrower range of medicinal applications: respiratory, antibiotics, cardiovascular, anxiety,
gastrointestinal, and local anesthetic. The antibiotic CECs of this class are uniquely characterized
as relatively large with MW greater than 400 g/mol, low solubility, highly polar, and
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hydrophobic with log Kow values less than 2.0. Conversely, the remaining positive charged
pharmaceutical CECs are generally characterized with MW in the 200-400 g/mol range, high
solubility, and hydrophyllic.
Table 4-2b: Pharmaceuticals (positive charge) QSAR Properties
CEC

CASN

Albuterol
(C26H44N2O10S)
Atenolol
(C14H22N2O3)
Azithromycin
(C38H72N2O12)
Bendroflumethiazide
(C15H14F3N3O4S2)
Cimetidine
(C10H16N6S)
Diltiazem
(C22H26N2O4S)
Erythrommycin
(C37H67NO13)
Lidocaine
(C14H22N2O)
Lincomycin
(C18H37CIN2O7S)
Lopressor
(C15H25NO3)
Trimethoprim
(C14H18N4O3)

MW
(g/mol)

PSA
(Å2)

Charge
pH 7.0
(mV)

pKa

log
Kow

log
Koa

α
(Å3)

Sw
(mg/L)

Hydro
Classa

51022-70-9

72.72

406.0

1

10.12

0.64

14.22

26.58

300,000

HL-I

29122-68-7

84.58

440.4

1

14.08

0.16

16.41

29.09

13,300

HL-I

83905-01-5

180.08

1284.6

1.8

4.02

30.68

79.01

0.06

HB-I

73-48-3

118.36

505.9

0.1

1.7

11.54

35.91

108

HL-I

51481-61-9

88.89

369.6

0.3

0.4

13.81

25.89

10,500

HL-I

42399-41-7

59.08

612.2

0.604

8.18

2.79

17.15

44.82

12.3

HB-I

114-07-8

193.91

1222.4

1.2

8.38

3.06

29.71

75.76

0.52

HB-I

137-58-6

32.34

424.0

1

7.75

2.84

10.71

27.64

4,100

HB-I

154-21-2

122.49

624.5

1

7.97

-0.3

21.11

41.49

92.19

HL-I

51384-51-1

50.72

474.7

1

9.67

1.76

13.12

30.34

16,900

HL-I

738-70-5

105.51

431.2

0.6

7.16

1.28

12.92

29.76

400

HL-I

9.04

Compiled from: ACS 2015, ChemAxon 2015
a
Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charge

The 18 negative charged pharmaceutical CECs, shown in Table 4-2c, consist mostly of
antibiotics but also anti-inflammatory and respiratory medicinal metabolites. The negative CECs
of this pharmaceutical class are characterized as relatively small with MW less than 400 g/mol,
moderate solubility, polar, and mostly HL-I.
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Table 4-2c: Pharmaceuticals (negative charge) QSAR Properties
CEC

CASN

Amoxicillin
(C16H25N3O8S)
Bezafibrate
(C19H20CINO4)
Carbadox
(C11H10N4O4)
Chloramphenicol
(C11H12Cl2N2O5)
Diclofenac
(C14H11Cl2NO2)
Flumequine
(C14H12FNO3)
Ibuprofen
(C13H18O2)
Meclofenamic
(C14H11Cl2NO2)
Oxolinic acid
(C13H11NO5)
Sulfachloropyridazine
(C10H9ClN4O2S)
Sulfadiazine
(C10H10N4O2S)
Sulfadimethoxine
(C12H14N4O4S)
Sulfamerazine
(C11H12N4O2S)
Sulfamethazine
(C12H14N4O2S)
Sulfamethizole
(C9H10N4O2S2)
Sulfamethoxazole
(C10H11N3O3S)
Sulfathiazole
(C9H9N3O2S2)
Theophylline
(C7H8N4O2)

MW
(g/mol)

PSA
(Å2)

Charge
pH 7.0
(mV)

pKa

log
Kow

log
Koa

α
(Å3)

Sw
(mg/L)

Hydro
Classa

26787-78-0

365.4

132.96

-0.33

3.23

0.87

19.86

35.52

3,433

HL-I

41859-67-0

361.8

75.63

-1

3.83

4.25

17.31

36.89

1.22

HB-I

6804-07-5

262.2

100.56

-0.02

0.78

-1.37

19.36

25.35

14,800

HL-I

56-75-7

323.1

112.70

-0.25

7.59

0.88

17.17

27.82

2,500

HL-I

15307-86-5

296.1

49.33

-1

4

4.26

14.22

29.03

2.37

HB-I

42835-25-6

261.3

57.61

-1

6

1.6

12.56

24.74

2,186

HL-I

15687-27-1

206.3

37.30

-1

4.85

3.84

9.18

23.65

21

HB-I

644-62-2

296.1

49.33

-1

3.7

6.09

15.30

28.93

30

HB-I

14698-29-4

262.2

76.07

-1

5.58

1.35

14.71

24.68

3.2

HL-I

80-32-0

284.7

97.97

-1

6.6

0.85

10.39

26.59

7,000

HL-I

68-35-9

250.3

97.97

-0.65

6.99

0.39

8.1

24.59

77

HL-I

122-11-2

310.3

116.43

-0.58

6.91

1.26

13.9

29.7

343

HL-I

127-79-7

264.3

97.97

-0.59

6.99

0.52

8.29

26.35

202

HL-I

57-68-1

278.3

97.97

-0.51

6.99

0.65

8.29

28.1

1,500

HL-I

144-82-1

270.3

97.97

-0.65

6.71

0.21

12.51

25.13

1,050

HL-I

723-46-6

253.3

98.22

-1

6.16

0.79

11.30

24.16

610

HL-I

72-14-0

255.3

85.08

-0.54

6.93

0.98

11.67

24.19

373

HL-I

58-55-9

180.2

69.30

-0.1

7.82

-0.77

10.12

16.13

7,360

HL-I

Compiled from: ACS 2015, ChemAxon 2015
a
Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charge

4.2.3

Stimulants
Characterization of the CEC study set reveals the QSAR properties for four stimulants as

provided in Table 4-3. The analyzed stimulants include caffeine and metabolites of caffeine,
nicotine, and chocolate. This group of CECs is readily classified as small with MW less than
200, low polarity, high solubility, and HL-N.
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Table 4-3: Stimulants QSAR Properties
MW
(g/mol)

Charge
pH 7.0
(mV)

PSA
(Å2)

log
Koa

α
(Å3)

-0.39

9.76

16.06

4,149

HL-N

0

-0.07

8.77

17.87

2,632

HL-N

0

0.07

9.94

19.11

999,000

HL-N

-0.77

8.40

16.05

330

HL-N

CEC

CASN

1,7-Dimethylxanthine
(C7H8N4O2)
Caffeine
(C8H10N4O2)
Cotinine
(C10H12N2O)
Theobromine
(C7H8N4O2)

611-59-6

180.2

67.23

0

58-08-2

194.2

58.44

486-56-6

176.2

33.20

83-67-0

180.2

log
Kow

pKa

10.76

0

9.28

Sw
(mg/L)

Hydro
Classa

Compiled from: ACS 2015, ChemAxon 2015
a
Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charge

4.2.4

Preservatives
Characterization of the CEC study set reveals the QSAR properties for eight

preservatives as provided in Table 4-4. This group of CECs includes preservatives for food and
personal care products and can be generally characterized as relatively small with MW less than
400, low polarity, moderately soluble, and mostly HB-N.
Table 4-4: Preservatives QSAR Properties
CEC

Quinoline
(C9H7N)
Butylparaben
(C11H14O3)
Ethylparaben
(C9H10O3)
Isobutylparaben
(C11H14O3)
Methylparaben
(C8H8O3)
Propylparaben
(C10H12O3)
Triclocarban
(C13H9Cl3N2O)
Triclosan
(C12H7Cl3O2)

CASN

MW
(g/mol)

PSA
(Å2)

Charge
pH 7.0
(mV)

pKa

log
Kow

log
Koa

α
(Å3)

Sw
(mg/L)

Hydro
Classa

91-22-5

129.2

12.89

0

4.5

2.13

6.2

17.08

6,110

HB-N

94-26-8

194.2

46.53

0

8.5

3

10.0

20.88

207

HB-N

120-47-8

166.2

46.53

0

8.5

2.03

9.18

17.2

885

HB-N

4247-02-3

194.2

46.53

0

8.5

2.92

9.86

20.88

224

HB-N

99-76-3

152.2

46.53

0

8.5

1.67

8.79

15.37

2,500

HL-N

94-13-3

180.2

46.53

0

8.5

2.55

9.62

19.04

500

HB-N

101-20-2

315.6

41.13

0

11.42

4.93

13.63

29.78

0.65

HB-N

3380-34-5

289.5

29.46

-0.14

7.68

4.98

11.45

26.96

10

HB-I

Compiled from: ACS 2015, ChemAxon 2015
Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charge

a

100

4.2.5

Artificial Sweeteners
Characterization of the CEC study set reveals the QSAR properties for two artificial

sweeteners as provided in Table 4-5. This group of CECs includes widely utilized products (e.g.,
Splenda) by the food and beverage industry for low to no-calorie consumption. As evidenced by
the relatively high concentrations seen in Table 4-5, these products are resistant to biodegradation in WRRF biological processes. This group is characterized as small with MW less
than 400, highly soluble, and HL-N.
Table 4-5: Artificial Sweeteners QSAR Properties
CEC

CASN

Acesulfame-K
(C4H4KNO4S)
Sucralose
(C12H19Cl3O8)

MW
(g/mol)

PSA
(Å2)

Charge
pH 7.0
(mV)

pKa

log
Kow

log
Koa

α
(Å3)

Sw
(mg/L)

Hydro
Classa

55589-62-3

201.2

78.79

0

2

-0.69

ND

13.29

1,000,000

HL-N

56038-13-2

397.6

128.84

0

11.9

-0.47

15.79

32.65

22,800

HL-N

Compiled from: ACS 2015, ChemAxon 2015
a
Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charge

4.2.6

Pesticides
Characterization of the CEC study set reveals the QSAR properties for 18 pesticides as

provided in Table 4-6. This group generally includes agents designed to inhibit, incapacitate, or
otherwise terminate plant and animal life (Spellman 2014). As such, this group of CECs is of
particular concern in public water supplies for human consumption. All 18 of the analyzed
pesticides can be characterized to be relatively small with MW less than 300 g/mol, low to
moderate solubility, and hydrophobic neutral. Five of the 18 pesticides, however, can be
characterized as chloraminated (NHCl) compounds with high solubility and are HL-N.
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Table 4-6: Pesticides QSAR Properties
MW
(g/mol)

PSA
(Å2)

Charge
pH 7.0
(mV)

CEC

CASN

Atrazine
(C8H14ClN5)
Bromacil
(C9H13BrN2O2)
Chloridazon
(C10H8ClN3O)
Chlorotoluron
(C10H13ClN2O)
Cyanazine
(C9H13ClN6)
DACT
(C3H4ClN5)
DEA
(C6H10ClN5)
DEET
(C12H17NO)
DIA
(C5H8ClN5)
Diuron
(C9H10Cl2N2O)
Isoproturon
(C12H18N2O)
Linuron
(C9H10Cl2N2O2)
Metazachlor
(C14H16ClN3O)
Metolachlor
(C15H22ClNO2)
Propazine
(C9H16ClN5)
Simazine
(C7H12ClN5)
2,4-D
(C8H6Cl2O3)
Clofibric Acid
(C10H11ClO3)

1912-24-9

215.7

62.73

0

314-40-9

261.1

49.41

0

1698-60-8

221.7

58.69

0

15545-48-9

212.7

32.34

0

21725-46-2

240.7

86.52

0

3397-62-4

145.6

90.71

0

6190-65-4

187.6

76.72

0

134-62-3

191.3

20.31

0

1007-28-9

173.6

76.72

0

330-54-1

233.1

32.34

34123-59-6

206.3

330-55-2

log
Kow

pKa

log
Koa

Α
(Å3)

Sw
(mg/L)

Hydro
Classa

2.61

9.63

21.19

214

HB-N

2.11

10.39

21.65

815

HB-N

1.14

9.0

21.65

3,585

HL-N

2.41

10.64

21.83

329

HB-N

2.22

12.20

22.91

170

HB-N

3.58

0.32

8.11

12.11

42,000

HL-N

3.38

1.51

8.71

17.55

2,593

HL-N

2.18

8.25

22.29

666

HB-N

3.41

1.15

8.47

15.73

6,160

HL-N

0

13.18

2.68

10.37

22.02

42

HB-N

32.34

0

13.5

2.57

11.2

23.63

65

HB-N

249.1

41.57

0

11.94

2.68

9.79

22.77

75

HB-N

67129-08-2

277.8

38.13

0

1.84

2.98

9.77

28.81

430

HB-N

51218-45-2

283.8

29.54

0

3.45

9.33

30.46

530

HB-N

139-40-2

229.7

62.73

0

3.17

2.61

9.66

23.02

8.6

HB-N

122-34-9

201.7

62.73

0

3

1.78

9.59

19.37

6.2

HL-N

94-75-7

221.0

46.53

0

2.81

2.5

8.65

19.13

677

HB-N

882-09-7

214.6

46.53

0

3.37

2.9

8.6

20.8

583

HB-N

9.95

13.53

Compiled from: ACS 2015, ChemAxon 2015
a
Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charge

4.2.7

Flame Retardants
This group of CECs that have been detected in secondary effluents include chlorinated

alkyl-phosphates that are typically applied to manufactured textiles, such as clothing and linens,
in order to inhibit, suppress, or prevent the spread of fire. While the eco-toxic and human health
effects of aqueous flame retardants are not clear, California has listed tris-2-chloroethyl
phosphate (TCEP) among carcinogens and reproductive toxins since 1992 (CAEPA 2006).
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Flame retardants have been shown to resist biodegradation and oxidation in treated effluents
(Westerhoff et al. 2005). With their resistance to conventional WRRF treatment processes and
relative abundance in the hydrosphere, it is apparent that alternative treatments for control of this
group of CECs is required (Watts and Linden 2009).
Characterization of the CEC study set reveals the QSAR properties for three flame
retardants as provided in Table 4-7. This group of CECs as relatively large (with MW > 350
g/mol) and neutral. Although log Kow values slightly greater than 2.0 are reported by ACS for
this group of CECs, solubility is reported as moderate to high.
Table 4-7: Flame Retardants QSAR Properties
CEC

CASN

TCEP
(C6H12Cl3O4P)
TCPP
(C9H18Cl3O4P)
TDCPP
(C9H15Cl6O4P)

MW
(g/mol)

PSA
(Å2)

Charge
pH 7.0
(mV)

pKa

log
Kow

log
Koa

Α
(Å3)

Sw
(mg/L)

Hydrophobicity
Classa

115-96-8

285.49

44.76

0

2.11

5.31

23.06

7,000

HB-N

13674-84-5

327.6

44.76

0

3.36

8.20

28.46

1,200

HB-N

13674-87-8

430.9

44.76

0

4.28

10.62

34.29

7

HB-N

Compiled from: ACS 2015, ChemAxon 2015
a
Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charge

4.3

Rejection Analysis
For the study set of 96 CECs, 82 were detected above the corresponding MRL in the

primary effluent. The 14 undetected CECs either did not exist at measurable concentration in the
WRRF influent or were effectively removed by the WRRF primary treatment gravity separation
barriers. Most relevant to this DPR research, 18 of the studied 96 CECs were 100% removed by
full-scale WRRF biological treatment. Conversely, 64 of the 96 studied CECs were found to
exist in the secondary effluent at recalcitrant residual concentrations above MRL.
Of the 3,456 discrete analytic events, CEC detections above MRL were discovered in
almost a third of the data set, as provided in Appendix C, or a total of 926 discrete occurrences.
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Table 4-8 provides the distribution of CEC detections. This distribution clearly reveals a high to
low profile across samples, thereby indicating a cursory assessment of the relative effectiveness
of WRRF biological, bench-scale NF, and bench-scale RO as absolute barriers for the removal of
CECs from the potential reuse supply.
Table 4-8: CEC Detections
Sample

COK

SOK

NTX

PE

158

142

144

SE

111

116

127

NF

36

27

48

RO

8

1

8

PE = primary effluent, SE = secondary effluent, NF = Nanofiltration permeate, RO = reverse osmosis permeate

For each of the 482 discrete SE to permeate events, observed rejection coefficients, R,
were calculated across corresponding treatment barrier samples according to the following
formula:

R = 1 − (C /C )

Eq. (4.1)

Cp = concentration of CEC in membrane permeate sample
C0 = concentration of CEC in SE sample
In most cases, a CEC detected in SE samples was not detected in permeate. In these
cases, Cp was taken to be zero, yielding R = 100%. This was interpreted as 100% removal of a
detectable chemical (concentrations greater than its MRL, in ηg/L). Recalcitrant CECs were, in
most cases, rejected by NF and to a greater degree by RO as indicated in the following
discussion for each of the CEC intended use classifications.
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4.3.1

Observed Rejection
Rejection analyses of the EDCs, as indicated in Table 4-9, revealed that most natural

human hormones existing in the primary effluent samples were readily removed to below MRL
by the WRRF biological processes. Estrone was the only natural human hormone not fully
biodegraded; NF effectively rejected approximately half the remaining fraction and RO rejected
all remaining fraction. The other two recalcitrant EDCs were 4-tert-Octylphenol (surfactant) and
BPA (plasticizer), for which both membranes were found to be very effective barriers. All three
EDCs detected in NF permeate samples have a MW just above the NF MWCO and are classified
HB-N, suggesting steric exclusion and hydrophobic sorption as the predominant rejection
mechanisms. 17α-Ethinyl Estradiol (contraceptive) was not detected in the primary effluent
samples, while 4-Nonylphenol (surfactant) was discounted from the dataset due to lab
interference as detected in control blanks.
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Table 4-9: EDC Rejection

CEC

Molecular
Weight
(g/mol)

Reverse Osmosis

Nanofiltration
Min
R
88%

Max
R

Mean
R

92%

90%

Min
R

Max
R

100%

100%

Mean
R
100%

4-tert-Octylphenol
(C14H22O)

206

HB-N

4-Nonylphenol
(C15H23KO)

221

HB-N

Bisphenol-A
(C15H16O2)

228

HB-N

95%

95%

95%

100%

100%

100%

Estrone
(C18H22O2)

270

HB-N

38%

62%

46%

100%

100%

100%

Estradiol
(C18H24O2)

272

HB-N

100% removed by WRRF biological treatment

Androstenedione
(C19H26O2)

286

HB-N

100% removed by WRRF biological treatment

Testosterone
(C19H28O2)

288

HB-N

100% removed by WRRF biological treatment

17α-Ethinyl
Estradiol (C20H24O2)
Norethisterone
(C20H26O2)

296

HB-N

298

HB-N

100% removed by WRRF biological treatment

315

HB-N

100% removed by WRRF biological treatment

Progesterone
(C21H30O2)
a

Hydro
Classa

Discounted due to lab interference

Not detected in primary effluent

Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charged

All but one of the 20 studied neutral-charged pharmaceuticals were detected in SE
samples at concentrations above MRL. Phenazone (analgesic) was not detected in the primary
effluent samples. Table 4-10a shows that both NF and RO were very effective barriers for the
rejection of this group of CECs. With a neutral charge, this group of CECs is likely rejected by
steric exclusion and some hydrophobic sorption, although the 100% exclusion of Acetaminophen
(MW = 151 g/mol) by the NF test membrane suggests molecular PSA may be a better QSAR
indicator than MW for steric exclusion. Table 4-2a also indicates that Acetaminophen has a
molecular PSA of 223Å2.

106

Table 4-10a: Pharmaceuticals (neutral) Rejection

CEC

a

Molecular
Weight
(g/mol)

Hydro
Classa

Reverse Osmosis

Nanofiltration
Min
R

Max
R

100%

100%

Mean
R

Min
R

Max
R

Mean
R

100%

100%

100%

100%

Acetaminophen
(C8H9NO2)

151

HL-N

Phenazone
(C11H12N2O)

188

HL-N

Meprobamate
(C9H18N2O4)

218

HL-N

89%

100%

99%

100%

100%

100%

Primidone
(C12H14N2O2)

218

HL-N

100%

100%

100%

100%

100%

100%

Butalbital
(C11H16N2O3)

224

HL-N

100%

100%

100%

100%

100%

100%

Naproxen
(C14H14O3)

230

HB-N

85%

100%

98%

100%

100%

100%

Carbamazepine
(C15H12N2O)

236

HB-N

85%

97%

94%

100%

100%

100%

Gemfibrozil
(C15H22O3)

250

HB-N

100%

100%

100%

100%

100%

100%

Dilantin
(C15H12N2O2)

252

HB-N

100%

100%

100%

100%

100%

100%

Ketoprofen
(C16H14O3)

254

HB-N

100%

100%

100%

100%

100%

100%

Ketorolac
(C15H13NO3)

255

HB-N

100%

100%

100%

100%

100%

100%

Carisoprodol
(C12H24N2O4)

260

HB-N

100%

100%

100%

100%

100%

100%

Pentoxifylline
(C13H18N4O3)

278

HL-N

100%

100%

100%

100%

100%

100%

Diazepam
(C16H13ClN2O)

285

HB-N

100%

100%

100%

100%

100%

100%

Warfarin
(C19H16O4)

308

HB-N

100%

100%

100%

100%

100%

100%

Fluoxetine
(C17H18F3NO)

309

HB-N

63%

100%

89%

100%

100%

100%

Dehydronifedipine
(C17H16N2O6)

344

HB-N

100%

100%

100%

100%

100%

100%

Nifedipine
(C17H18N2O6)

346

HL-N

100%

100%

100%

100%

100%

100%

Iopromide
(C18H24I3N3O8)

791

HL-N

100%

100%

100%

100%

100%

100%

Iohexal
(C19H26I3N3O9)

821

HL-N

100%

100%

100%

100%

100%

100%

Not detected in primary effluent

Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charged

All but one of the 11 studied positive-charged pharmaceuticals were detected above MRL
in secondary effluent samples. With characteristically high MW (e.g., antibiotics) and positive-
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charge, as seen in Table 4-10b, this group of CECs was highly rejected by both tested
membranes by steric and electrostatic exclusion.
Table 4-10b: Pharmaceuticals (positive) Rejection

CEC

a

Molecular
Weight
(g/mol)

Hydro
Classa

Nanofiltration
Min
R

Max
R

Reverse Osmosis

Mean
R

Min
R

Max
R

Mean
R

Lidocaine
(C14H22N2O)

234

HB-I

100%

100%

100%

100%

100%

100%

Albuterol
(C26H44N2O10S)

239

HL-I

100%

100%

100%

100%

100%

100%

Cimetidine
(C10H16N6S)

252

HL-I

78%

100%

97%

100%

100%

100%

Atenolol
(C14H22N2O3)

266

HL-I

90%

100%

98%

100%

100%

100%

Lopressor
(C15H25NO3)

267

HL-I

100%

100%

100%

100%

100%

100%

Trimethoprim
(C14H18N4O3)

290

HL-I

94%

100%

99%

100%

100%

100%

Diltiazem
(C22H26N2O4S)

415

HB-I

100%

100%

100%

100%

100%

100%

Bendroflumethiazide
(C15H14F3N3O4S2)

421

HL-I

Lincomycin
(C18H37CIN2O7S)

461

HL-I

100%

100%

100%

100%

100%

100%

Erythrommycin
(C37H67NO13)

734

HB-I

100%

100%

100%

100%

100%

100%

Azithromycin
(C38H72N2O12)

749

HB-I

92%

100%

99%

99%

100%

100%

Not detected in primary effluent

Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charged

The group of 18 negative-charged pharmaceuticals was found with the most variable
occurrence of the studied CECs. Table 4-10c indicates that eight were not detected in primary
effluent samples and two were fully removed through WRRF biological treatment. The seven
recalcitrant negative-charged pharmaceuticals were found to be highly rejected by both test
membranes, via steric and electrostatic exclusion. Only the hydrophilic Sulfamethoxazole
(antibiotic) was detected in any membrane permeate samples.
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Table 4-10c: Pharmaceuticals (negative) Rejection

CEC

a

Molecular
Weight
(g/mol)

Hydro
Classa

Reverse Osmosis

Nanofiltration
Min
R

Max
R

100%

100%

Mean
R
100%

Min
R

Max
R

Mean
R

100%

100%

100%

Theophylline
(C7H8N4O2)

180

HL-I

Ibuprofen
(C13H18O2)

206

HB-I

Sulfadiazine
(C10H10N4O2S)

250

HL-I

100%

100%

100%

100%

100%

100%

Sulfamethoxazole
(C10H11N3O3S)

253

HL-I

83%

98%

91%

99%

100%

100%

Sulfathiazole
(C9H9N3O2S2)

255

HL-I

100%

100%

100%

100%

100%

100%

Flumequine
(C14H12FNO3)

261

HL-I

Not detected in primary effluent

Carbadox
(C11H10N4O4)

262

HL-I

Not detected in primary effluent

Oxolinic acid
(C13H11NO5)

262

HL-I

Not detected in primary effluent

Sulfamerazine
(C11H12N4O2S)

264

HL-I

Not detected in primary effluent

Sulfamethizole
(C9H10N4O2S2)

270

HL-I

Not detected in primary effluent

Sulfamethazine
(C12H14N4O2S)

278

HL-I

Not detected in primary effluent

Sulfachloropyridazine
(C10H9ClN4O2S)

285

HL-I

Not detected in primary effluent

Meclofenamic
(C14H11Cl2NO2)

296

HB-I

Not detected in primary effluent

Diclofenac
(C14H11Cl2NO2)

296

HB-I

100%

100%

100%

100%

100%

100%

Sulfadimethoxine
(C12H14N4O4S)

310

HL-I

100%

100%

100%

100%

100%

100%

Chloramphenicol
(C11H12Cl2N2O5)

323

HL-I

100% removed by WRRF biological treatment

Bezafibrate
(C19H20CINO4)

362

HB-I

100% removed by WRRF biological treatment

Amoxicillin
(C16H25N3O8S)

365

HL-I

100% removed by WRRF biological treatment

100%

100%

100%

100%

100%

100%

Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charged

Representing caffeine and associated degradates of caffeine, nicotine, and chocolate, the
stimulants group was somewhat surprisingly found to be recalcitrant. All studied stimulants were
characterized previously as HL-N with relatively low molecular weights, thereby suggesting a
possible challenge for NF membrane rejection. However, as indicated below in Table 4-11, the
stimulants group were highly rejected by both test membranes with only one NF permeate
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sample indicating an 11 ηg/L occurrence of caffeine, albeit considerably below the MRL of 500
ηg/L.
Table 4-11: Stimulants Rejection

CEC

a

Molecular
Weight
(g/mol)

Hydro
Classa

Nanofiltration
Min
R

Max
R

Reverse Osmosis

Mean
R

Min
R

Max
R

Mean
R

Cotinine
(C10H12N2O)

176

HL-N

100%

100%

100%

100%

100%

100%

Theobromine
(C7H8N4O2)

180

HL-N

100%

100%

100%

100%

100%

100%

1,7-Dimethylxanthine
(C7H8N4O2)

180

HL-N

100%

100%

100%

100%

100%

100%

Caffeine
(C8H10N4O2)

194

HL-N

70%

100%

97%

100%

100%

100%

Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charged

The preservatives group of CECs were QSAR-characterized as having relatively low
MW and mostly HB-N. Generally, such properties suggest the predominant membrane rejection
mechanism for this group may be more sorption and less exclusion.
Notably, as evidenced in Table 4-12, five of the eight studied preservatives were found to
be 100% removed by WRRF biological treatment. Of the three recalcitrant preservatives, results
indicated the two largest, Triclocarban and Triclosan, were highly rejected by both test
membranes, with the ionic analyte in the group (Triclosan) fully rejected. The other recalcitrant
preservative, Quinoline, represents the smallest analyte (MW = 129 g/mol) in the study set of 96
CECs. Rejection analysis revealed moderate (89%) removal of Quinoline by both membranes.
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Table 4-12: Preservatives Rejection

CEC

a

Molecular
Weight
(g/mol)

Hydro
Classa

Reverse Osmosis

Nanofiltration
Min
R

Max
R

56%

Mean
R

Min
R

Max
R

Mean
R

89%

56%

100%

89%

Quinoline
(C9H7N)

129

HB-N

100%

Methylparaben
(C8H8O3)

152

HL-N

100% removed by WRRF biological treatment

Ethylparaben
(C9H10O3)

166

HB-N

100% removed by WRRF biological treatment

Propylparaben
(C10H12O3)

180

HB-N

100% removed by WRRF biological treatment

Butylparaben
(C11H14O3)

194

HB-N

100% removed by WRRF biological treatment

Isobutylparaben
(C11H14O3)

194

HB-N

100% removed by WRRF biological treatment

Triclosan
(C12H7Cl3O2)

290

HB-I

100%

100%

100%

100%

100%

100%

Triclocarban
(C13H9Cl3N2O)

316

HB-N

80%

100%

95%

63%

100%

93%

Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charged

Table 4-13 shows that the artificial sweeteners study group included two HL-N CECs.
This group of CECs was found to be fully recalcitrant in the WRRF SE. Results indicated the
larger sweetener, Sucralose, was highly rejected by both test membranes by steric exclusion.
However, the smaller Acesulfame-K (MW = 201) was only rejected at 56% by the NF
membrane.
Table 4-13: Artificial Sweeteners Rejection

CEC

a

Molecular
Weight
(g/mol)

Hydro
Classa

Nanofiltration
Min
R

Max
R

Reverse Osmosis

Mean
R

Min
R

Max
R

Mean
R

Acesulfame-K
(C4H4KNO4S)

201

HL-N

8%

98%

56%

100%

100%

100%

Sucralose
(C12H19Cl3O8)

398

HL-N

99%

100%

99%

100%

100%

100%

Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charged

Similar to artificial sweeteners, the flame retardants were found to be highly recalcitrant
in the WRRF SE. Table 4-14 shows that this group of CECs is QSAR-characterized as moderate
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size and HB-N. Mean rejection by NF of this group ranged from 55% for the smallest, TCEP, to
89% for the largest, TDCPP, whereas the tighter RO test membrane proved to be a highly
effective barrier to this group of CECs.
Table 4-14: Flame Retardants Rejection

CEC

a

Molecular
Weight
(g/mol)

Hydro
Classa

Reverse Osmosis

Nanofiltration
Min
R

Max
R

Mean
R

Min
R

Max
R

Mean
R

TCEP
(C6H12Cl3O4P)

285

HB-N

8%

97%

55%

95%

100%

99.5%

TCPP
(C9H18Cl3O4P)
TDCPP
(C9H15Cl6O4P)

328

HB-N

29%

100%

81%

100%

100%

100%

431

HB-N

77%

100%

89%

100%

100%

100%

Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charged

Table 4-15 identifies that the pesticides group of 18 CECs were QSAR-characterized as
relatively low to moderate in size, with MW ranging from 146 to 284 g/mol, and of neutral
charge. Three of the 18 were not detected in the primary effluent, while 2 of the pesticides were
found to be fully removed by the WRRF biological processes. The remaining 13 pesticides were
found to be recalcitrant CECs in the secondary effluents. With the exception of Atrazine, the NF
test membrane proved to be most effective (92-100%) for rejection of the nine hydrophobic
pesticides and slightly less effective (74-89%) for rejection of the four hydrophilic species.
Notably, the tighter RO membrane was found to fully reject all recalcitrant pesticides regardless
of hydrophobicity.
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Table 4-15: Pesticides Rejection

CEC

a

Molecular
Weight
(g/mol)

Hydro
Classa

Reverse Osmosis

Nanofiltration
Min
R

Max
R

Mean
R

Min
R

Max
R

Mean
R

DACT
(C3H4ClN5)

146

HL-N

18%

100%

84%

100%

100%

100%

DIA
(C5H8ClN5)

174

HL-N

20%

100%

74%

100%

100%

100%

DEA
(C6H10ClN5)

188

HL-N

13%

100%

80%

100%

100%

100%

DEET
(C12H17NO)

191

HB-N

84%

100%

97%

100%

100%

100%

Simazine
(C7H12ClN5)

202

HL-N

76%

100%

89%

100%

100%

100%

Isoproturon
(C12H18N2O)

206

HB-N

Not detected in primary effluent

Chlorotoluron
(C10H13ClN2O)

213

HB-N

100% removed by WRRF biological treatment

Clofibric Acid
(C10H11ClO3)

215

HB-N

100% removed by WRRF biological treatment

Atrazine
(C8H14ClN5)

216

HB-N

10%

89%

68%

100%

2,4-D
(C8H6Cl2O3)

221

HB-N

64%

100%

92%

100%

Chloridazon
(C10H8ClN3O)

222

HL-N

Not detected in primary effluent

Propazine
(C9H16ClN5)

230

HB-N

Not detected in primary effluent

Diuron
(C9H10Cl2N2O)

233

HB-N

100%

100%

100%

100%

100%

100%

Cyanazine
(C9H13ClN6)

241

HB-N

100%

100%

100%

100%

100%

100%

Linuron
(C9H10Cl2N2O2)

249

HB-N

100%

100%

100%

100%

100%

100%

Bromacil
(C9H13BrN2O2)

261

HB-N

100%

100%

100%

100%

100%

100%

Metazachlor
(C14H16ClN3O)

278

HB-N

100%

100%

100%

100%

100%

100%

Metolachlor
(C15H22ClNO2)

284

HB-N

100%

100%

100%

100%

100%

100%

100%
100%

100%
100%

Hydrophobicity Class: HL = Hydrophilic, HB = Hydrophobic, N = Neutral, I = Ionic charged

4.3.2

NF Rejection Coefficient Outliers
Under the assumption that every non-complete CEC removal (R < 100%) by the NF test

membrane was statistically an outlier for the general data population, rejection (R), as a function
of a CEC and its properties, is not a normally-distributed dataset; thus, subpopulations of the
CEC rejection data were further analyzed for statistical outliers. Subsets of the data were
populated for each of the selected CECs. Standard boxplot analysis for each such CEC are shown
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in Appendix C. This analysis demonstrated that rejection was consistent throughout the dataset
(with well-defined lower- and upper-quartiles) for most CECs. This is to be expected. The
fundamental assumption of QSAR is that the behavior of an analyte (in this case, rejection by NF
membranes) will be a function of the properties of that analyte; therefore, each CEC should have
a repeatable rate of rejection with repeated membrane filtration testing. However, for 12 cases of
CEC detection, removal varied significantly despite the analyte and membrane properties
remaining constant. Table 4-16 shows a complete list of the identified statistical outliers.
Table 4-16: Identified Outliers for Observed NF Rejection of CECs
OUTLIER

ANALYTE

SAMPLE
SOURCE

OBSERVED
REJECTION

1

2,4-D

Lawton

64%

2

Atrazine

Garland

9%

3

BPA

Garland

-13%

4

Caffeine

Garland

70%

5

Cimetidine

Garland

78%

6

DACT

Garland

18%

7

DEA

Lawton

13%

8

DIA

Garland

35%

9

Fluoxetine

Norman

63%

10

Quinoline

Garland

56%

11

Triclosan

Garland

-8%

12

Triclosan

Norman

-7%

In three of the 12 outlier cases, the reported analyte concentration was greater in the
membrane permeate than in the secondary effluent, resulting in negative coefficients.
Subsequently, outliers, negative coefficients, and cases where a chemical was not detected in
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secondary effluent (i.e., R = 100% through WRRF primary and secondary treatment) were
removed for development of the NF rejection model.
4.4

Nanofiltration Rejection Model
A multi-level, multi-variable model was developed to predict the probable rejection of a

CEC in reclaimed secondary effluent with the studied NF membrane. The model was developed
from predictor variables selected for their association with known membrane removal
mechanisms for dissolved organic solutes, CEC-specific chemical properties based on QSAR
properties, and matrix characteristics of the secondary effluent. The developed QMPM was then
successfully applied to an independent CEC rejection database for model validation.
4.4.1

Pearson Correlation Analysis
As previously discussed, three predominant mechanisms for rejection of organic solutes

by nano-porous membranes are steric (size) exclusion, electrostatic repulsion, and hydrophobic
sorption. A variety of potential predictors for CEC rejection by NF was tested in categories
according to descriptors for matrix quality and CEC-specific QSAR-based chemical properties.
Chemical properties were selected for analysis for their potential relationship to these
known removal mechanisms for the rejection of dissolved organic compounds by NF membrane
filtration, including:
1. Electrostatic surface interactions
2. Size-exclusion
3. Hydrophobicity/Hydrophilicity
Table 4-17 lists the variables tested for significance in predicting the rejection of CECs
by NF. Values for each chemical-specific property were compiled from existing online databases
(US EPA EPI Suite v.2, ChemAxon: www.chemicalize.org).
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Table 4-17: QSAR Properties Tested for Predicting the Rejection of CECs by NF

Previous efforts to build predictive models for regulated pesticide rejection by NF of
drinking waters (Sanches et al. 2013) have highlighted the complexity of the underlying
phenomena governing micropollutant rejection, requiring multivariate statistical analysis. Each
of the listed predictor variables in Table 4-17 were evaluated individually for statistical
significance in predicting the rejection of the 96 CEC study set. Initially, each variable was
systematically compared to another to determine incidences of collinearity. Figure 4-1 is a
graphical representation of a Pearson Correlation Matrix for the predictor variables evaluated
from Table 4-17.
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Figure 4-1: Pearson Correlation Matrix for QSAR Properties of the Examined CECs
The color intensity and the size of the circles, represented in Figure 4-1, are proportional
to the Pearson correlation coefficients. Large, dark blue circles are indicative of strong, positive
correlations between variables. Large, dark red circles are indicative of strong, negative (or
inverse) correlations between variables. Examining the correlation coefficients among the
partitioning coefficients, the value of Kow is collinear with Kaw, while independent of Koa in the
CEC study dataset. This was somewhat surprising given that Koa also describes the ratio of
Kow/Kaw. As expected, Kaw displays some collinearity and dependence with Koa. Therefore, for
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the purposes of developing a QMPM, both Kow and Koa (Kow/Kaw) were evaluated as potential
predictors of CEC selectivity with NF.
Steric measures (molecular size descriptors) also correlated with three of the four
partitioning properties, thereby demonstrating that the size and shape of an organic molecule
does have a significant impact on the partitioning behavior of that molecule. CEC polar surface
area (PSA), a measure of the molecular surface area occupied by polar atoms (e.g., O and N for
many CECs), revealed limited collinearity with Koa (Kow/Kaw) and therefore is an independent
predictor. Nevertheless, MW was preserved for QMPM development in order to evaluate the
potential MWCO of the studied NF membrane.
Parameters that can be used to describe the polarity of the studied CECs, charge at neutral
pH and solubility constant (S) in water, were determined to be independent of the partitioning
coefficient Kow. Molecular polarizability (α) was also found to have limited association with
either solubility or charge at neutral pH.
From the Pearson Correlation analysis, an initial set of independent QSAR parameters
was selected for model development:
1. Log Kow
2. Log Koa (Kow/Kaw)
3. Molecular Charge at Neutral pH
4. Molecular Weight
5. Polar Surface Area
6. Polarizability
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4.4.2

Model Predictor Variables
The following predictor variables had the lowest mutual dependence and best collinearity

with the predominant rejection mechanisms of the NF test membrane: size exclusion,
hydrophobic sorption, and electrostatic surface interactions.
4.4.2.1 Molecular Weight
As previously discussed, one approach to assessing the absolute MWCO of a membrane
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Figure 4-2: MW versus Observed Rejection
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In Figure 4-2, the dashed line represents the observed molecular weight rejection
threshold for the studied NF membrane above which nearly complete rejection of CECs was
observed. For smaller molecular weight CECs (< 330 g/mol), observed rejection ranged from 0
to 100%. With a clear molecular weight rejection cutoff established for the tested membrane, it
was apparent that a QSAR-based CEC rejection model would be most useful in predicting the
variability in rejection of the smaller CECs (with molecular weight < 330 g/mol).
4.4.2.2 Molecular Charge at Neutral pH
Electrostatic repulsion and attraction of dissolved CECs by the charged membrane
surface (with a negative zeta potential) can be described by the molecular charge at the neutral
pH of the sampled matrix (for the purposes of safe stream discharge or water reuse, typical
reclaimed municipal effluents will have a pH between 7 and 8). By plotting the molecular
surface charge density (C/m2) of each CEC versus its observed rejection coefficient, a clear
delineation can be observed in Figure 4-3 between the rates of rejection of charged and neutral
species. With the exception of four observations, charged CECs (positive or negative) at neutral
pH were removed by 90% or more (for greater than 1-log rejection). However, neutral CECs
(solutes with zero surface charge density at pH =7) could potentially see less efficient rejection
by the tested NF membrane. As recently observed by Chen et al. (2015), the CECs furthest away
from their isoelectric point in neutral pH reclaimed waters have the greatest probability of NF
rejection.
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Figure 4-3: Surface Charge Density versus Observed Rejection
To assess the expected percent rejection of charged/ionic CECs, frequency distributions
were plotted for observed NF rejection (excluding observations for nonionic, or neutral, CECs).
Figure 4-4 shows the frequency of observed rejection coefficients for negatively charged CECs.
With few exceptions, negatively charged CECs were rejected fully (R = 1.00) by the NF test
membrane, and the 1st-quartile, median, and 3rd-quartile observed R were all 1.00 for these
compounds.
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Figure 4-4: Frequency Distribution of NF Rejected Negative CECs
Similarly, positive-charged CECs were also rejected fully (R = 1.00) by the NF test
membrane, and the 1st-quartile, median, and 3rd-quartile observed R were all 1.00 for these
compounds. Figure 4-5 illustrates the frequency of observed R for positively charged CECs.
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Figure 4-5: Frequency Distribution of NF Rejected Positive CECs
4.4.2.3 Phase Partitioning
Having identified that the greatest variation in observed NF rejection could be explained
by small molecular weight CECs with neutral surface charges at pH =7, hydrophobic sorption
was next examined as potential predictors. Solute hydrophobicity has been previously described
by phase partition coefficients like Kow. However, for this dataset, neither Kow nor the log of Kow
was found to be a statistically significant predictor, in itself, of CEC rejection by NF.
Other phase partitioning constants, either empirical or model-derived, were considered as
well, including the air-water partitioning coefficient (Kaw). Individually, these partitioning
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coefficients were also ruled out as strong predictors of CEC rejection coefficients due to lack of
correlation with the observed rejection dataset. However, an obvious trend was identified when
the ratio of log Kow to log Kaw was examined for its relationship to observed CEC rejection. As
evidenced by Figure 4-6, for log Kow/Kaw greater than 17, all cases had an observed rate of
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Figure 4-6: NF Rejection as a Function of log (Kow/Kaw)

Applying linear regression to the observed CEC rejection coefficients when MW<330
g/mol, ionic (i.e., charged) CECs at pH =7, and log (Kow/Kaw) > 17, the resulting model for
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rejection coefficients as a function of CEC log (Kow/Kaw) has a negligible slope, and an intercept
of 0.99. Thus, the minimum predicted rejection with NF of smaller, charged CECs with log
(Kow/Kaw) > 17 is expected to be 100%.
4.4.3

NF Rejection Model
Having characterized the variability in CEC rejection by NF as a function of small

molecular weight, neutrally charged at pH =7, and having a log Kow/Kaw less than 17, a clear
taxonomy for CEC selectivity with NF was formed. Figure 4-7 allows for classification of the
likelihood for CEC rejection by NF by steric, electrostatic, and hydrophobic/hydrophilic
mechanisms.
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Figure 4-7: Quantitative Molecular Properties Model
As defined, the Bin 4 CECs (i.e., small, neutral, hydrophilic) had the greatest variability
in observed rejection coefficients with the tested NF membrane. However, as seen in Figure 4-8,
this subset of data remains heavily weighted by occurrences of complete, or nearly complete,
rejection.
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Figure 4-8: Distribution of Bin 4 CEC Rejection Coefficients
To better predict the rate of rejection of CECs that are less selective for NF, a regression
model was fit to the subset of Bin 4 data where R<99% (excluding cases of 100% rejection). The
resulting model applies the variable function log (Kow/Kaw) to quantify the trend in increasing
CEC rejection by NF with increasing Kow/Kaw. Notably, the Bin 4 equation includes both
hydrophobic and steric rejection functions.
=

(
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(
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%,

≤
>

Eq. (4.2)
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Where:
β1, β2 = model coefficients
PSA = polar surface area
R = predicted CEC rejection by NF
The best-fit model parameter and corresponding summary statistics for the Bin 4 linear
regression model are provided in Table 4-18 below. Summary statistics were calculated using
statistical software (R v.3.1.1). Table 4-18 lists the estimated parameter coefficients and standard
errors. The p-value was the test statistic used to assess the significance of the estimated mean in
relationship to the null hypothesis (that the true mean is actually 0). A p-value less than 0.05 was
considered highly significant, with 95% confidence.
Table 4-18: Summary Statistics for Bin 4 Equation

4.4.4

Parameter

Estimated
Mean

Standard
Error

p-value

β1

0.05301

0.01520

0.0011

β2

0.16502

0.07720

0.0380

Model Validation
With a predictive NF rejection model for Bin 4 CECs, a comparison of the predicted NF

rejection of incompletely removed (Bin 4) CECs to observed NF rejection is a useful exercise for
assessing model validity. Figure 4-9 shows a side-by-side comparison of observed Bin 4 CECs
rejection, with the studied NF membrane, and model-predicted rejection.
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Figure 4-9: Observed (mean) Rejection for 10 Bin 4 CECs vs. Model Predicted
For all ten Bin 4-CECs examined, the QMPM slightly under-predicts the rate of NF
rejection. This result was expected, considering the mean observed CEC rejection includes cases
where rejection was 99% or more. The average under-prediction for each of the 10 CECs was
20% of the observed mean rejection coefficient. From a design and treatment selection
perspective, this consistent under-prediction by the QMPM provides a necessary factor-of-safety
when assessing the viability of NF to meet potential treatment and regulatory requirements for
filtrate concentrations of monitored CECs.
4.5

Model Verification
The close proximity of modeled and observed CEC rejection for the Bin 4 CECs

highlights the potential utility of this predictive QMPM model. For further validation, an
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independent dataset for bench-scale NF rejection testing of CECs in purified water was selected
for comparison. Yangali-Quintanilla published a dataset in 2010 that was collected from a
similar bench-scale, membrane pressure cell testing apparatus. Although, a continuous crossflow was applied to the membrane coupon, rather than dead-end operation. The NF membrane
utilized by Yanagali-Quintanilla was very similar to the GE Osmonics DK membrane used for
this research: commercially available (Dow-Filmtec NF-90), thin-film polyamide composite
hydrophilic membrane with MWCO of 200 Da and negative zeta potential. However, relative to
this thesis research, Yangali-Quintanilla’s NF rejection study represents an idealized system for
observing CEC rejection. The relative purity of the Yangali-Quintanilla water matrix makes it an
applicable test case for the universality of the QMPM.
Yangali-Quintanilla’s (2010) data set included the following QMPM Bin 4 CECs:
•

Phenacetin (log Kow/Kaw=9.6)

•

Atrazine (log Kow/Kaw=9.6)

•

Metronidazole (log Kow/Kaw=9.14)

•

Caffeine (log Kow/Kaw=8.77)

•

Phenazone (log Kow/Kaw=7.95)

•

4-Nonylphenol (log Kow/Kaw=9.37)

•

Ibuprofen (log Kow/Kaw=9.18)

The constituents highlighted in bold were not present in the study set of 96 CECs
analyzed in samples from Garland, Lawton, and Norman. For comparison, Figure 4-10 plots the
observed CEC rejection with NF by Yangali-Quintanilla and subsequent predicted CEC rejection
for these Bin 4 constituents.
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Figure 4-10: Observed Bin 4 CEC rejection (by NF) versus model-predicted CEC rejection
for Yangali-Quintanilla (2010) data set. Red dashed lines depict upper and lower 95%
confidence intervals on the regression line.
Despite testing the NF membrane in a different filtration mode (cross-flow vs. dead-end)
with artificially spiked CECs in ideal, laboratory-grade water, the QMPM also under-predicts
Yangali-Quintanilla’s observed Bin 4 CEC rejection coefficients by 20%. As previously
discussed, CECs that would be classified as Bin 4 according to QSAR are the most challenging
to remove by tight TFC NF membranes. As such, some factor of safety (FOS) would be prudent.
The utility of a predictive rejection model which provides a FOS for the most poorly rejected Bin
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4 CECs is that it provides a conservative tool for assessing NF as treatment technology for
potable reuse applications where numerical criteria for CECs in produced water are a likely
eventual reality.
As opposed to a priori models of NF rejection, the QMPM is independent of membraneor solution-specific properties. Thus, the developed model can be used to screen or select CECs
that could be classified as Bin 4 contaminants and therefore most challenging to NF filtration.
For I/DPR applications of NF, the window of CECs that must be analyzed for prior to design and
monitored for during full-scale operation is reduced to the Bin 4 CECs that resist WRRF removal
and are known to exist in the treated effluent water matrix.
The conservatism of the developed QMPM can be attributed to discounting the 100% NF
rejection observations in the modeled data set for Bin 4 CECs. While it can be argued that this
approach artificially lowers the predicted rejection of CECs by NF, the goal of this work was not
to develop a multi-parameter, membrane-specific, fundamental mechanism model (which would
provide inherently greater prediction precision), but to synthesize a simple, universal, CEC
rejection prediction and screening tool. The ultimate success of the QMPM will depend on future
application and improvement through NF pilot- and full-scale testing, and consequently the
adoption of the QMPM by engineers and regulators for screening and selection of CECs for NF
process monitoring during potable reuse water production.
As previously discussed, the QMPM is a departure from fundamental, first-principlesbased solute rejection models for RO. Models based on SK theory and Fick’s Law have been
proven useful for developing a complete mass-balance of single solutes in an idealized
membrane filtration system, typical of RO desalination applications. The complexity of
predicting rejection of a mixed-liquor of trace organic solutes (i.e., CECs) in a constantly-

132

changing water matrix such as a reclaimed wastewater requires a more robust, universal
modeling approach than fixed-film theory can provide. The Yangali-Quintanilla data set was
purposely selected to validate the universality of the QMPM for conservative prediction of
observed CEC rejection. By selecting chemical-specific QSAR prediction parameters, rather than
membrane-specific properties, the QMPM can consistently predict the minimum rejection
coefficient for recalcitrant trace organic wastewater contaminants regardless of the quality of the
water matrix being filtered. While the QMPM is not a ‘black box’ solution and can be adapted to
predict NF rejection of future CECs after identifying the solute’s bin classification based on
QSAR properties, it does not consider changes in membrane properties, such as irreversible
fouling and swelling, due to aging and continued use. As such, the best application of the QMPM
will be as a decision science screening tool for developing a priority list of CECs for testing and
monitoring during NF application for I/DPR.
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CHAPTER 5 - CONCLUSIONS AND FUTURE WORK
The objective of this research was to elucidate the recalcitrant CEC rejection performance
of a commercially available tight thin-film composite (GE Osmonics DK) NF membrane in
parallel with and relative to a typical water industry specified (GE Osmonics AG) RO membrane
with actual secondary effluents from three WRRFs where the PWS managers are currently
considering the addition of reuse water to their water supply portfolio. And, ultimately, the
objective was to conceive and develop a novel but practical decision science tool, derived from
CEC QSAR properties and membrane rejection mechanisms, for regulators, PWS managers, and
designers to utilize when selecting barrier treatment technologies for the implementation of
potable reuse systems.
5.1

Rejection Conclusions
Nanofiltration of WRRF SE was observed to meet published and regulated human health

criterion for the CEC study set. As provided in Table 5-1, a factor of safety (FOS) greater than
30 was achieved for all CEC analytes. The FOS for CECs regulated by the US EPA NPDWR for
potable water supply ranged from 125 to 2,059. The following discussion summarizes the
observed rejection coefficients by CEC intended use classification.
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Table 5-1: Human Health Criterion Factor of Safety with NF
Human Health
CEC

Criterion
(ηg/L)

a

Observed NF Reuse Supply
Minimum
(ηg/L)

Mean
(ηg/L)

Maximum
(ηg/L)

NF
Factor of Safety

Ethinyl estradiol

5

Not detected in PE

--

17-β-estradiol

5

Not detected in SE

--

Estrone

320

ND

ND

ND

64

Cotinine

1,000

ND

ND

ND

100

Primidone

10,000

ND

ND

ND

2,000

Dilantin

2,000

ND

ND

ND

100

200,000

ND

<5

9

22,222

Atenolol

4,000

ND

<5

27

148

Carbamazepine

10,000

5

12

19

526

150,000,000

ND

< 100

160

937,500

TCEP

5,000

ND

92

160

31

DEET

200,000

ND

<5

21

9,524

Triclosan

50,000

ND

9

35

1,429

2,4-D

MCL: 70,000

ND

6

34

2,059

Atrazine

MCL: 3,000

ND

11

24

125

Simazine

MCL: 4,000

ND

11

31
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Meprobamate

Sucralose

a

Adapted from NWRI, US EPA NPDWR.
MCL = maximum contaminant level. ND = not detected. PE = primary effluent. SE = secondary effluent.

For the study set of 96 CECs, 82 were detected above the corresponding MRL in the
primary effluent. The 14 undetected CECs either did not exist at measurable concentration in the
WRRF influent or were effectively removed by the WRRF primary treatment gravity separation
barriers. Of significant relevance for potable reuse applications, 18 of the studied 96 CECs were
fully (100%) removed by full-scale WRRF biological treatment. Conversely, 64 of the 96 studied
135

CECs were found to exist in the SE at recalcitrant residual concentrations above MRL. Of the
recalcitrant CECs, mean rejection by the tested NF was 90% or higher for 53 of the 64. The other
11 CECs were rejected at a range from 46% to 89%. Notably, the tested RO membrane fully
(100%) rejected all but 2 of the 64 recalcitrant CECs: Quinoline (89%) and Triclocarban (93%).
Rejection analyses of the EDCs revealed that most natural human hormones were readily
removed to below MRL by the WRRF biological processes. Estrone was the only natural human
hormone not fully biodegraded, and NF effectively rejected approximately half the remaining
fraction. The other two recalcitrant EDCs were 4-tert-Octylphenol (surfactant) and BPA
(plasticizer), for which the NF membrane was found to be a very effective barrier rejecting 90%
to 95%. All three EDCs detected in NF permeate samples have a MW above the NF MWCO and
are classified hydrophobic neutral, suggesting steric exclusion and hydrophobic sorption as the
predominant rejection mechanisms.
NF proved very effective for the rejection (84% to 100%) of neutral-charged
pharmaceuticals. With a neutral charge, this group of CECs is likely rejected by steric exclusion
and some hydrophobic sorption, although the 100% exclusion of Acetaminophen (MW = 151
g/mol) by the NF test membrane was evidence molecular PSA may be a better QSAR indicator
than MW for steric exclusion. With characteristically high MW (e.g., antibiotics) and ionic
charge, the positive-charged pharmaceuticals were highly rejected (97% to 100%) by the tested
NF membrane by steric and electrostatic exclusion. The recalcitrant negative-charged
pharmaceuticals were also found to be highly rejected (97% to 100%) by the NF test membranes,
via steric and electrostatic exclusion.
Representing caffeine and associated degradates of caffeine, nicotine, and chocolate, the
stimulants group was somewhat surprisingly found to be in recalcitrant non-biodegraded trace
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occurrence in secondary effluent samples. All studied stimulants were characterized as
hydrophilic-neutral with relatively low molecular weights, thereby suggesting a possible
challenge for NF membrane rejection. However, all stimulants but caffeine (97%) were rejected
fully by the NF test membranes.
The preservatives group of CECs were QSAR characterized as relatively low MW and
mostly hydrophobic neutral. Generally, such properties suggest the predominant membrane
rejection mechanism for this group may be more sorption and less exclusion. Five of the eight
studied preservatives were found to be 100% removed by WRRF biological treatment. Of the
three recalcitrant preservatives, results indicated the two largest, Triclocarban and Triclosan,
were highly rejected (95 to 100%) by the NF test membrane, with the ionic analyte (Triclosan)
fully rejected. The third recalcitrant preservative, Quinoline, represented the smallest analyte
(MW = 129 g/mol) in the study set of 96 CECs. Rejection analysis revealed good (89%) removal
of Quinoline by the NF membrane.
The studied artificial sweeteners group included two hydrophilic neutral CECs. As
suspected, this group of CECs was found to be resistent to biodegradation by the WRRFs and
fully recalcitrant. Results indicated the larger sweetener, Sucralose, was highly rejected (99 to
100%) by the NF test membrane by steric exclusion. However, the smaller Acesulfame-K was
rejected at 56%.
Similar to artificial sweeteners, the flame retardants were found to be highly recalcitrant
in the WRRF secondary effluents. This group of CECs is QSAR characterized as moderate size
and hydrophobic neutral. Mean rejection by NF of this group ranged from 55% for the smallest
to 89% for the largest analyte.
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The pesticides group of 18 CECs were QSAR characterized as relatively low to moderate
in size, with MW ranging from 146 to 284 g/mol, and of neutral charge. Three of the 18 were not
detected in the primary effluent, while two of the pesticides were found to be fully removed by
the WRRF biological processes. The remaining 13 pesticides were found to be recalcitrant CECs
in the secondary effluents. With the exception of Atrazine, the NF test membrane proved to be
highly effective (92-100%) for rejection of the nine hydrophobic pesticides and slightly less
effective (74-89%) for rejection of the four hydrophilic species.
5.2

Modeling Conclusions
A multi-level, multi-variable model was developed to predict the probable rejection

coefficient (R = 1 – C/C0) of recalcitrant CECs in secondary effluent with the studied NF
membrane. The model was developed from predictor variables selected for their association with
known membrane rejection mechanisms for organic solutes (size-exclusion, electro-static
interactions, and hydrophobicity), CEC-specific chemical properties based on QSAR, and
wastewater matrix characteristics of the samples. The resulting QMPM, as presented in Figure 51, was then successfully applied and verified to evaluate the mechanisms governing the rejection
(by NF) of the studied recalcitrant CECs.
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Figure 5-1: NF Quantitative Molecular Properties Model (QMPM)
Similar to other decision science tools released by the EPA for compliance with rules of
the SDWA (e.g. SWTR, DBPR), a “bin” approach was adopted for development of the QMPM.
Each of the four bins represents a unique set of conditions consisting of CEC QSAR properties
and membrane rejection mechanisms. Figure 2 shows the respective bin classifications for the
Norman 96.
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Figure 5-2: Bin Classification of Norman 96

For Bin 1, steric exclusion represents the predominant NF rejection mechanism. The
model predicts 100% rejection of the larger CECs with a MW greater than or equal to 330 g/mol.
A total of 10 CECs from the study set fell in Bin 1. Examples of large CECs captured by Bin 1
include antibiotics from the pharmaceuticals classification. With Bin 2, steric and electrostatic
exclusion are the predominant rejection mechanisms. From the study set, a total of 30 CECs with
a MW ranging 130-330 g/mol and an ionic charge (positive or negative) at neutral pH were fully
rejected in Bin 2. These CECs consisted of the ionic pharmaceuticals and the preservative
Triclosan.
For Bins 3 and 4, including over half the CEC study set, steric exclusion and hydrophobic
sorption are the rejection mechanisms. The model predicts neutral charged CECs with a MW
ranging 130-330 g/mol and hydrophobic, log (Kow/Kaw) > 17, in nature will be rejected fully
(100%) in Bin 3 by the hydrophilic NF test membrane, whereas the Bin 4 hydrophilic-neutral
CECs with log (Kow/Kaw) ≤ 17 were not fully rejected in many cases by the tested NF membrane.
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As such, the QMPM predicts Bin 4 CECs are rejected at a rate as determined by the Equation
5.1.
R = 0.05301 log (Kow/Kaw) + 0.16502 log (PSA)

Eq (5.1)

Where:
PSA = polar surface area
R = Bin 4 predicted CEC rejection by NF
The QMPM-predicted rejection coefficients were validated against the observed data set.
Furthermore, the QMPM was verified against the hydrophilic-neutral CEC data set reported by
Yangali-Quintanilla in 2010. CECs that would be classified as Bin 4 according to QSAR are the
most challenging to remove by tight TFC NF membranes. As such, some FOS would be prudent.
A predictive rejection model which provides a FOS for the less highly rejected Bin 4 CECs is
useful because it provides a conservative tool for assessing NF as treatment technology for
I/DPR applications where numerical criteria for CECs in produced water are a likely eventual
reality.
5.3

Future Work
The exhaustive literature review performed by EPA in 2014 of over 400 publications

shows that zero full-scale and only 13 bench-scale NF membrane units were found from which
to report CEC rejection. With the lack of knowledge, the default approach can be an overconservative and cost-prohibitive design. Currently, RO in existing I/DPR treatment facilities is
the default FAT barrier for CEC control. RO represents a major capital and O&M expense not
seen with conventional technologies. Further, an RO system produces a brine reject waste that
can represent new treatment/disposal challenges. However, the default RO approach to CEC
control may be questioned if we consider new commercially available tight (i.e., MWCO ≤ 200
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Da) TFC NF membranes. Tight NF membranes may provide suitable CEC rejection efficacies
for less capital, O&M, power, and waste generated. Clearly, more research is required to
ascertain if tight NF membranes can be acceptable FAT barriers for CEC control in potable reuse
systems.
More research is required to assess the NF membrane sorption rejection mechanism of
recalcitrant hydrophilic-neutral CECs in actual secondary effluents. Some bench-scale research
has reported that NF membrane rejection can be overestimated if the sorption mechanism of a
fresh membrane is not allowed to reach equilibrium (Kimura et al. 2003). Other bench-scale
research has studied the sorption equilibrium effect and reported only nominal differences (i.e.,
<1 to 5%) in CEC rejection with and without adsorption equilibrium (Yangali-Quintanilla 2010).
This researcher also reported a fouled NF membrane could produce higher hydrophilic-neutral
CEC rejection coefficients than a fresh membrane. For bench-scale testing, a cross-flow
apparatus must be utilized if the sorption mass is to be determined. However, bench-scale testing
cannot simulate the sorption rejection recovery effect of a pilot or full-scale NF membrane
following backwash, maintenance clean, or clean-in-place. As such, NF pilot or full-scale testing
to research the rejection of recalcitrant hydrophilic-neutral CECs is recommended.
Regarding future work in NF predictive modeling, Mohammad and his research team
reported that
… the overwhelming majority of NF predictive rejection models to date are
inadequate because they have been developed with idealized solutions typically
containing only 2, 3, or sometimes 4 solutes. If accurate modeling of
concentrated multi-solute solutions realistic of industrial processing is to become
common place then more effort needs to be placed into modeling systems of real
industrial relevance. (Mohammad et al. 2015)

142

As such, future work is recommended with WRRF secondary effluent matrices (not
synthetic lab solutions) and recalcitrant occurring (not spiked) CECs at environmentally relevant
ηg/L concentrations.
And finally, more work is required to determine human health criterion based MCLs for
high-risk CECs. Treatment goals should be based on human health, rather than setting treatment
goals as full (100%) rejection of MRL as established by the latest analytical methods. Complete
removal of all chemicals is impractical (Tchobanoglous et al. 2015).

143

REFERENCES
Abolmaali, B., Hanson, E., Libby, B., and Schloss, J. (2015). Membrane Manufacturing and
Testing – Factory Observation. GE Osmonics, Minnetonka, MN.
Agenson, K., Kikuta, J., and Urase, T. (2003). “Rejection Mechanisms of Plastic Additives and
Natural Hormones in Drinking Water Treatment by NF Membranes.” Membranes in
Drinking and Industrial Water Conference, Mulheim an der Ruhr, Germany.
Agenson, K., Kikuta, J., and Urase, T. (2003). “Retention of a Wide Variety of Organic
Pollutants by Different Nanofiltration and Reverse Osmosis Membranes: Controlling
Parameters of Process.” J. Membr. Sci., 225, 91-103.
Ahmad, A., Tan, L., and Shukor, A. (2009). “Modeling of the Retention of Atrazine and
Dimethoate with Nanofiltration.” Chem. Eng. J., 147 (2009) 280-286.
Al-Rifai, J., Khabbaz, H., and Schafer, A. (2011). “Removal of Pharmaceuticals and Endocrine
Disrupting Compounds in a Water Recycling Process using Reverse Osmosis Systems.”
Sep. Purif. Technol., 77, 60-67.
ACS (American Chemical Society), Chemical Abstracts Division. (2015). CAS Registry.
<https://www.cas.org> (April 22, 2016).
Anderson, P., Denslow, N., Drewes, J., Olivieri, A., Schlenk, D., and Snyder, S. (2010).
“Monitoring Strategies for Chemicals of Emerging Concern (CECs) in Recycled Water:
Final Report.” California State Water Resources Control Board, Sacramento, CA, 220.
Appleman, T., Dickenson, E., Bellona, C., and Higgina, C. (2013). “Nanofiltration and Granular
Activated Carbon Treatment of Perfluoroalkyl Acids.” J. Hazard. Mater., 260, 740-746.
Asano, T., Burton, F., Leverenz, H., Tsuchihashi, R., and Tchobanoglous, G. (2007). Water
Reuse: Issues, Technologies, and Applications, 1st Edition, McGraw Hill, New York, NY.
ASTM (American Society for Testing and Materials. (2006). “Standard D3370 - Sampling from
Closed and Open Conduits.” Annual Book of ASTM Standards, Vol. 11.01.
Behera, S., Hyeong, W., Jeong-Eun, O., and Hing-Such, P. (2011). “Occurrence and Removal of
Antibiotics, Hormones, and several Other Pharmaceuticals in Wastewater Treatment
Plants of the Largest Industrial City of Korea.” Sci. Total Environ., 409(20), 4351-4360.
Bellona, C; Drews, J.; Oelker, G.; Luna, J.; Filteau, G; and Amy, G. (2008). “Comparing
Nanofiltration and Reverse Osmosis for Drinking Water Augmentation.” J. Amer. Water
Works Assn., 100(9), 102-116.

144

Bellona, C.; Heil, D.; Yu, C; Fu, P.; and Drewes, J. (2012). “The Pros and Cons of Using
Nanofiltration in Lieu of Reverse Osmosis for Indirect Potable Reuse Applications.” Sep.
Purif. Technol., 85, 69-76.
Bellona, C., Drewes, J., Xu, P., and Amy, G. (2004). “Factors Affecting the Rejection of Organic
Solutes during NF/RO Treatment - A Literature Review.” Water Res., 38(12), 2795-2809.
Benjamin, M., and Lawler, D. (2013). Water Quality Engineering: Physical/Chemical Treatment
Processes. J. Wiley & Sons, Hoboken, NJ.
Birkett, J., and Lester, J. (2003). Endocrine Disruptors in Wastewater and Sludge Treatment.
CRC Press, Boca Raton, FL.
Bishop, C., Brooks, R., and Cary, J. (1991). “The Case for a Cause-Effect Linkage Between
Environmental Contamination and Development in Eggs of the Common Snapping Turtle
(Chelydra S.serpentina) from Ontario, Canada.” J. Toxicol. Environ. Health, 33(4), 521547.
BOR (US Bureau of Reclamation). (2009). “Secondary Effluent Constituents of Emerging
Concern Report, Southern California Regional Brine-Concentrate Management Study.”
US Department of the Interior Bureau of Reclamation, Washington, DC.
Bowen, R., and Doneva, T. (2000). “Atomic Force Microscopy Characterization of
Ultrafiltration Membranes: Correspondence between Surface Pore Dimensions and
Molecular Weight Cut‐Off.” Surface and Interface Analysis, 29(8), 544-547.
Brooks, B. (2014). “Fish on Prozac (and Zoloft): Ten Years Later.” Aquatic Toxicology, 151, 6167.
Brooks, B., Chambliss, K., Stanley, J., Ramirez, A., Banks, K., Johnson, R., and Lewis, R.
(2005). “Determination of Select Antidepressants in Fish from an Effluent-Dominated
Stream.” Environ. Toxicol. Chem., 24(2), 464-469.
CAEPA (California Environmental Protection Agency). (2006). “Chemicals Known to Cause
Cancer or Reproductive Toxicity.” Office of Environmental Health Hazard Assessment.
Cayan, D., Tapash, D., Pierce, D., Barnett, T., Tyree, M., and Gershunov, A. (2010). “Future
Dryness in the Southwest US and the Hydrology of the Early 21st Century Drought.”
Proc. National Academy of Sciences, 107(50), 21271-21276.
CDPH (California Department of Public Health). (2011). Title 22, “Direct and Indirect Potable
Reuse.” Drinking Water Program, Chapter 7. January 2011.
ChemAxon. (2015). Chemical Abstract Service Number (CASN) Search Engine.
<http://www.chemicalize.org> (April 22, 2016).

145

Chen, X., Zhao, Y., Moutinho, J., Shao, J., Zydney, A., and He, Y. (2015). “Recovery of small
dye molecules from aqueous solutions using charged ultrafiltration membranes.” J.
Hazard. Mater., 284, 58-64.
Clara, M., Strenn, B., Saracevic, E., and Kruezinger, N. (2004). “Adsorption of Bisphenol, 17βEstradiole, and 17α-Ethinylestradiole to Sewage Sludge.” Chemosphere, 56(9), 843-851.
Cook, B., Ault, T., and Smerdon, J. (2015). “Unprecedented 21st Century Drought Risk in the
American Southwest and Central Plains.” Sci. Adv., 1(1), e1400082.
Crowley, T., and Mattingly, C. (2009). “Pharmaceutical and Algal Toxin IPR Bench Scale
Study.” Final Report prepared for City of Norman. Carollo, Overland Park, KS, January
2009.
Crook, J. (2010). “Regulatory Aspects of Direct Potable Reuse in California.” National Water
Research Institute, Fountain Valley, CA.
CSWRCB (California State Water Resources Control Board). (2014a). “Draft Recycled Water
Policy Amendment.” State Water Resources Control Board, Sacramento, CA.
<http://www.waterboards.ca.gov/water issues/programs/index.shtml#waterrecycling>
(March 2015).
CSWRCB (California State Water Resources Control Board). (2014b). “Pilot Study on CEC
Monitoring in Aquatic Ecosystems.” Minutes from Mid-term Meeting May 9, 2014,
Southern California Coastal Water Research Project Authority, Costa Mesa, CA.
Dang, H., Price, W., and Nghiem, L. (2015). “Rejection and Adsorption Behaviour of
Phytoestrogens by Nanofiltration and Reverse Osmosis Membranes.” Desalin. Water
Treat., 54(4-5), 890-899.
Dang, H., Nghiem, L., and Price, W. (2014). “Factors Governing the Rejection of Trace Organic
Contaminants by Nanofiltration and Reverse Osmosis Membranes.” Desalin. Water
Treat., 52, 589-599.
Delgado, L., Charles, P., Glucina, K., and Morlay, C. (2012). “QSAR-Like Models: A Potential
Tool for the Selection of PhACs and EDCs for Monitoring Purposes in Drinking Water
Systems – A Review.” Water Res., 46(19), 6196-6209.
Dickenson, E., and Drewes, J.(2008). “Removal of Pharmaceuticals and Personal Care Products
during Activated‐Sludge Wastewater Treatment.” Proc., World Environmental and Water
Resources Congress, Environmental & Water Resources Institute, Reston, VA.
Drewes, J., Hemming, J., Schauer, J., and Sonzogni, W. (2006). “Removal of Endocrine
Disrupting Compounds in Water Reclamation Processes.” Water Environment Research
Foundation, US EPA, Colorado School of Mines, Ch.1, 3, 5, 6, 7.

146

Drewes, J., Bellona, C., Oedekoven, M., Xu, P., Kim, T., and Amy, G. (2005). “Rejection of
Wastewater-Derived Micropollutants in High-Pressure Membranes Leading to Indirect
Potable Reuse.” Environ. Progress, 24(4), 400-409.
Drewes, J., Fox, P., Reinhard, M.; Sarikaya, A., Montgomery-Brown, J., and Soellner, A. (2001).
“Removal of Organics in Indirect Potable Reuse Systems: A Comparison of Efficiencies
of Long-Term Soil-Aquifer Treatment (SAT) and Best Available Technologies (BAT).”
National Centers for Water Treatment Technologies, 699-799-005.
Eaton, A., and Haghani, A. (2012). “The List of Lists – Are We Measuring the Best PPCPs for
Detecting Wastewater Impact on a Receiving Water?” Water Pract. Technol., 7(4), 069083.
EPA (US Environmental Protection Agency). (2007). Method 1964: Pharmaceuticals and
Personal Care Products in Water, Soil, Sediment, and Biosolids by HPLC/MS/MS.
EPA (US Environmental Protection Agency). (2010). Method 539: Determination of Hormones
in Drinking Water by Solid Phase Extraction (SPE) and Liquid Chromatography
Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS/MS).
EPA (US Environmental Protection Agency). (2012). “Guidelines for Water Reuse.” Office of
Wastewater Management. EPA 600-R-12-618, September 2012.
EPA (US Environmental Protection Agency). (2014). “Treating Contaminants of Emerging
Concern – A Literature Review Database.” Water: Pharamceuticals and Personal Care
Products. <grvr.us/epa> (April 25, 2016).
EPA (US Environmental Protection Agency). (2015a). “Science and Technology: Glossary of
Technical Terms.” US Environmental Protection Agency webpage,
<http://www2.epa.gov> (September 2015).
EPA (US Environmental Protection Agency). (2015b). “The Third Unregulated Contaminant
Monitoring Rule (UCMR3) Data Summary.” Office of Water (MS-140), EPA 815-S-15002.
EPA (US Environmental Protection Agency). (2015c). “80 FR 6076, Drinking Water
Contaminant Candidate List 4 – Draft.” Federal Register 80(23), FR Doc 2015 – D2210.
Facemire, C., Gross, T., and Gillette, L. (1995). “Reproductive Impairment in the Florida
Panther: Nature or Nurture?” Environ. Health Perspect., 103(4), 79-86.
Fane, A., Fell, C., and Waters, A. (1983). “Ultrafiltration of protein solutions through partially
permeable membranes—the effect of adsorption and solution environment.” J. Membr.
Sci., 16, 211-224.

147

FDEP (Florida Department of Environmental Protection). (2014). “Reuse of Reclaimed Water.”
Florida Administrative Code, Chapter 62-610, Section 403.064.
<http://www.dep.state.fl.us/water/reuse/apprules.htm> (March 2015).
Folmar, L., Denslow, N., Rao, V., Chow, M., Crain, D., Enblom, J., Marcino, J., and Guillette, L.
(1996). “Vitellogenin Induction and Reduced Serum Testosterone Concentrations in Feral
Male Carp Captured Near a Major Metropolitan Sewage Treatment Plant.” Environ.
Health Perspect; 104(10), 1096-1101.
Fujioka, T., McDonald, J., Khan, S., Roux, A., Poussade, Y., Drewes, J., and Nghiem, L.
(2014a). “Modeling the Rejection of N-nitrosamines by a Spiral-Wound Reverse
Osmosis System: Mathematical Model Development and Validation.” J. Membr. Sci.,
454, 212-219.
Fujioka, T., McDonald, J., Khan, S., Roux, A., Poussade, Y., Drewes, J., and Nghiem, L.
(2014b). “Rejection of Small Solutes by Reverse Osmosis Membranes for Water Reuse
Applications: A Pilot-Scale Study.” Desalination, 350, 28-34.
GEPD (Georgia Environmental Protection Division). (2015). “TMDL and 303d Approach
Including Georgia Draft Priority Framework Document.”
<http://epd.georgia.gov/sites/epd.georgia.gov/files/related_files/site_page/GAEPD_Priori
ty_Framework_2_13_2015.pdf> (March 2015).
Gerrity, D., Holady, J., Mawhinney, D., Quinones, O., Trenholm, R., and Snyder, S. (2013a).
“The Effects of Solids Retention Time in Full-Scale Activated Sludge Basins on Trace
Organic Contaminant Concentrations.” Wat. Environ. Res., 85(8), 715-724.
Gerrity, D., Pecson, B., Trussell, S., and Trussell, R. (2013b). “Potable Reuse Treatment Trains
Throughout the World.” WaterReuse Research Foundation (WRRF) Research Project
No. 11-02: Equivalency of advanced treatment trains for potable reuse.
Gillesby, B., and Zacharewski, T. (1998). “Exoestrogens: Mechanisms of Action and Strategies
for Identification and Assessment.” Environ. Toxicol. Chem., 17(1), 3-14.
Gomez, V., Majamaa, K., Pocurull, E., and Borrull, F. (2012). “Determination and Occurrence of
Organic Micropollutants in Reverse Osmosis Treatment for Advanced Water Reuse.”
Water Sci. Technol., 66(1), 61-71.
Graves, M., Kruger, K., Watts, M., Cutright, J., and Jones, S. (2015). “Lawton Direct Potable
Reuse Feasibility Study.” Garver report as submitted to City Staff and Council.
Guillette, L., Crain, D., Rooney, A., and Pickford, D. (1995). “Organization versus Activation:
The Role of Endocrine Disruting Compounds (EDCs) During Embryonic Development in
Wildlife.” Environ. Health Perspect., 103(7), 157-164.

148

Harries, J., Sheahan, D., Jobling, S., Matthiessen, P., Neall, M., Sumpter, J., Taylor, T., and
Zaman, N. (1997). “Estrogenic Activity in Five United Kingdom Rivers Detected by
Measurement of Vitellogenesis in Caged Male Trout.” Enviro. Toxicl. Chem., 16(3), 534542.
Himstedt, H.; Marshall, K; and Wickramasinghe, S. (2011). “pH-responsive nanofiltration
membranes by surface modification.” J. Membr. Sci., 366(1), 373-381.
Holbrook, R.D., Novak, J.T., Grizzard, T.J., and Love, N.G. (2002). “Estrogen Receptor Agonist
Fate during Wastewater and Biosolids Treatment Processes: A Mass Balance Analysis.”
Environ. Sci. Technol., 36, 4533-4539.
Howe, K., and Clark, M. (2002). “Fouling of microfiltration and ultrafiltration membranes by
natural waters.” Environ. Sci. Technol., 36(16), 3571-3576.
Johnson, A., and Sumpter, J. (2001). “Removal of Endocrine-Disrupting Chemicals in Activated
Sludge Treatment Works.” Environ. Sci. Technol., 35(24), 4967-4703.
Jones, S., and Sober, J. (2014). “Membrane Separation Technology for Direct Potable Reuse.”
Proc., Texas WateReuse Symposium. WateReuse, Alexandria, VA.
Jones, S., Kruger, K., and Mullins, K. (2014). “Big Spring Series UF/NF Membrane Plant
Handles Hardness and Blending Objectives Cost Effectively.” American Membrane
Technology Association Solutions, 53(1), 12-17.
Jones, S., and Kruger, K. (2013). “Big Spring Series UF/NF Membrane Design Objectives.”
Proc., American Membrane Technology Conference & Exposition, American Membrane
Technology Association, Stuart, Florida, and American Water Works Association,
Denver, CO.
Jones, S. (1990). “Volatile Organic Chemical Removal from Arkansas River Water by Granular
Activated Carbon Adsorption and Ozone Oxidation.” Master of Science Civil
Engineering Thesis, University of Arkansas, Fayetteville, AR.
Jonsson, G. (1985). “Molecular Weight Cut-off Curves for Ultrafiltration Membranes of Varying
Pore Sizes.” Proceedings of Symposium on Membrane Technology. Desalination, 53(13), 3-10.
Kimura, K., Amy, G., Drewes, J., Heberer, T., Kim, T., and Watanabe, Y. (2003). “Rejection of
Organic Micropollutants (disinfection by-products, endocrine disrupting compounds, and
pharmaceutically active compounds) by NF/RO Membranes.” J. Membr. Sci., 227(1-2),
113–121.
Kolpin, D., Furlong, E., Meyer, M., Thurman, E., Zaugg, S., Barber, L., and Buxton, H. (2002).
“Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S.
Streams, 1999–2000: A National Reconnaissance.” Environ. Sci. Technol., 36(6), 12021211.
149

Kreuzinger, M., Clara, M., Strenn, B., and Kroiss, H. (2004). “Relevence of the Sludge Retention
Time (SRT) as Design Criteria for Wastewater Treatment Plants for the Removal of
Endocrine Disruptors and Pharmaceuticals from Wastewater.” Water Sci. Technol., 50(5),
149-156.
Kruger, K., Cutright, J., Watts, M., Graves, M., and Jones, S. (2013). “Norman WRRF
Improvements Preliminary Engineering Report.” Garver document as submitted to and
approved by ODEQ.
Lauer, W. (1993). “Denver’s direct potable water reuse demonstration project final report.”
Denver Water Department, Denver, CO.
Leatherland, J. (1993). “Field Observations on Reproduction and Developmental Dysfunction
Introduced in Native Trout and Salmonoids from the Great Lakes.” J. Great Lakes Res.,
19(4), 737-751.
Lee, B., and Richards, F. (1971). “The Interpretation of Protein Structures: Estimation of Static
Accessibility.” J. Mol. Biol., 55(3), 379–400.
Lee, Y.M., Oleszkiewicz, J.A., and Cicek, N. (2003). “Fate of Pharmaceuticals and Endocrine
Disruptors in Municipal Wastewater Treatment Facilities: Methodology for Assessment
of Environmental Levels”. Proc., 3rd International Conference on Pharmaceuticals and
Endocrine Disrupting Chemicals in Water, National Groundwater Association,
Westerville, OH.
Lemanik, S., Spring, A., Andrews, R. Yang, P., and Bagely, D. (2007). “Removal of Endocrine
Disrupting Compounds using a Membrane Bioreactor and Disinfection.” J. Environ. Eng.
Sci., 6(2), 131-137.
Li, C., and Colosi, L. (2012). “Molecular Similarity Analysis as a Tool to Prioritize Research
Among Emerging Contaminants in the Enviroment.” Sep. Purif. Technol., 84(9), 22-28.
Li, X., Chen, J., Zhang, L., Qiao, X., and Huang, L. (2006). “The Fragment Constant Method for
Predicting Octanol-Air Partition Coefficients of Persistent Organic Pollutants at Different
Temperatures.” J. Phys. Chem. Ref. Data, 35(3), 1365-1366.
Lin, S., Sicairos, S., and Navarro, R. (2007). “Preparation, characterization and salt rejection of
negatively charged polyamide nanofiltration membranes.” J. Mex. Chem. Soc., 51(3),
129-135.
Lin, Y., and Chung-Hsiang, L. (2014). “Elucidating the Rejection Mechanisims of PPCPs by
Nanofiltration and Reverse Osmosis Membranes.” Ind. Eng. Chem. Res., 53(16), 67986806.

150

Linden, K., Salveson, A., and Thurston, J. (2012). “Study of Innovative Treatments for
Reclaimed Water.” WateReuse Research Foundation, Southwest Florida Water
Management District, US Bureau of Reclamation, City of Phoenix, Los Angeles County
Sanitation District, and Dublin San Ramon Services District. WRF-02-009. Alexandria,
VA. ISBN 978-1-934183-54-0.
Loh, S., Beuscher, U., Poddar, T., Porter, A., Wingard, J., Husson, S., and Wickramasinghe, S.
(2009). “Interplay among membrane properties, protein properties and operating
conditions on protein fouling during normal-flow microfiltration.” J. Membr. Sci., 332(1),
93-103.
Luo, Y., Guo, W., Ngo, H., Nghiem, L., Faisal, I., and Zhang, J. (2014). “A Review on the
Occurrence of Micropollutants in the Aquatic Environment and their Fate and Removal
during Wastewater Treatment.” Sci. Total Environ., 473-474, 619-641.
Mac, M., Schwartz, T., Edsall, C., and Frank, A. (1993). “Polychlorinated Biphenyls in Great
Lakes Trout and their Eggs: Relations to Survival and Congener Composition 19791988.” J. Great Lakes Res., 19(4), 752-765.
Mac, M., and Edsall, C. (1991). “Environmental Contaminants and the Reproductive Success of
Lake Trout in the Great Lakes: an Epidemiological Approach.” J. Toxicol. Environ.
Health, 33(4), 375-394.
Majewska-Nowak, K., Kabsch-Korbutowicz, M., Dodz, M., and Winnicki, T. (2002). “The
Influence of Organic Carbon Concentration on Atrazine Removal by UF Membranes.”
Desalination, 147, 117-122.
McDonald, E., Nellor, M., Trussell, S., Drewes, J., Duranceau, S., Lawler, D., Snyder, S., and
Tchobanoglous, G. (2015). Final Report: Direct Potable Reuse Resource Document.
Texas Water Development Board, Austin, Texas. TWDB 1248321508 v.1.
MDH (Minnesota Department of Health). (2015). “Human Health-Based Water Guidance
Table.” Webpage posted by MDH. Minneapolis, MN.
<http://www.health.state.mn.us/divs/eh/risk/guidance/gw/table.html> (September 2015).
Miller, K., and Savchik, J. (1979). “A New Empirical Method to Calculate Average Molecular
Polarizabilities.” Journal of American Chemical Society, 101(24), 7206-7213.
Mohammed, A., and Ali, N. (2002). “Understanding the Steric and Charge Contributions in NF
Membranes using Increasing MWCO Polyamide Membranes.” Desalination, 147, 205212.
Mohammad, A., Teow, Y., Ang, W., Chung, Y., Oatley-Radcliffe, D., and Hilal, N. (2015).
“Nanofiltration Membranes Review: Recent Advances and Future Prospects.”
Desalination, 356, 226-254.

151

MPCA (Minnesota Pollution Control Agency). (2015). “Pharmaceuticals, Personal Care
Products, and Endocrine Active Chemical Monitoring in Lakes and Rivers: 2013.”
Doc.No.tdr-g1-18. Saint Paul, MN.
Musale, D., and Kulkarni, S. (1997). “Relative rates of protein transmission through poly
(acrylonitrile) based ultrafiltration membranes.” J. Membr. Sci., 136(1), 13-23.
Nellor, M., Baird, R., and Smyth, J. (1985). “Health effects of indirect potable reuse.” J.
American Water Works Association, 77, 88-96.
Ngheim, L., Schafer, A., and Elimelech, M. (2004). “Removal of Natural Hormones by
Nanofiltration Membranes: Measurements, Modeling, and Mechanisms.” Environ. Sci.
Technol., 38, 1888-1896.
Nghiem, L., Manis, A., Soldenhoff, K., and Schafer, A. (2004). “Estrogenic Hormone Removal
from Wastewater using NF/RO Membranes.” J. Membr. Sci., 242, 37-45.
Ngheim, L., Schafer, A., and Waite, T. (2002). “Adsorption of Estrone on NF and RO
Membranes in Water and Wastewater Treatment.” Water Sci. Technol., 46, 265-272.
Nix, D., and Schreiber, R. (2015). “Keep it Coming! Extending DPR in Wichita Falls.” Proc.,
WateReuse Texas Annual Conference, Austin, TX.
NMED (New Mexico Environment Department. (2007). “Ground Water Quality Bureau
Guidance: Above Ground Use of Reclaimed Domestic Wastewater.”
<https://www.env.nm.gov/gwb/documents/NMED_REUSE_1-24-07.pdf> (March 2015).
NMED (New Mexico Environment Department). (2014). “Capital Outlay: Review of Select
Water Projects.” Report to Legislative Finance Committee by Office of the State
Engineer. Report #14-12: 23-27.
NRC (National Research Council). (2012). Water Reuse: Potential for Expanding the Nation’s
Water Supply through Reuse of Municipal Wastewater. The National Academies Press,
Washington, DC, 262.
NWRI (National Water Research Institute). (2013). “Examining the Criteria for Direct Potable
Reuse.” Independent Advisory Panel Final Report. WateReuse Research Foundation
Project No. 11-02. National Water Research Institute, Fountain Valley, CA.
ODEQ (Oklahoma Department of Environmental Quality). (2015). “Regulatory Path Forward for
Direct and Indirect Potable Reuse of Reclaimed Water.” ODEQ Water Quality Standards
and Technical Committees in conjunction with Oklahoma Water Resources Board,
Oklahoma Water Survey, and University of Oklahoma. Presented to Oklahoma State
Legislature, July 2015. Oklahoma City, OK.

152

Oppenheimer, J., Eaton, A., Badruzzaman, M., Haghani, A., and Jacangelo, J. (2011).
“Occurrence and Suitability of Sucralose as an Indicator Compound of Wastewater
Loading to Surface Waters in Urbanized Regions.” Water Res., 45(13), 4019-4027.
Ozaki, H., Ikejima, N., Shimizu, K., Fukami, S., Taniguchi, R., Giri, R., and Matsui, S. (2008).
“Rejection of Pharmaceuticals and Personal Care Products (PPCPs) and Endocrine
Disrupting Chemicals (EDCs) by Low Pressure Reverse Osmosis Membranes.” Water
Sci. Technol., 58(1),73-81.
Peakall, D., and Fox, G. (1987). “Toxicological Investigations of Pollutant-Related Effects in
Great Lakes Gulls.” Environ. Health Perspect., 71,187-193.
Pelley, J. (2014). “How Best to Treat Microconstituents.” Water Environment Federation
Journal: Water Environment & Technology, 26(4), 18-22.
Plakas, K., and Karabelas, A. (2012). “Removal of Pesticides from Water by NF and RO
Membranes.” Desalination, 287, 255-265.
Purdom, C., Hardiman, P., Bye, V., Eno, N., Tyler, C., and Sumpter, J. (1994). “Estrogenic
Effects of Effluents from Sewage Treatment Works.” Chem. Ecol., 8(4), 275-285.
Rattier, M., Reungoat, J., Keller, J., and Gernjak, W. (2014). “Removal of Micropollutants
during Tertiary Wastewater Treatment by Biofiltration: Role of Nitrifiers and Removal
Mechanisms.” Water Res., 54, 89-99.
Rodgers-Gray, T., Jobling, S., Morris, S., Kelly, C., Kirby, S., Janbakhsh, A., Harries, J.,
Waldock, M., Sumpter, J., and Tyler, C. (2000). “Long-Term Temporal Changes in the
Estrogenic Composition of Treated Sewage Effluent and Its Biological Effects on Fish.”
Environ. Sci. Technol., 34, 1521-1528.
Rodriguez, C., Buynder, P., Lugg, R., Blair, P., Devine, B., Cook, A., and Weinstein, P. (2009).
“Indirect Potable Reuse: A Sustainable Water Supply Alternative.” Int. J. Environ. Res.
Public Health, 6(3), 1174-1209.
Rice, E., and Bridgewater, L. (2012). Standard Methods for the Examination of Water and
Wastewater, 22nd Edition. American Public Health Association, American Water Works
Association, Water Environment Federation.
Ryan, S. (2016). “Europe moves forward on water reuse.” Water Reuse & Desalination, 7(1), 1113.
Salveson, A., Steinle-Darling, E., and Sutherland, J. (2016). “Sampled Direct Potable Reuse
Water Shows Promising Results.” Opflow, 42(2), 20-22.

153

Sanches, S., Galinha, C., Crespo, M., Pereira, V., and Crespo, J. (2013). “Assessment of
Phenomena Underlying the Removal of Micropollutants during Water Treatment by
Nanofiltration using Multivariate Statistical Analysis.” Sep. Purif. Technol., 118, 377386.
Schafer, A., Nghiem, L., and Waite, T. (2003). “Removal of Natural Hormone Estrone from
Aqueous Solutions using Nanofiltration and Reverse Osmosis.” Environ. Sci. Technol.,
37, 182-188.
Schafer, A., Ngheim, L., and Waite, T. (2001). “Removal of Natural Hormone Estrone from
Secondary Effluent and Natural Water Using Membranes.” Proc., Membrane Technology
for Wastewater Reclamation and Reuse Conference, Tel Aviv, Israel.
Schwarzenbach, R., Gschwend, P., and Imboden, D. (2003). Environmental Organic Chemistry,
2nd Edition, J.Wiley & Sons, Inc. Hoboken, NJ.
Seader, J., Henley, J., and Roper, D. (2011). Separation Process Principles, 3rd Edition, J.Wiley
& Sons, Inc. New York, NY.
Shahmansouri, A., and Bellona, C. (2013). “Application of Quantitative Structure-Property
Relationships (QSPRs) to Predict the Rejection of Organic Solutes by Nanofiltration.”
Sep. Purif. Technol., 118, 627-638.
Shrake, A., and Rupley, J. (1973). “Environment and Exposure to Solvent of Protein Atoms:
Lysozyme and Insulin.” J. Mol. Biol., 79(2), 351–371.
Silva, A., Amador, J., Cherchi, C., Miller, S., Morse, A., Pellegrin, M., and Wells, M. (2013).
“Emerging Pollutants – Part 1: Occurrence, Fate and Transport.” Water Environ. Res.,
85(10), 1978-2021.
Sloan, D. (2013). “Implementing Direct Potable Reuse – Extending our Water Frontier.” Proc.,
Joint Conference of Texas AWWA: Water Environment Association of Texas; and Water
Reuse Texas, Austin, TX.
Snyder, S., Westerhoff, P., Yoon, Y., and Sedlak, D. (2005). “Pharmaceuticals, Personal Care
Products, and Endocrine Disrupters in Water: Implications for the Water Industry.”
Environ. Eng. Sci., 20(5), 449-469.
Snyder, S., Vanderford, B., Adham, S., Oppenheimer, J., Gillogly, T., Bond, R., and
Veerapaneni, V. (2004). “Pilot Scale Evaluations of Membranes for the Removal of
Endocrine Disruptors and Pharmaceuticals.” Proc., AWWA Water Quality and
Technology Conference, Denver, CO.
Snyder, S., Vanderford, B., Pearson, R., Quinones, O., and Yoon, Y. (2003). “Analytical
Methods Used to Measure Endocrine Disrupting Compounds in Water.” Pract. Period.
Hazard. Toxic Radioact. Waste Manage., 7(4), 224-234.
154

Sober, J. (2016). Anecdotal report regarding operation of the Garland, Texas Rowlett Water
Resource Recovery Facility.
Spellman, F. (2014). Personal Care Products and Pharmaceuticals in Wastewater and the
Environment, DEStech Publications, Inc., Lancaster, PA.
Steering Committee on Arizona Potable Reuse (SCAPR). (2013). “The Future of Potable Reuse
in Arizona: A Changing Conversation.” Proc., WateReuse Arizona and Arizona
Municipal Water Users Association Conference, WateReuse Arizona and Arizona
Municipal Water Users Association, Phoenix, AZ.
Tchobanoglous, G., Cotruvo, J., Crook, J., McDonald, E., Olivieri. A., Salveson, A., and
Trussell, S. (2015). “Framework for Direct Potable Reuse.” WateReuse Research
Foundation (WRF), National Water Research Institute (NWRI), American Water Works
Association (AWWA), Water Environment Federation (WEF), Alexandria, VA.
Tchobanoglous, G., Stensel, D., Tsuchihashi, R., and Burton, F. (2014). Wastewater
Engineering: Treatment and Resource Recovery, 5th Edition, Metcalf & Eddy/AECOM,
McGraw Hill, New York, NY.
Tirosh, U., and Eting, S. (2016). “Israel’s journey to reusing 78 percent of wastewater.” Water
Reuse & Desalination, 7(1), 14-16.
Tisdale, R. (2015). “U.S. Municipal Wastewater Reuse: Opportunities and Forecasts, 20152025.” International Desalination Association. 6(15): 14-18.
Tu, K., Chivas, A., and Nghiem, L. (2015). “Chemical Cleaning Effects on Properties and
Separation Efficiency of an RO Membrane.” Membrane Water Treatment, 6(2), 141-160.
TWDB (Texas Water Development Board). (2015). “Final Report: Direct Potable Reuse
Resource Document.” API. TWDB Contract No. 1248321508. Austin, TX.
Van der Bruggen, B., Braeken, L., and Vandecasteele, C. (2002). “Evaluation of Parameters
Describing Flux Decline in Nanofiltration of Aqueous Solutions Containing Organic
Compounds.” Desalination, 147, 281-288.
Vanderford, B., Drewes, J., Jones, C., Eaton, A., Haghani, A., Guo, Y., Snyder, S., Ternes, T.,
Schluesner, M., and Wood, C. (2012). Evaluation of Analytical Methods for EDCs and
PPCPs Via Interlaboratory Comparison [Project #4167], Water Research Foundation,
Denver, CO.
VDEQ (Virginia Department of Environmental Quality). (2008). “Water Reclamation and Reuse
Regulation.” Virginia Administrative Code, Agency 25, Chapter 740.
<http://lis.virginia.gov/000/reg/TOC09025.HTM#C0740> (March 22, 2015).

155

Washington State Legislature. (2007). “Reclaimed Water Use.” Revised Code of Washington.
Chapter 90, Section 46. Olympia, Washington.
<http://app.leg.wa.gov/RCW/default.aspx?cite=90.46> (March 22, 2015).
WEF (Water Environment Federation). (2014). “Changing The Terms.” reported action of the
WEF Board of Trustees. Alexandria, VA. <http://news.wef.org/changing-the-terms/>
(April 24, 2016).
Watts, M., Sloan, D., Rosenfeldt, E., and Jones, S. (2016). “The Impact of Upstream Treatment
on the Effectiveness of HOCl/UV and H2O2/UV AOPs for Potable Reuse.” Proc., 20th
Annual WateReuse Research Conference, WateReuse, Arlington, VA.
Watts, M., and Linden, K. (2009). “Advanced Oxidation Kinetics of Aqueous Tri Alkyl
Phosphate Flame Retardants and Plasticizers.” Environ Sci. Technol., 43(8),2937-2942.
Westerhoff, P., Yoon, Y., Snyder, S., and Wert, E. (2005). “Fate of Endocrine Disruptor,
Pharmaceutical, and Personal Care Product Chemicals during Simulated Drinking Water
Treatment Processes.” Environ. Sci. Technol., 39(17), 6649-6663.
White, D., and Hoffman, D. (1995). “Effects of Polychlorinated Dibenzo-p-dioxins and
Dibenzofurans on Nesting Wood Ducks (Aix Sponsa) at Bayou Meto, Arkansas.”
Environ. Health Perspect., 103, 37-39.
Wickramasinghe, R. (2015). Test Membrane Properties – Lab Results. Membrane Applied
Science & Technology Research Center (MAST). Cato Springs Laboratory, University of
Arkansas, Fayetteville, AR.
Wickramasinghe, R., and Jones, S. (2013). “Treating Hydraulic Fracturing Flowback Waters:
Potential Membrane Applications.” American Institute of Chemical Engineering Broadcast Webinar. <http://www.aiche.org/academy/webinars/treating-hydraulicfracturing-flowback-waters> (April 24, 2016).
Williams, M., Hestekin, J., Smothers, C., and Bhattacharyya, D. (1999). “Separation of Organic
Pollutants by Reverse Osmosis and Nanofiltration Membranes: Mathematical Models and
Experimental Verification.” Ind. Eng. Chem. Res., 38(10), 3683-3695.
Wintgens, T., Gallenkemper, M., and Melin. (2002). “Endocrine Disruptor Removal from
Wastewater using Membrane Bioreactor and Nanofiltration Technology.” Desalination,.
146, 387-391.
Wren, C. (1991). “Cause-Effect Linkages bewteen Chemicals and Populations of Mink and Otter
in the Great Lakes Basin.” J. Toxicol. Environ. Health, 33(4), 549-585.
Xu, Y., and Lebrun, R. (1999). “Investigation of the solute separation by charged nanofiltration
membrane: effect of pH, ionic strength and solute type.” J. Membr. Sci., 158(1), 93-104.

156

Yangali-Quintanilla, V., Sung, K., Takahiro, F., Kennedy, M., Li, Z., Amy, G. (2011).
“Nanofiltration vs. Reverse Osmosis for the Removal of Emerging Organic
Contamininats in Water Reuse.” Desalin. Water Treat., 34, 50-56.
Yangali-Quintanilla, V. (2010). “Rejection of Emerging Organic Conatminants by NF and RO
Membranes: Effects of Fouling, Modeling, and Water Reuse.” Dissertation submitted in
fullfillment of the requirements of Board of Doctorates of Delft University of
Technology. Delft, the Netherlands.
Yoon, Y., Westerhoff, P., Snyder, S., Wert, E. (2006). “Nanofiltration and Ultrafiltration of
Endocrine Disrupting Compounds, Pharmaceuticals and Personal Care Products.” J.
Membr. Sci.. 270, 88-100.
Yoon, Y., Westerhoff, P., Snyder, S., Wert, E., Yoon, J. (2007). “Removal of Endocrine
Disrupting Compounds and Pharmaceuticals by Nanofiltration and Ultrafiltration
Membranes.” Desalination, 202, 16-23.
Zhang, W., Wickramasinghe, R., Qian, X., Martin, J., Eswaranandam, S. (2014). “Removal of
Endocrine Disruptors from Wastewater Stream.” Proc., Membrane Applied Science &
Technology NSF IAB Conference, National Science Foundation, Arlington, VA.
Zwijnenberg, H.; Dutczak, S.; Boerrigter, M.; Hempenius, M.; Luiten-Olieman, M.; Benes, N.;
and Stamatialis, D. (2012). “Important factors influencing molecular weight cut-off
determination of membranes in organic solvents.” J. Membr. Sci., 390, 211-217.

157

APPENDIX A
A-1: Recommended CEC Control Indicators for DPR Systems
A-2: UCMR3 NCOD Summary
A-3: USEPA Draft CCL4 List of 100
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Table A-1: Recommended CEC Control Indicators for DPR Systems
CEC

Criterion

Atazine

3 ug/L

2,4-D
(dichlorophenooxyacetic)

70 ug/L

Methoxychlor

40 ug/L

Simazine

4 ug/L

Rationale

NPDWS MCL

Perfluorooctanoic acid

0.4 ug/L

Perfluorooctane sulfonate

0.2 ug/L

U.S. EPA health
advisory

Perchlorate

6 ug/L

CDPH MCL

1,4-Dioxane

1 ug/L

CSWRCB
notification

None yet, but MCL
will approach MRL
(low ng/L)

Evaluate presence
in source water

Ethinyl estradiol
17β-estradiol
Cotinine

1 ug/L

Primidone

10 ug/L

Phenyltoin

2 ug/L

Meprobamate

200 ug/L

Surrogate for low
MW CECs

Atenolol

4 ug/L

Occurs frequently at
ng/L level

Carbamazepine

10 ug/L

Unique structure

Estrone

320 ng/L

Sucralose
Tris (2-Carboxyethyl
phosphine) hydrochloride
N,N-diethyl-metatoluamide
Triclosan

150,000 ug/L
5 ug/L
200 ug/L
2,100 ug/L

Surrogate for
steroids
Surrogate for
neutral solutes w/
moderate MW
MDH 2015
guidance value
NRC 2012 riskbased action level

Source: WRRF 2015; NWRI 2013
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Table A-2: UCMR3 NCOD Summary (U.S. EPA, June 2015)
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Table A-3: Draft CCL4 – Chemical Contaminant List
Compound

CASRN

Compound

CASRN

630-20-6

Captan

133-06-2

75-34-3

Chlorate

1,2,3-Trichloropropane

96-18-4

Chloromethane

1,3-Butadiene

106-99-0

Clethodim

1,4-Dioxane

123-91-1

7440-48-4

17 alpha-Estradiol

57-91-0

1-Butanol

71-36-3

Cobalt
Cumene
hydroperoxide
Cyanotoxins

2-Methoxyethanol

109-86-4

Dicrotophos

141-66-2

2-Propen-1-ol

107-18-6

Dimethipin

55290-64-7

16655-82-6

Disulfoton

298-04-4

Diuron

330-54-1

Equilenin

517-09-9

1,1,1,2Tetrachloroethane
1,1-Dichloroethane

3-Hydroxycarbofuran
4,4-Methylenedianiline
Acephate

107-77-9
30560-19-1

14866-68-3
74-87-3
110429-62-4

80-15-9
N/A

Acetaldehyde

75-07-0

Equilin

474-86-2

Acetamide

60-35-5

Erythromycin

114-07-8

Acetochlor

34256-82-1

Estradiol

50-28-2

ESA acid

187022-11-3

Estriol

50-27-1

Acetochlor OA acid

194992-44-4

Estrone

53-16-7

Ethinyl Estradiol

57-63-6

Acrolein

107-02-8

Alachlor ESA acid

142363-53-9

Ethoprop

Alachlor OA acid
alphaHexachlorocyclohexane
Aniline

171262-17-2

Ethylene glycol

107-21-1

319-84-6

Ethylene oxide

75-21-8

62-53-3

Ethylene thiourea

96-45-7

Bensulide

741-58-2

Fenamiphos

Benzyl chloride
Butylated
hydroxyanisole

100-44-7

Formaldehyde

2501316-5

Germanium

13194-48-4

22224-92-6
50-00-0
7440-56-4
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Table A-3: Draft CCL4 – Chemical Contaminant List (Cont.)
Compound

CASRN

Compound

CASRN

Halon 1011

74-97-5

n-Propylbenzene

103-65-1

HCFC-22

75-45-6

o-Toluidine

95-53-4

Hexane

110-54-3

75-56-9

Hydrazine

302-01-2

Manganese

7439-96-5

Oxirane, methylOxydemetonmethyl
Oxyfluorfen

42874-03-3

Mestranol

72-33-3

PFOS

1763-23-1

10265-92-6

PFOA

335-67-1

Methamidophos

301-12-2

Methanol

67-56-1

Permethrin

52645-53-1

Methyl bromide

74-83-9

Profenofos

41198-08-7

MTBE

1634-04-4

Quinoline

91-22-5

Metolachlor

51218-45-2

RDX

121-82-4

Metolachlor ESA acid

171118-09-5

sec-Butylbenzene

135-98-8

Metolachlor OA acid

152019-73-3

Tebuconazole

107534-96-3

Molinate

2212-67-1

Tebufenozide

112410-23-8

Molybdenum

7439-98-7

Tellurium

13494-80-9

Nitrobenzene

98-95-3

Thiodicarb

59669-26-0

Nitroglycerin

55-63-0

23564-05-8

N-Methyl-2-pyroidone

872-50-4

NDEA

55-18-5

Thiophonate-methyl
Tolulene
diisocyanate
Tribufos

NDMA

62-75-9

Triethylamine

121-44-8

NDPA

621-64-7

TPTH

76-87-9

N-Nitrosodimethylamine

86-30-6

Urethane

51-79-6

NPYR

930-55-2

Vanadium

7440-62-2

25154-52-3

Vinclozolin

50471-44-8

Nonylphenol
Norethindrone

68-22-4

Ziram

26471-62-5
78-48-8

137-30-4

Source: Federal Register, Vol.80, No.23, Wed, February 4, 2015
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APPENDIX B
Exhibit B-1: WRRF Operational Data
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Exhibit B-4: Sample Shipping Destinations
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Exhibit B-8: Eurofins Eaton Analytical Certifications
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Exhibit B-1: WRRF Operational Data
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Exhibit B-2: Sample Naming Convention
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Exhibit B-3: Laboratory Sampling and Packaging Instructions
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Exhibit B-3: Laboratory Sampling and Packaging Instructions (Cont.)
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Exhibit B-3: Laboratory Sampling and Packaging Instructions (Cont.)
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Exhibit B-3: Laboratory Sampling and Packaging Instructions (Cont.)
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Exhibit B-4: Sample Shipping Destinations
Osmonics Membrane Test Samples:
GE Osmonics Water & Process Technologies
5951 Clearwater Drive
Minnetonka, MN 55343

Eurofins Laboratory Analysis Samples Destination:
Eurofins Eaton Analytical, Inc.
750 Royal Oaks Drive,
Monrovia, CA 91016
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Exhibit B-5: Nanofiltration (NF) Membrane (DK) Manufacturer Data Sheet
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Exhibit B-5: Nanofiltration (NF) Membrane (DK) Manufacturer Data Sheet (Cont.)
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Exhibit B-6: Reverse Osmosis (RO) Membrane (AG) Manufacturer Data Sheet
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Exhibit B-6: Reverse Osmosis (RO) Membrane (AG) Manufacturer Data Sheet (Cont.)
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Exhibit B-7: UA MAST Lab Results – Test Membrane Properties
a) AFM
1. DK (NF)

b) Contact Angle
c) Surface Zeta Potential
a) AFM

2. AG (RO)

b) Contact Angle
c) Surface Zeta Potential

1) DK – Nanofiltration Membrane
a) Atomic Force Microscopy (AFM)

Area
Size of measurement
2 μm
Normal (gray)
1 μm
500 nm
2 μm
Purple
1 μm
500 nm

Roughness, Rq (nm)
4.1
5.03
3.81
12.1
10.5
7.12
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Exhibit B-7: UA MAST Lab Results – Test Membrane Properties (Cont.)
Normal Area
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Exhibit B-7: UA MAST Lab Results – Test Membrane Properties (Cont.)
Purple Area
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Exhibit B-7: UA MAST Lab Results – Test Membrane Properties (Cont.)
b) Contact Angle (~20-25°)

c) Surface Zeta Potential

DK membrane
Surface Zeta potential (mV)

20
15
10
5
0
-5

0

2

4

6

8

10

12

-10
-15
-20

pH
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Exhibit B-7: UA MAST Lab Results – Test Membrane Properties (Cont.)
2) AG – Reverse Osmosis Membrane
a) Atomic Force Microscopy (AFM)

Area
Flat (gray)

Stripe

Size of measurement
2 μm
1 μm
500 nm
2 μm
1 μm
500 nm

Roughness, Rq (nm)
7.66
5.69
3.31
28.3
9.81
6.03
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Exhibit B-7: UA MAST Lab Results – Test Membrane Properties (Cont.)
Flat area (gray)
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Exhibit B-7: UA MAST Lab Results – Test Membrane Properties (Cont.)
Stripe area
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Exhibit B-7: UA MAST Lab Results – Test Membrane Properties (Cont.)
b) Contact Angle (~23-30°)

c) Surface Zeta Potential

AGM membrane
Surface Zeta potential (mV)

5
0
0

2

4

6

8

10

12

-5
-10
-15
-20
-25

pH
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Exhibit B-8: Eurofins Eaton Analytical Certifications
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Exhibit B-8: Eurofins Eaton Analytical Certifications (Cont.)

Certifications

Every assignment you entrust to us will be performed to the highest possible standards. Eaton
Analytical meets the stringent certification requirements in 50 states and territories, and is accredited
by the NELAC Institute (TNI) and ISO/IEC17025.
Each year our laboratories are audited by many organizations including the states in which we are
certified, as well as the American National Standards Institute, US Air Force, US Army Public Health
Command, and the United States Environmental Protection Agency.
For a copy of our current certification in a particular state, please look at the list of states and
territories. Click on a link in the list to download the information in Adobe Acrobat (PDF) format.

Monrovia, CA

South Bend, IN

•

Alabama.pdf

•

Alabama.pdf

•

Arizona.pdf

•

Alaska.pdf

•

Arkansas.pdf

•

Arizona.pdf

•

California.pdf

•

Arkansas.pdf

•

Colorado.pdf

•

California.pdf

•

Connecticut.pdf

•

Colorado Radiochemistry.pdf

•

Delaware.pdf

•

Colorado.pdf

•

Florida.pdf

•

Connecticut.pdf

•

Georgia.pdf

•

Delaware.pdf

•

Hawaii LT2.pdf

•

Florida.pdf

•

Hawaii.pdf

•

Georgia.pdf
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•

Idaho.pdf

•

Hawaii.pdf

•

Illinois.pdf

•

Idaho.pdf

•

Indiana.pdf

•

Illinois Micro.pdf

•

Kansas.pdf

•

Illinois.pdf

•

Kentucky.pdf

•

Indiana Micro.PDF

•

Louisiana.pdf

•

Indiana.pdf

•

Maine.pdf

•

Iowa.pdf

•

Maryland.pdf

•

Kansas.pdf

•

Massachusetts.pdf

•

Kentucky.pdf

•

Michigan.pdf

•

Louisiana.pdf

•

Mississippi.pdf

•

Maine.pdf

•

Montana.pdf

•

Maryland.pdf

•

Nebraska.pdf

•

Massachusetts.pdf

•

Nevada.pdf

•

Michigan.pdf

•

New Hampshire.pdf

•

Minnesota.pdf

•

New Jersey.pdf

•

Mississippi.pdf

•

New Mexico.pdf

•

Missouri.pdf

•

New York.pdf

•

Montana.pdf

•

North Carolina.pdf

•

Nebraska.pdf

•

North Dakota.pdf

•

Nevada.pdf

•

Oregon.pdf

•

New Hampshire.pdf

•

Pennsylvania.pdf

•

New Jersey.pdf

•

Puerto Rico.pdf

•

New Mexico.pdf

•

Rhode Island.pdf

•

New York.pdf

•

South Carolina.pdf

•

North Carolina.pdf

•

South Dakota.pdf

•

North Dakota.pdf

•

Tennessee.pdf

•

Ohio.pdf

•

Texas.pdf

•

Oklahoma.pdf

•

Utah.pdf

•

Oregon.pdf

•

Vermont.pdf

•

Pennsylvania.pdf

•

Virginia.pdf

•

Puerto Rico.pdf

•

Washington.pdf

•

Rhode Island.pdf

•

Wisconsin.pdf

•

South Carolina.pdf

•

Wyoming.pdf

•

South Dakota.pdf
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•

ALL EPA ICR Approval.pdf

•

UCMR Aeromonas Approval.pdf

•

Legionella Certificate.pdf

•

UCMR CLO4.pdf

•

UCMR2 Approval.pdf

•

ISO certificate of Accreditation.pdf

•

UCMR3 Approval.pdf

•

Soil Certificate.pdf

•

Fresno Service Center.pdf

•

Inland Empire Service Center.pdf

•

Sacramento Service Center.pdf

•

Monrovia ELAP.pdf

•

Monrovia NELAP.pdf

•

Tennessee.pdf

•

Texas.pdf

•

Utah.pdf

•

Vermont.pdf

•

Virginia.pdf

•

Washington.pdf

•

West Virginia.pdf

•

Wisconsin.pdf

•

Wyoming.pdf

•

UCMR3 - Approval.pdf

•

NELAP Approval.pdf
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Exhibit B-8b: EEA Sample Certifications – US EPA UCMR3, California, Texas
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Exhibit B-8b: EEA Sample Certifications – US EPA UCMR3, California, Texas (Cont.)
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Exhibit B-8b: EEA Sample Certifications – US EPA UCMR3, California, Texas (Cont.)
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APPENDIX C
Exhibit C-1: COK CEC Analytical Results
Exhibit C-2: SOK CEC Analytical Results
Exhibit C-3: NTX CEC Analytical Results
Exhibit C-4: Modeled Rejection Coefficients by CEC Analyte
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Exhibit C-1: COK CEC Analytical Results
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Exhibit C-2: SOK CEC Analytical Results
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Exhibit C-3: NTX CEC Analytical Results
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Exhibit C-4: Modeled Rejection Coefficients by CEC Analyte

Warfarin.n.1
X2.4.D.n.9
X4.nonylphenol..SQ..n.2
X4.tert.Octylphenol.n.3
Acesulfame.K.n.9
Acetaminophen.n.5
Albuterol.n.8
Amoxicillin..SQ..n.8
Atenolol.n.8
Atrazine.n.6
Azithromycin.n.9
BPA.n.4
Bromacil.n.1
Butalbital.n.6
Caffeine.n.8
Carbamazepine.n.9
Carisoprodol.n.5
Cimetidine.n.8
Clofibric.Acid.n.1
Cotinine.n.8
Cyanazine.n.1
DACT.n.5
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Note: If a sample was not detected (“ND”) in SE, it was not modeled and therefore not shown
below. Each analyte’s name is associated with an “n.#” where # indicates the data sample actual
size.

Rejection Coefficient

Rejection Coefficient

Exhibit C-4: Modeled Rejection Coefficients by CEC Analyte (Cont.)

1.0

0.8

0.6

0.4

0.2

0.0
DEA.n.7
DEET.n.8
Dehydronifedipine.n.3
DIA.n.7
Diazepam.n.1
Diclofenac.n.9
Dilantin.n.9
Diltiazem.n.9
Diuron.n.1
Erythromycin.n.1
Estrone.n.5
Fluoxetine.n.8
Gemfibrozil.n.9
Iohexal.n.8
Iopromide.n.4
Ketoprofen.n.2
Ketorolac.n.2
Lidocaine.n.9
Lincomycin.n.2
Linuron.n.1
Lopressor.n.9
Meprobamate.n.9
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Rejection Coefficient
1.0

Exhibit C-4: Modeled Rejection Coefficients by CEC Analyte (Cont.)

Theophylline.n.4
Triclocarban.n.8
Triclosan.n.9
Trimethoprim.n.8
Warfarin n:2

0.8

TCPP.n.9
TDCPP.n.9
Theobromine.n.6

0.6

Sulfathiazole.n.1
TCEP.n.9

0.4

Sulfadiazine.n.2
Sulfadimethoxine.n.1
Sulfamethoxazole.n.9

0.2

0.0
Metolachlor.n.1
Naproxen.n.9
Nifedipine.n.3
Pentoxifylline.n.1
Primidone.n.9
Quinoline.n.5
Simazine.n.7
Sucralose.n.9
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